var title_f28_46_29408="Dermatitis herpetiformis excoriated papules";
var content_f28_46_29408=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatitis herpetiformis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple excoriated papules and crusts are present near the elbow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29408=[""].join("\n");
var outline_f28_46_29408=null;
var title_f28_46_29409="Patient information: Androgens and other hormones to boost sports performance: Risks and side effects (The Basics)";
var content_f28_46_29409=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?17/26/17826\">",
"         Patient information: Growth hormone treatment (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Androgens and other hormones to boost sports performance: Risks and side effects (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H99569121\">",
"      <span class=\"h1\">",
"       What are androgens and other hormones to boost sports performance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Androgens are male sex hormones that are made naturally by the body.",
"     </p>",
"     <p>",
"      Testosterone is the most important androgen. It is the reason men have male sexual features, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hair on the body and face",
"       </li>",
"       <li>",
"        Large, strong muscles",
"       </li>",
"       <li>",
"        A deep, low voice",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Women also make testosterone but in much lower amounts than men.",
"     </p>",
"     <p>",
"      Androgens can also be made in a lab and are called &ldquo;synthetic androgens.&rdquo; They are also called &ldquo;anabolic steroids,&rdquo; or just &ldquo;steroids.&rdquo;",
"     </p>",
"     <p>",
"      Doctors sometimes prescribe testosterone to men whose bodies don&rsquo;t make enough. It is taken as an injection (shot), as a patch placed on the skin, or a gel rubbed into the skin.",
"     </p>",
"     <p>",
"      Some people (mostly men, but sometimes women) take androgens or other hormones to build up their muscles and perform better in sports. But there are some serious side effects to people who do this.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H99569136\">",
"      <span class=\"h1\">",
"       What are the different types of androgens and other hormones to boost sports performance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Androgens and other hormones to boost sports performance include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Testosterone &ndash; This is the main androgen made by the body. Doctors agree that it is safe to give testosterone to men who cannot make a normal amount of testosterone on their own. For men with normal testosterone levels, taking extra hormone might help sports performance a little bit. But it can be also harmful.",
"       </li>",
"       <li>",
"        Synthetic androgens &ndash; These include stanozolol and nadrolone, which come in pills.",
"       </li>",
"       <li>",
"        Chemicals that change into androgens in the body &ndash; These include androstenedione (also called &ldquo;andro&rdquo;) and DHEA. Androstenedione used to be sold as an over-the-counter pill. But it is now prescription-only. There is no proof that it makes your muscles stronger. DHEA pills are sold over-the-counter.",
"       </li>",
"       <li>",
"        Chemicals that help to body make more testosterone &ndash; One example is",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?5/28/5574?source=see_link\">",
"         tamoxifen",
"        </a>",
"        , a pill that blocks the female hormone estrogen. Another is human chorionic gonadotropin (also called hCG), a hormone women&rsquo;s bodies make when they are pregnant.",
"       </li>",
"       <li>",
"        Growth hormone &ndash; This hormone normally helps the body grow and build muscle. Doctors prescribe it to people who don&rsquo;t make enough of it. But people who have normal amounts of growth hormone sometimes take extra to try to boost their performance. There is no proof that this works, and it can be harmful.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H99569153\">",
"      <span class=\"h1\">",
"       What are the risks and side effects of steroids to boost sports performance?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Androgens can cause the following side effects:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Liver problems",
"       </li>",
"       <li>",
"        Mood problems, such as being aggressive",
"       </li>",
"       <li>",
"        Too many red blood cells and a higher-than-normal risk of blood clots",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In men, androgens cause the testes to stop making natural testosterone and sperm. They also cause men&rsquo;s breasts to grow (called &ldquo;gynecomastia&rdquo;).",
"     </p>",
"     <p>",
"      In women, androgens cause a deep voice and hair growth on the face and other parts of the body.",
"     </p>",
"     <p>",
"      In teenagers, androgens can cause the ends of certain bones to fuse together earlier than normal.",
"     </p>",
"     <p>",
"      In men, hCG and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?5/28/5574?source=see_link\">",
"       tamoxifen",
"      </a>",
"      can cause the breasts to swell and grow larger.",
"     </p>",
"     <p>",
"      Growth hormone has many side effects, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Diabetes",
"       </li>",
"       <li>",
"        High blood pressure",
"       </li>",
"       <li>",
"        An enlarged heart",
"       </li>",
"       <li>",
"        Hand swelling",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H99569168\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/26/17826?source=see_link\">",
"       Patient information: Growth hormone treatment (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?28/46/29409?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86461 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-29E1B55F6D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29409=[""].join("\n");
var outline_f28_46_29409=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99569121\">",
"      What are androgens and other hormones to boost sports performance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99569136\">",
"      What are the different types of androgens and other hormones to boost sports performance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99569153\">",
"      What are the risks and side effects of steroids to boost sports performance?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99569168\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/26/17826?source=related_link\">",
"      Patient information: Growth hormone treatment (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29410="Patient information: HELLP syndrome (The Basics)";
var content_f28_46_29410=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?16/21/16723\">",
"         Patient information: C-section (cesarean delivery) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/32/7682\">",
"         Patient information: High blood pressure and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/53/28498\">",
"         Patient information: Preeclampsia (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?39/58/40867\">",
"         Patient information: Preeclampsia (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: HELLP syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hellp-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H15139976\">",
"      <span class=\"h1\">",
"       What is HELLP syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;HELLP syndrome is a serious condition some women get when they are pregnant. It can cause pain in the upper belly and other symptoms.",
"     </p>",
"     <p>",
"      HELLP syndrome usually happens in the last 3 months of pregnancy. It can also happen earlier, or 1 or 2 days after the baby is born.",
"     </p>",
"     <p>",
"      Some women with HELLP also have another medical problem that happens during pregnancy called &ldquo;preeclampsia.&rdquo; Women with preeclampsia have high blood pressure and too much protein in their urine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15139991\">",
"      <span class=\"h1\">",
"       What are the symptoms of HELLP syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Belly pain, especially in the upper belly",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Feeling sick",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140006\">",
"      <span class=\"h1\">",
"       How will HELLP syndrome affect my pregnancy and my baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;HELLP syndrome can be dangerous for you and your baby. It can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Harm your blood cells, and your liver, kidneys, and other organs",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Harm your placenta -- The placenta is the organ that brings the baby nutrients and oxygen and takes away waste. It might pull away from the uterus before your baby is born. If this happens, your baby might not get all the nutrients and oxygen he or she needs. The placenta pulling away can also cause heavy bleeding that can be dangerous for you and your baby. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Having HELLP syndrome can make it more likely that your baby will:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Be born early -- Being born early can cause babies to have lung, eye, brain, and other problems.",
"       </li>",
"       <li>",
"        Be small",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140023\">",
"      <span class=\"h1\">",
"       Is there a test for HELLP syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. HELLP syndrome causes many changes in the blood. To check for the condition, your doctor or nurse can do a series of blood tests. You might also have other tests, but that is not always necessary.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140040\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you are pregnant and:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You have belly pain, especially in your upper belly",
"       </li>",
"       <li>",
"        You have nausea and vomiting, especially along with belly pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140055\">",
"      <span class=\"h1\">",
"       How is HELLP syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The only cure for HELLP syndrome is giving birth to the baby. Doctors usually treat the condition by giving women medicines to make them go into labor, even if that means the baby will be born early. In some cases, doctors do a C-section (surgery to get the baby out) instead of giving medicines that cause labor. The risks of having HELLP are worse than the risks of having a baby born early. &nbsp;",
"     </p>",
"     <p>",
"      Doctors sometimes give women medicines called steroids for 2 days before delivering the baby. These medicines speed up the growth of the baby&rsquo;s lungs so he or she can breathe more easily after birth. (The steroid medicines are not the same as the steroids that athletes take to build muscle.)",
"     </p>",
"     <p>",
"      Other treatments might include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Medicines to control high blood pressure",
"       </li>",
"       <li>",
"        Medicines to prevent seizures (preeclampsia can cause seizures)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140070\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you had HELLP syndrome in 1 pregnancy, you could have it again. You also have a higher chance of getting preeclampsia.",
"     </p>",
"     <p>",
"      Before you get pregnant again, see your doctor or nurse for a checkup. Talk with your doctor, nurse, or midwife about HELLP syndrome, preeclampsia, and other health conditions that could affect your next pregnancy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H15140085\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/53/28498?source=see_link\">",
"       Patient information: Preeclampsia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/32/7682?source=see_link\">",
"       Patient information: High blood pressure and pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=see_link\">",
"       Patient information: C-section (cesarean delivery) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/58/40867?source=see_link\">",
"       Patient information: Preeclampsia (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?28/46/29410?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17162 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-BD8FC545DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29410=[""].join("\n");
var outline_f28_46_29410=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15139976\">",
"      What is HELLP syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15139991\">",
"      What are the symptoms of HELLP syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140006\">",
"      How will HELLP syndrome affect my pregnancy and my baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140023\">",
"      Is there a test for HELLP syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140040\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140055\">",
"      How is HELLP syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140070\">",
"      What if I want to get pregnant again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15140085\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=related_link\">",
"      Patient information: C-section (cesarean delivery) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/32/7682?source=related_link\">",
"      Patient information: High blood pressure and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/58/40867?source=related_link\">",
"      Patient information: Preeclampsia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/53/28498?source=related_link\">",
"      Patient information: Preeclampsia (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29411="Cafe-au-lait macule 2";
var content_f28_46_29411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Caf&eacute; au lait macule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This uniformly tan patch is a caf&eacute; au lait macule.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Smeltzer SC, Bare BG. Textbook of Medical-Surgical Nursing, 9th ed., Lippincott Williams &amp; Wilkins, Philadelphia 2000. Copyright &copy; 2000 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29411=[""].join("\n");
var outline_f28_46_29411=null;
var title_f28_46_29412="TB tracheal stenosis CXR";
var content_f28_46_29412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77978%7EPULM%2F70279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77978%7EPULM%2F70279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tuberculosis tracheobronchial stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph demonstrates total collapse of right lung, narrowing of the lower trachea, complete occlusion of right mainstem bronchus, and marked hyperexpansion of the left lung, which crosses the midline towards the right hemithorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe tracheal stenosis caused by tuberculosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 224px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADgAYQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC78Hvhf4O1v4Z6BqeqaFbXV9cRO0sjyyAviRwDgMB0Arsv+FOeAApz4YtAfaWX/wCLq7+z3ZvJ8G/C7gDBgkGfT989ejDT8nLucnt60AeY/wDCmfh90Phi1+omlI/9DoHwa+H3P/FMWv4zTf8AxdenmxTn1x+VH9nKDgcj+VAHmI+Dfw+OD/wi9rjv++l/+LpW+Dfw9HH/AAi1pn/rtL/8XXpf2LAHt0pDan0P86APNl+DXw9PI8K2x/7azf8AxdKPgx8Pe/ha1/7/AE3/AMXXpKWbthchfc1OlkuV83JI6EUAeZRfBTwA/TwtafjNN/8AF1bh+Bfw8/5aeF7X8J5v/i69LQKowox+H86MncTQB51/wo74cY/5Fa06f89pf/i6T/hR/wAOMc+FbXP/AF2m/wDi69E3Y6n2poJPQZGKAPPf+FIfDj/oVbX/AL/S/wDxdH/CkPhuc48LWn/f6X/4uvRMNjkfLn/JqKe8trcFpZVXHJycUAef/wDCkPhxnA8K2v8A3+l/+LpT8EPhzjjwraE/9dpv/i66W68YaVbsV3l2HHysDV/SNXt9UkxE2CATjigDjx8Dfhvjnwta/wDf6X/4ul/4UZ8N/wDoVrX/AL/S/wDxdekBgRkEGloA82/4UZ8N/wDoVrX/AL/S/wDxdH/CjPhv/wBCta/9/pf/AIuvSQaKAPNv+FGfDf8A6Fa1/wC/0v8A8XSf8KM+G/8A0Ktr/wB/pf8A4uvSgc0UAebf8KM+G/8A0K1r/wB/pf8A4uj/AIUZ8N/+hWtf+/0v/wAXXpNFAHm3/CjPhv8A9Cta/wDf6X/4uj/hRnw3/wChWtf+/wBL/wDF16RkYznijcM9aAPN/wDhRnw3/wChWtf+/wBL/wDF0f8ACjPhv/0K1r/3+l/+Lr0migDzX/hRvw2/6Fa1/wC/0v8A8XR/wo34b/8AQrW3/f6X/wCLr0llB69e1CrtHFAHm3/CjPhv/wBCta/9/pf/AIuj/hRnw3/6Fa1/7/S//F16VRQB5r/woz4b/wDQrWv/AH+l/wDi6T/hRnw4yP8AilrXHf8AfTf/ABdel0UAeaH4HfDcHH/CK2pP/XaX/wCLpjfBD4cDH/FK2vP/AE2l/wDi69OIqDcC5GeRwaAPOE+CHw2kGV8LWuORzLMOhx/fpr/A34d7fk8L2n1Ms3/xdel8EdeaARnFAHl//ClPh2v3vCVoQPSaUf8As9Rt8GfhoeG8Jwofa4l/+Lr1QqrDDdPeqs9pvOVbn2NAHlkvwI+Gk4IGitCf9m5k/wDiqxdS/Zv8HTKxsVaEkcZuHIz+dewvAVPzCoyhGew9KAPnrUf2Yoth+w3NvnqN0zZPtXnviX9nrxVpu97W3gnVecJITkc+1fZBeSP7rYH1py3lwn8W4dMmgD849Y8Mazo87R3+mXUZUcsYm2/XOKzVMBVYpYjE4PMgyT+Ir9Mbi5iuYGhvLZZYz1B71wXiL4QfD/xI8k11pC21264Escrr+mcUAfBCW7Su4tx5gUFvQ4HtUFfTPiz9ly9iS4uvDGsw3SKCUtXjIc+wbOPzrxDxN4I8TeFYA3iTQ7uyhzhZHQbc/wC8Mg80AcrRSmigD9Bf2c/+SK+FQf8AnhIf/Iz16QBkgkj0xXm37OZx8FfC3H/LCT/0dJXpPXjOKADHpR7YoUnAB5pBwe+KAF2+1G0c+lJ0AGc0E46ZoAd1xijbxUDzEHCgE+9IN8pCj5T3I5oAmdgq80whywwD9alWFQOeT61z3ivxRZ6NE8bzqsw6juKANt3jj4kcD6isbUfFGnadu8ydQw9Sf8K8W8WfE+GKIlLgbRwVU/SvKdd8ezXku0Fij5AOMkj14/CgD3/xL8VbeFGFrLFgcls8Yry/XPijPPu8u5VlbptPBH515LNrtzN5qeZFHuHG9SpHPpmqq3C+Ygd42duCu/OevT1oA7VPFF/dzF0n4j5ycjODz68811XhPx7f2NyJPMLIe65z+NeSxX8UStGiq0rE8LySD1Gfw6VPBqaWrMY40KuuQqqSSP50AfW3hXx2Lxt9xMowOhOMV2aeMdFEaebeoHI5GK+H49cvdzeSNkezdkE/litfTNSvlhMkedwBzhugxnvQB9qWXiTS71ttvdo3OB15rY6gGvjPwh4wFtewJKz7GYZOeevUivatW+IMFvaRxxz4OPmx1/lQB7FTDKobBNcJ4G8WjUwUkYtkcZPtXVpL50hKnIPYUAXjNk4Tn3oy3fGKaigE8U7HHPegByDC4AxzQVXr29KQAd+tKwwO9AAwyCRxUQm2DBqfqOKqXEQbPODQA06jEhHmHbnvVuGaOZN0Th19RXC+JLqSzYjPA5rC03xbLZygxypg/eR80AetUVg6L4ktdQADuqOeg7VspPG3R1J+tAEtJmmO3GVII+tZSa1Abvyt2BnFAGzUTRDeWU7c+3WlEq+V5mflHNVzqMCxs7naq9zQBNg7uDikzkY9utYg162juW8zKq3PPar8OpWdz8kc0ZY8YzQBeHT1BpCRj/6/NNyB905FICOnt1zQA91D9R146VXktgMFetS7vc0K3OMn2x2oArPahjk5zUMloSvKg/WtIHkdzQ2M0AYzRuowV59aYQGPz5/OttlRslgOnWoJLSF+mQfagDLDvGcxuwPoDTb77Hqds1rrFla31q2VZZow4x9D3q8+nuo/dyD8apyQzoCCp9c7aAPhf9obQNL8N/FC+sNDg8ixMMMqxAABSyAkADtRWn+1P/yV+96f8etvn/v2KKAPqb9nZwvwV8K5/wCeEn/o6SvRfNJ6LXnn7Og/4sp4VyAf3EnX/rs9ekgew/AUARMXPC7elIyOerMO/WpQD6L+NLyTwaAIfLO7gnj2qTB456mlwFBJOB1rOvtRAGyDg9CcUAWZJGaURQjMn8Rz90VbjRYYySQOMsarWkMdlbNLK46b3duMCvFfiv8AFO3iZ7PTZwsUeQ7nHJH4dKAOt+J/xMs/DGlONPcXF82AAoyEycZIr5N8U+PL/UHLXM7EludowT+vtVHxJ4gvNSnNws3mwsMDaOMnpnmubeS5Mbo82SzdTjAwPr04NAEVzqVzPJNG7tuJ4XbuPTkZ+lRpI8sTjzSTHwA0f4ccfnU6rMzboHhLLycLkE/l3qraTO2pb7jy48nadqDH16dKABJLZpX+2TyI4+XcE5GDV/SpdJivZ5Li5kjRACmxOGJ6kgelUNRhks5ZUl8kqxyMcjPXt+FMV3hcmF4zGOxOVGR6Z+tAGqlvDqFxLd2sygxtllYFRgdyfeo7Rka/PlJHkttI4+YZ65x1qezjaDQL6ZSkpmTaFC8AZGcHms+1jeSSFjbKrRtuJGVJ5+nr/L0oA1rhZrHJKRJEX+XnBOauaVM4u7eNpYlMmARvyWUnGcfSodT1KLXJE22UqT20SqcSABwOwFT2M9pkLLaTo4OD8w+UgdffFAGo9rLaX0gtbZpGLlh5fOffPepp7+4kukjuldX2ZxjBHH/6qr67DPY3tpLl0hmhDAqT1P4VKTDcxbJkl85QD5g54x6+tAHq/wAE9ami1z7NOQ0bAgc9sV9JabENu4dD3zxXyh8GrF7jxRbwW7S7lBzuIyOnWvruCNYIUjz90YoAUZGPQ+lL2z3FDDABGc0c8EdKAHDIzmgE9D+dC9OuRS+1ABioJAQ2eBU2elIwXoeKAMTxDpx1GwfywvmhTgkcGvn7xHJc6feSpNGu9cjAyO9fTYzg4Irz34n+DRrNi97YKgvYlJK4++vf8aAPG9N8RvHOpMz468jPT8K7Kz8ZkgBZSCuOgz19a8nmYWzMZLdUZGxIpBH6Y96sQaiLORg6JHbzDMbBvvdufSgD3Sz8Xf6DJK7hmQZ9K8n1nxXLPeOyvtJPUEHH0rnZdSvp9LuUbaVUjJzjvWBp9iNVgnae4ijngK+WmDls9RwKAPUNB+Jl5aWjQXM4deQPlHArTuPHi3ZREmTD4O1W/wDr14kCqMIYY3QnI2k5JPrSxfbZbeWeK3l/cAlgMgHnrjNAHt174pWe32pICSu0MpzgY61Dp+vTpIhWUhsDrkE815RbaumRJMjiTAAA5U1Na6vcXF8qbGVCQAN2cDPTpQB9I6F4vZ40EjjPTnNdhaanHdKDE67j2zXy1pHiFobiaNjKcZ27jwBXf6J4okj8sMT0yRkdKAPdFds8kjtS+YQcf0rjtD8URXCoHfqOpHT9K6m3eK5iDxvnvigC7vGAeSPX0pwxg88mo4om2feBx7U/5l+917UAO5xRxt64x1pob1x9KN6suOD7GgBwb0GO3pTZCH4Y/KDyBzn607v1/WkZeB0zQB8LftZKq/Ga/CABfstvwP8ArmKKX9rT/ks19/162/8A6LFFAH1F+zp/yRXwr6+RJ/6Okr0cZzxk/WvM/wBnSZR8GPCyvgDyJOf+20lejtMQeANvrmgCXqcHpUFzdJECB8z9+KgluTJlASD2OOlViq7gCxJ7jFADHu5WyGPHpjpU+kWxklFxKvA5Q560yQRW6+ZIwAziuM+LfxGtPCOhTQ6fKhvSuFbORH06/nQByH7QXxRTTlPh/SXV52/17KQeP7uO1fMOoXb3KGdnVy0hGAO464/lU99Pd6rqDX97O0ssh3EHJHUnnrWfax2c0kkYn8lnPJc4GeenH1+vFAECsYQ7xEjghgW647cd6hiRpNNCQtGi7898ge3Pr2rSvtKmgt223Nu8eOQDgnj2rLhuCrtHMoAXpyS3WgB9izxu5QQOF5c564/Oh9Ut2kZ20+DZnAVeD1+nepbCzku5pzbhSY0L9eSO5HByazkNv5cgmRDLvICr1HNAG4LSLxGzARrZ3KHGV+ZZGI9e3Ssu40K9thNJLaq0K9dsg+U+vX61dsLqO0064ELhi52sATnpjk5qGOMRWLjzD8+0fezjnt1z3/SgDVXTr6bwLPqcNn/ocR/eyFhhcvx/n3rn0ZC8bGOSRDyuxsAHv6V2HhnxBdWnhu70dUSWxuVAaPytxO0k5yR9KwbO8ByJLEOynKIEAIHtgdaAI5zLZ3byW6S57knLHPpz/nNXZZFSJHnilXPI2Dt6H8zz7VVntpRK0jZeMgkKjfN+HPXkfnWjZFrtg0od1AXcASePpzg0AdJd2lxq2iWEXmKDFICzt/CgHQE/hVLVLriKHTg4SJtsj7cMSPw5+tT6rNKdDiMJaH5ig2jqB26VHpOlG60u5nEv+k2qmYK2Bvx0GaAPbP2Q7Fbq31zU7xg91FdNDFk8quFycdua+jG++dxr5Q/ZX1U6XrN+16PLF5KysPQkr/hX1kwyMjnNACjBX9Kg385A4JqZc7SSKrEnABFAFkONuaXtyPzpqfyFOI5PU5/KgBO3U4pOnHFAGTzj8qOMnA60AH8RzTdoOOM+1L39qMEnuPWgDxT40+C/s0R1zRbUMZHxcxKcZ3dXrw7XvJhhSOaJkUY2SF8hf1/WvtLWbBNV0i8sZcbZ42jye2R1r4613w/dWF/qWkXoOy2nIjO7G9R0xnk0AVfDkKXl1Osjr5MYbexHGQK5+58i3kc2ymVB9x0Ix0HtXVeBdKhYalBqMsqC43eWqthgSuASa5nWfDt94WlW1vUkdWH7uQAmNgD0OR3oAWy2NerMpy2DtY/rTdP1O5tC8gLvE5IdDkluep56VVsrry7hcxKYwSOF6H2GabdCa1vykZYIucAHg554oAfNHBLdxPC77GboRgDj6VGtxJYuLhWICnK8fNx3AApNLuFlguvOjfzARsz9fpUhjia8i3MVuFGQCvPt/UUAX9Vjv9HvEmvTvjeMTZWQcg44/lVmPVbizu0RJzidQ6Lnkg8jr+VYMV497Obed2kmXgMTwR6Yz9av3MuoRatbzyxB7eJVViVxjr1/D+dAHb6L4vEVyYnBiZOCcjIx+HSvTvCnjhNy/vFOB6g14Bf3kAmW6gQkMcMMZ9TkcUWmriOYNbuAGIJUHDCgD7X0HXoNQdVDqHYZ6it1iMfMDivlTwX45NrqdpI0zeUki5bfw3qOvSvqPTruDULGC6tHV4ZFDqQc9RQBIUOcnAPtUbxBzxwTUz4A3GmZyfl6UARhWVRk7u1IZOQGFSgkYpGG7qR3xxQB8L/taf8AJZr7/r1t/wD0WKKP2s/+SzX2P+fS3/8ARYooA+l/2ebYv8GvC7FyF+zyHHH/AD2eu9mbZuUSZ/DrXnnwDkJ+C/hZBwPs8nfv50lehW8TE/hzQA2KMsc7ue1WZdlnbNNOwGBk5/8A1VZQCOPJXGBx7mvJfi74ySxtZLaFxvx8w/pQBT8bePY0u3VJ4gkYOB9R9a+e/FeuXOvazHiaKWPBJGSSfTvRqesyag7eYjKMZXcMZ4471naFZ/aL07mjE6IxDDpnHfmgDEjlu4JhI0cAyxG0nG7B6dOMVDrFl5dxFIqwtbuDtIAIPfHT/wCvUN9FIboidFbLEgJnv2HH/wCutB9WtYLKHT7iwgnijAAbPzLk+n+f6UAU4ZZ3huDG6+XGm4pnr2OSOQKSPUUvlcXenwglMeYDz7cH6Vc0bS1m+03FpPuhUgOCSvB7YB+vasiWY3U8kU5J5AD7hx+P9aANTw3FNaeIbKWBCbWZ1jd1xgAkEjpWZ4jEKeINQRYG3POxTnHU8dv85rS8G3tloetLqDy+cIiCq+pB9xWj4u8WWXie9ae+sXjdDiN0CpwOgP8A9egDnhamOwLPA28uMhTwfXv+lJbm3dVjaF2YEKFL5GOvTJzij92zKqzSRKWGCXyMnOe/tSsUeRgs8ZIbAJ4474/z24oA1NPe0s9WSR1kZTwehIzjoAKn1y2077W8+myzQPLIqiN3GAe+QKwlgzdf66QMSWzjnPbt6ZrR1myawitJmlAmnG8kEdQTg5oAm1WxW1vZd95dIWI3CNSeSO1b2i3WjaZp7Ryy3Dbusjxkk88ZFc1NPdyX3nvdyOX5VT93GOec8VpyTIxiLIspJ3Db6ce3HWgDpfGGg3Ftp9uI5ZktD8ybV65HPbjrXG3LwrZKtvdujqTklTx2xjjpz1rq/EvxA1fXdQWyiKQ6dbqPLi2hgeADzgf55rnzIGaOQAHJ+ZeMg8ZOaAOw8M3jaZZxywynzgdxHqePevqb4V+NIvEempbylRdRJyM8kdK+UIZoNkcCKAw7Z/Wu/wDhRcmHV1uorhVeN87A2AwBGRjvQB9Vn5T+NMdMsv8AKoLG7S/tFuIsYI5HoamZgNpb+dAEyrgdetISe2KPvR+2O1JwV/xoAUAnnPPrijB44ANAGR1OPSkO3uSeaAD9KTp07UpHHH6UmQT056UAOQ4Jz6182/tAWD2Xii3n2FIZiHEgOBkk8Zr6QXgj1rzn456NFqfhaO4YfNayeYXHHAB70AfNGs3cKyRmxaaO4WPOS35kGsXUNYvdQi8nVbm4mhUnYzHcR7dOK2/FFlD/AGfb6haPMYFdVdmXIyOuDjpXKNOpcm1dyszZw3A5oAj8yJHT5mKd8gZyD0xVy9cXMazxHa0YO4bTkn/IqPDpaPGxxIzhge+O9aet2uoaRo0OqyRYhbCBuDnJwPWgDK0iwv7kp9gVnJYY2kc5POM/Wt7xj4O1rSdRsLryJFjuAdwUDCYUAHOfWudi8RavDcQzacYFhwxZTEGOe/0+laWu6tqFy8V6LwStJndGc4Q9sc0AWpETw9ENQu5opbojCoExtPXnnpXPG9kfzpjdKySDlCflBz6Y4q7Z3ssaXP2pYpcgbRIu4D170sZ0m4V5XiJYAkKq/Ln3oAorLKpxJJGFydqnHzDHuKnt4WM+F25JyRtAA+mKzpibmV5bi3iQDkYbkgHjIA/GtDQ4zca1bQQKzu0nLBun0/H8KANDTYJblruFJEUxIZM5xgjt/wDWr2X4MfFKTTYINK1Pa0JIAO8nZwB6V4jMLeDVnwqsobEhxj5s89akurVLf9/bEvJuyAMgr3x0oA+/YJY7q2SWIho5FyD6g1QLyWsxjKfuc/K1eK/s7/EMXiLoGpzETAfud+M54G3j8a9y1FAYCwUlhwMUAPjcSDIP4UoBxyMD61Qt5AgUktnoc1d3BuVwRj1oA+Gf2tB/xee//wCvW3/9Fiik/ayQL8Z9QwACba3J9z5Y5ooA+kv2eU8z4QeFsjgQPz/22kr1FAqDc3Cj1Nef/s4wofgt4WYjkwSd/wDps9aPjnxOmjrJCQC+PXpQBW8d+LItPtpUhk/ebccEV8weL9Z/tG7eSWR/vnJBBA+tXvG3im4v7lwkUhBPqc9+v+TXOi2hm0JbyGF/tfmlZYZcAYx1HrQBnsouHUxNllBIAOMe/Wr8ESJbCWBo1vDxtV8bvXJqo4aC0cxxurlduDzwe/BrPtreKO8M0DSO8S7mVh1x6/8A1qAHXv2grIkkMj8ldx+Zl47DHP8AjWDKHFxsZpNo2gvJCQSfy6V6v4Q8U6Mt5Hfa3ZMvl5UMzH5h3PtXourXGma/Al3otqHtpYsnaAQp/hHPP/66APn3TFGmanDA4DW2oD/XHgkr269Kx76KCC8mgjXDRsMc84x1r0+XTb4xyWd5A8LK24GSIcYPse9Z/i3Q7PXba2mtT5WpLkPkYA6AcD6UAebWxeLDTJycBgy54z1xinpAsgERVAQwbGOoyev61dvNDuLGWI3lwk8DEgyoCcZ7HI4qpdwXGn3KmRlAbAV9vGOvtQBXOHH2V4sIGJXYeQfz+tOigihQl4wWH3WHIb69asXLo0Yd50hYtuGFIPI+8ea1vDukS64ggs/KlLf89PlIbPJ4/SgDnvs/mxM8W6JgNpVc/wCAr1P4f6ToHirwncWXiC4WLVIQwtpWwSFA4we3IrgbnSbvSb+S3uiiSN8ikvuyew+ntTRayzXawmZRI3yCPfjcehwPT+dAGnNBBZSfYHkBlszsMgb7469M1JcxiFIHVyyMpO0YxnP0rmbi1niupbW1bzZt2woDk8fyxX058KvhJoni7wFbya7Ixu0i2ERyFShxnJ/MUAeBxzzCB5oYvmz90AHI/wAaluLaL7TFKFdY5SOAeoAweM1s+IPAGq+GtWntbCc6np6OfLe2BY/XmsuFWhvPLminiaP5SsmBj9eKAOlvJFtY4zEVa4KgHPpjjirfhnV2h1a2jw6TSYH7pPl61zrXCSuSwm34wS2cH0x+FXLGUR3sFxbGUPGc9MAdaAPsTwA7/YgjSMQUDbWGME1k/HbxgfBHg6PU0DbmuFiG0Z6gn+lQfBXxJF4isrh1XbJCiow2kdOM5/Cl/aH8Hnxn8Nr22hDNd2Z+124U4y6g8H2IJH40AdP8O9XbXPCWnX7yiVp4VkyDkYIB710PJzg+1eTfs0eKE8QeAY7OSKO3vdJb7FLEGLEBQAGOfXmvVPMIZhnAFAEo56kUvGeQaReRzjJoYc9qAH7s9jSE89MGk5ByCKXPPUUANz6c1z/xD01tW8EazYQsUkmgZEZeqk+ldFkDPHNU9XJXTZypAO3igD5d8S654csvBEHhW3UvqfmsZcIfTB56Zry2aNYSVjUoUyUUAHcecEenNb3jDShb+KbrZAGkV97MGx1P0/yKxpWic7pGw4BUnp/SgBtvcGe4zMP3q/wgf54rQ8Q+MpNb0SHw/qAzHC6eWY1C4APAP1NZdlbFDK0r8upUKGIAB/HnvVNBHaz7nVpJFO3IJyTQA2e2UCSWGYZgJjx3yR7CpdLjSHRJraeRWeRgUZh2q1fRRvZeZGTGJGDbA2Wz1weO/PNZ0m5xbx7pQ2zdx7etAEv7pnkjY8DGTu2547HNMSRPNZx8hYYKjp+J/OoDN9pjZfLcycj96Mfjx+n0q1o1uscT3F4S0a9AwJ56ent6UAV5ShkEQUeWw27y2GPsRV3w/dzafq0EloyxiM5wD7dee3NVEmjLcRCNCfTt69KUPHDGxkm3MOM7cAjP1+lAGhPbJJe3FxJPmV8vw2eTUXmiKQQwqxiPOT82D35qB7X7NpltcXW5HuWZY1bPb8en+NNgKOfKbd833ccg+1AGjpOoXGmanHqlkGR7c7zj0GDn2HSvtj4e+JoPFnha1vUkR5mQLKFI+9gZOMn1r4ftleOE7M+VISoYgkE9/wAMV6X8E/Gp8Paz9i3N5D9ix2nJ6Dn2oA+p3RoXIJJXOMjtTY5yrMFYlR0zTrW8g1OBJ7fayldxGe/vULwDfnADZ+XB6/SgD4q/awbd8ZL0/wDTpbf+ixRTP2q8D4xXwBJxa245/wCuYooA+q/2cP8AkinhX/rhJ/6NevG/2gdfltfiLfWG91jMMZXgkZ25OO2a9i/ZxJHwU8LHjaLeTP8A39evmH4qamPEfxBvLncWMMmASTgcD/P6YoA5552Ztp3GTcSC2cZ7U25dmmH76SNzjEa8j69OtNuJJisKyR+XGOdwGf6UyS78opIJQWU8ZAH+e9ABHFOJX8m5dDjcS3OR34zUDSupZprglE+4cDhffuaslJVud8kJVAAwY98/j/nNSMBLLIsm2LAzk/59MUAUDFcTKyC58wk5Qqg49FIxz9eK2tIvNY06eOFFkYHB2Icf1qpDfmCPzLR4cKxGHGcn8ulb2h+LNVe5jSCwsJeP3jPB0HfBFAHP6n4l1mDxCiyiRIWcBwcn5cjPeuh13xTbaNLaTaMkdylyCrJc/NtJ+lVdf1q31JpYjbQ/auclAACcfX1rm9H077Q1y8xDiJsCIvkAAcf40AdJBqs2ppJbalY20ecFPKXIPuc1He+HtRmCzwpazwqcKJ3C4+nuaZpsxgZZnYuu4ADP3R6V3t7Y2F7p4Y3RAcAiFh0P55oA5+88JS3C25Oi6eMj55Em5x+f1rsdH0vRNCjP2ZoknZQWQA4z9cH3rIl0SO1tU+0zGdpQV3AkHHboelcveWem6ba/abi4wmeF3EY9B+tAHQ/E3wTY6nYWl54Nsk+3iYSS7ercdTn/AGjWdeeALrU/EmhXQsmtoYliW8ctxkdTweK5SK4uLrUBFpl6+2UDDoxIrZ8M6xe2OqT6RNPK1pMv76VmOYwc5O7OV6UAdd8VvBHg/SDb6jpcsk0hULK8c2Rv5yMHv0rk9H1dGSO2tb7Vre24Q/Zp2VmHvj2Nd/8ADrwhFnWbWe9TWLS5hLRBZDKUZiOec4Irm/Efw6m8OXUd3BPPhnBEaP0/DbQBkapout2cq3GjzanPAxBCPKxJXPcDvjNWVWK7jie/sJYbxB++MiEEn1HPNe5+FfAF3H4eg1RtQnld4hKIXZSq8Z9Otcxd7dWvJoNQ0e0d4JNoldypYeuc0AefSJoDws7TXAmB+4YeM022s0vJEgtLTAY4U9M+pNdRqvhLSJLuFl1c2EnX7NHGGT8DVi78PTW6+fZ3u+JeQhjAB/GgD0v4FWltomnGzC4uJSS5yeeTivWMjeVPzKRjBFeK/BK41GfUbm31CFnjjOUlAAx1617Mznf93IoA858F/DtvA/j7WtX0i5J0nVx5k9qwLbJd5bcp7D5ulej3Cb1LhgABk1MCCB6d80OoeNkPCkYNAEUOTGpOCCOMVJ05OPY5rgPhD4w/4Se31u3uJ4JLiw1K4gRY+CIVchNwJznArv2B7jigAztPOOKOM5280Hp124pD7nrQAo5x2qteDMbL+lWME9x+FRyLnIxyRxQB8kfFmxZfH90IYARtTBzwcCuFubK7kChbZA+chWPBP1H+elevfGjTrqXxrEllazSMwPCDOcCvKL64uLO8EV5DPCx6Bxgg+/NAFJIDfajHHHC8ToQrbjgYH0PWq/iEwx3G1bdxcWwEky87TGD29+nWuy+D/h5/EevXsvmEwRKoKs3UZ5xzWp458H6Tp+oSRzX1wl2FHnBQrAp1AoA8mguJdTkV0sXjEScMvRl9B7+1bF3prKYJFhlSGSIb/qfbNaF7qFtpdykGnRg28Y3lMEBm7/0q5Brtpreky2l5cizuFbKZBOR/d+lAGII7HS1Ej753OMA5+Q/hVO91KadfOjupI0VsKrKP8Khu7QWVpcTW+oLK6IWJPXg8/X/9VTbCsh/0iLPfcM7v060AJNqljPCsVyGM6E5cEAZ7jpVOOJb5QsVwREGyzgZGM9M54q2L5l85MW4jHDF0HT2z1ot7r/RtsfksgAwV44x04PSgDS8Ty2s8ttHZTI0UIzhhnnGP8/Ss+3h+2XMjiSFUiwXOMDnoOlWHnNlcM4ihlV8kh/uj9a0bV7TWLH7LYA215jEq7Aqv34J60AZs1zMIthMAtlbIAY8n39KhQyxyia3kCsjBwPU/n71FehrZ/sl9bFWQ/wBw4f8AH8Kkt1gWENIi5z8u3gA/hmgD6D+D/jFxKkE0ykFQHGScj16V726rNAskYBR1yCK+FdGuW0G/S5hXzLNjksG79cdPevr74a64upaFAGJ3bQfwx9KAPkf9q1dnxivl9LW3H/kMUVJ+1mAPjPf4PW1t/wD0WKKAPpv4CTLD8A/DxZsf6JLj/v5JXy5qNtDb+LdSiuppEh3bgQC2SO/SvePhj4gi034GeF4PN2ytbScY/wCmsleIeNrhH197qIhg2S3v79P8aAMiab7VG8E7GFMZ80jpjnpioxZWEFmb6a/FxEoyFU43frTZD9sZHm/fKmQwUbSvtjFMme2uz9jiZIoI+pY55+uaANnW/G93rmjWdq81vFHAWZf3ahse5B5FYlnukHmS3Mc6E8rEMkevOOR1qpCEsyI28ptzlVJXgjrxk/5xSpLPMWeH7MAV6x/L36jg/wCTQBpfYZpyUhCRoevmKAB75xU66yumpLYaYYJJShLSFf4vQEHj/wCtVTT5XltZLWSfLnPRwO547Csq1329wI44VjZcOzEgkN0I680ASwSSvvkDwiQsRjPBP5nB7VLIksU8Tx+T5ijDgHIPrnjOKkvxDeoWS0hEwbDHPJI4JrL+xLbJmW23Arn/AFhB6euKANG3vCLoLDBGxByVz0wc8k49/wAqu3N6l5q4kkmjSZf4AxyMjr15rKgjgWRZ49Plxt3DbNjP1Bx61N9ks5ozNLut7tT1Zun4BufzoAtvrGspfOYJFuGgx+6BGeeMY/KtFrya8heLWNOkIAB4Axk9O3+fSuYtdKv7u8eWGN41D5eQZwe+SeR69fSupt5rW+tZoZpiNuApR8Ed+v5UAQ6AkMF/BBJGy25LeY6kDbnpzxW1LZKUKxyp9kALF/M/eMPQnPIrm/7QgtLcxxo0iPxvIG5f1FU7a9jOnSNd3V5H5x2xqqd8nrz9PyoA7m18cXGh2ot/D1ooBOJJYgVce/Ga6HQ/FNxewmPW2kldsOHfllBrzfRLS4bM0LlbRTl8eg9OOalElypK205Bc45HQUAe26d8QdZ8iW0s2K2kCHI/2R3rj9Xv/tt4Z7rxBIsDqcwmHjn3BrmdB1G/0r7RMJ+ZkMJBxjGfrSo0cy5YeWxO4jJNAG00zQQKtneeYgHykx9R+NdF4Bs7jXdQMc8xW2j++pGMn2PaufsojtSSVkVCAEBH/wBau++Dtld6j4knW3UC1QEvIBlR04+tAHunhy0t7HT1jgRVOBk45JrWVM8tRDCsSKq9hipKAGFBjilXPINOpD0oA+VvD+ja58Mv2lBbb45NJ8TSzyq69GX55ACM8MrcfQ+9fU6EsoJ4rzz4r6BcavrHgu+tIFkGm6p9ombdtKx+Wwz15528V6DGVKAjGO9AD2z26U3GO+Oc5pzfT9aYRjqOKAFOOlNycjA5pePpmkxg4oA86+Mevnwhpq6ra6bDdTnOWeLcR06V4H4p8a6b4xsIr46WttcIPmaODBPQdz7V7x8fRC/g1llZlYkYIFfNuh2cF54YvlSWYToByBnjkk9aANHwl4ij8IJNdaU8ht5OhPBXnJ4ye5NYOv6rca413fSvJ9oI5fBJx2zxz/8AXrn1mWXSbsGZisbgYCnOTjr/AJ7Vd02+ktflacEsvzggfPjp2oAz9J8r7aBI3mBgCEPGD3HrnvUurPF56xysQr8rhtp56d/rXYfBfwLB4t8fTi/vCumJ83k4IMxI5AIPGK1v2j/h/p/hLVNIv9FuD9nJCyWhYu8ajPzcnoeaAPNLWASzLHbEt0yAxIT3JqNoY7eZo5buOZ9xdyWwR26Y4xj/AOtVi11C7tpS9uLYWzAgs0fzD6UXibTE7Nb/ADDcSB1/SgCpMwDMiTxSgoCuSACCexzVi1m8q3KRCFm+/tZv8+1WNReCGS3jto4BEEBbgDB9Ov4/jWVfztbbGiRHkJGCoJ4NAGpdWJnhsLkmEQXMe6VC4yCDwKrRh7K+N1E7FwMomFxg9+lXl06WXQbe6ubZEcBdoOQQDyTyP0qjDDHllWJHRTyQ2Md6AOmg8TC7jjOvQrcOq4AOFz78H2rG1W1utzzaeii3PIhAzj8ao3iIyfu4NyxZwQc89fX2/WnWCqkcr3EchICjBkOCf69f0oAqz3DmABo3SbaflTnkdv8A69e2fAjxU8EkVvPIAvBAPYH3rx+2AdpM2jSQqQNy4IPXj/PWtDwderp+seWi3EUbOMB+/wCRoAuftWyCX4wXcikENZ2zAj/rmKKyP2grr7X8Q2lySfsVsOfaMUUAelwGTT/g14PuxIwjezk6DoRNJ715bPqFvf3LXE+4RgYGf8cV9KeCPD//AAkP7MWgwpHG8sVtLIoYcnEsmQDXzNDayxXt3ayJBFslKHe5yVBxjGDzQAk81vbRjYdkONq7Tg0lq0cs4AaNGIyA7DHHTv71PdRmxnjzbpOrqGAGMZ54JNONmbly3l2qAAthpAGU+o5oAg1GJlRFuRhmU7Rglf8APFVbGBX3/IF3HAXGO/J6Vvae9jNLHBqKuzRqRHJ97afTNZV8lrDeXLpbSLEvCsvOQfXHv3oALrTlsrhSZDvUfKQ4YHPp0GRmqt2m69W4NyyOgHJGcZ9cHHP5Ve066iZXtnt7gp1UOu7dg9c/41btrO01rUjZ2FtMk8q44HUdfWgDNhnhIw0rDBIYnk9vTt1rZ13SrXTZ4ZLfUo54pYFyhjIxnkjp+FVNU8KR6EzR3F28koA3L5ZGM9OOajubeyuEgt5pJ92RhlJAB7dRQAl5PbfYN1rFIZVPTcTuH0/Kuu8CeCF1eKLUtfuxb20eJFRnKk45HOec89a4+xisHeWNZXUI2CxzggemT+lTP4ge+uEskuZorSIAbSCgYDgjGelAHWePfHOmbG0bw9bxqq5j8wRjLN7MO1efW01zHFGEt08zA3HYevOOgq/d6ZY29751uVIcZ+XtnsOKr+VFAzSjU5ow5zjA6Y6c0AVTFNJBFIysCG5ycHk9CB0709rG7vPs8MbSKzEBEI469jnHrV20khuWCpfBsAEliM9+CM1s6fG8ur2duJU+zLgrtxjj8aAOs8QwReF/B8GlRt5+oSqd7FeRyD2rl5JGhSGcRmXc4Teo5j4J3HtgYwf850PG0iyeJnjS4QquOp5BwP8AGsy2EpvY1klVYyPmbPGPSgCxk3Kr+93OhyyAdc9M810KafLZWwu543O7kKV6HA60/VLDSdFs7C70y+try8kOHCyblA6jK5qvcy3sErpcZZ3QEIOg3c8DtQAyN5tRvoLNdwuLmUIhUYAJPA+lfWXw78NweGfDsFskIS6dQ1w2Blnx615x8GfhvLa3K69r0Z8wgNbwuPunOQ2CP1r2+gAoopNoyT3NAC0UUUAMbAIBAwfWmRA85Bp8oJQ4HI6UyDOOSaAHnnAx9KYTnrUkn3ajzjoAT+VAA3r170LnA6/lTQ+c5BU/nSlxGrOx+UDJoA8x+Od8o0yOzC7nkHr71xvw/wBK8N+GPBmpXWtXKGeYgAkHOdpAAweat/FvUv7Q1WOFDll+TOexNeceOphYQ6fp8DZVog78nqD65oA525jtYZLmLSroae14QVmaPzFfHbB/GqD2KyTSTXsiXEkeABGuzHHp34p18/2mBlBQEHaXJwEPBxjrWz8MPB8/ifWXtrS7XPJfcWO3/wCvQBlG+1HTdLik0aRrW+wfKZDgnHfg/WsDSde1DX725fxDd3FzPtCFZGJxjpwTwePSu68ZQXfgjxDPpWrLBcIuBBJBGSeeucn3FcZvSLVnkSJMuoYrgj86AG31kJLRorPII6eaeAa2/EfhN9MsNOuxNaXSzBVkEMwk2cZ59B2zU2nW9vqm6BdiOwwEA4z6kEVD4k0C/wDAtvDcXFoxg1HMLspzgYznp70AVCdDWJIrnAPUjBbn8DxXUeH28NWH754UmmK5RSWHPUd68zuoo1kZpdwDJnJY9D+PFQMbaZIVIk3BimFLDj+tAHovi3V5tZtvISxMUWflKvkD8MVwyWt1E7RyzAxrxwPTp/Wpp3dvJiiJEgKgHJ69Dx+FNlu3QxozZkaQDoOCfXn/ADmgBrRXUyP+6mwTgqpH55B/SpNNjGkx4vIbgBmAWNudo+noPWk8+YX5Rp4oyvJCnGPxBq1d64jP5N/EskQz+8CFi36e/SgDLuNUmkQLGI0tmPBQbSfr278VVW5u7ZreQykS7wpKncAMjHfrx+tat1b2t5FFdadLIojGJAyhefTB+lUtWVLeyBkYq+OoXJHPCjnp9aAKnxKvDfeI45yd2bSAZ9cIOaKq+NowmpWhH8dlA/5oKKAPuX9nJh/wpXwsjYwbeTg/9dnrx/8AaO+GrWGrLr+kwIbWVi0qBeh5J4A9cV6/+zpEX+C3hVh2gkH/AJGeu38RaPDrmkT2F0oYOpAyKAPgNBLgtKE2ouEUNySO3PSo38ueTm1BY8YA6H8//rc11nxA8LyeFNeuIZYmELO2zcpw2ST1A4rnI7mMbRbKqyg8MrdPbk8/hQBLo2lR6hfyQzTtEgXzNhGcgVE0kf22S2GnCKHJCusgGRjpjFT2qSG9luJZW3qhBTsw9KgutroSsxTJBIJ5A9M46e9AEU9zNFGPs0bYU4HIHHTOa6Hwj4lu4dN1GIKiz7gEbCkgc9TnPf1rmYkkEzqrFkkGGbdkc9h6GrFvBLp6bLoXGHBKMn8Q9zn3oAU3l3K6m5dmdmO4Oen+etSHTZrW+L3M6yQYG0KeRxk9uahEMt7ERHIwjIznbkr9TirtpBNqb22mpM3mxBiCeN2MH06UAV/7UsreO1nhAkiLkOCAcd+n4VSu783khuI4RHHggKEGR+vT8Kz5Uhj1OW2Kxq0fG8nkHGSfSrkV610DFbD9+uQGAzuX86ALc995qgruQqoRlWI849eKdEUWAySFG5GBgAjj9KzoJ7uC9SG5Ii3dUKlstj0A469atrdWscuHeLzTnBxgeh9vSgC9fCwghgNvHDDuTMpUZG7/ADj866DwnFp8NrLql4gkIykRA2lsj/GsSzXT7hoku7iHYzAk5I/WtLxFcRG8tLC3niS3SEYAJ5GeCaAK2oXMlxes81tEpZsjKjLD19amNjFHbPdMilnGSA33ee1PjaKeZLd/LkU/8tF69uhqfWVW1lWKE7kTgqW4P+TQBTtreFlRWgRfLOVNdn8OdMHiT4iaTBKPNjDFpsnPyqp/wrjzNFHE0hGZDgcMD/Wvfv2Z/BlxY2Vz4m1SDypb8KbVG+8iAEEkds0Ae6ooRFVeABgUtHeigAooooAKKKKACmY2kc/nT6bIMrx17UAMmfaAARzTFbPHTvxWX4hvhY+SWICtnOagh1eCRTsZVPfmgDZlnCLkkE+npWLr9/LHp7GNV+Yd+Kr3mqRwqWWQfU9q8z8a+KY8bDdIWOcKDj+lAGP4gmRDLc3Hls207MHHzV59q2rPrDeXLBGJYxhW7EVNdanNOssTyxvG2STyKxNO0y61TxXp9pZRyuZpArEHIxmgDHYGR5/3UWI8qQzYxT9G16+8JzpqWmLLHKzAMFkxlTwSfU0zxLbyWOvX1hJGYXhmIbIxk5+nSk8RRrBoMEvleczADHVjn2x1oA6LWrp/EUkmqaj5s2/EikuGI4rmJDHcTm4WOWOU8EqoyP6U7S7u7h0mKKTAiYDI3/dFV5nQ4SDepUHgZ+agBdKuf7K1dLpY3EoOVJ7+ua9R8UeOtd1HSDZzW017booKLlRj9K888LaU91I+oajG1vawL0cZDk5war6L4mew1531FJRaTNwGI6D9e/6UATp4tgZWWbT7gSLwS4BGO4z7e1aH/CcWkltHb3FiwUE/8sV3EY9cE1N8QtEI08a3okMk1lIMt5Rz+v1riIW8yVfMjuYi/B3YwBjNAHQjVfC13PskivLcnJ3khVBzgkGoTo+gfaEmi1WUosm7a0ufm/ziqGn2CXb3flSRRjYSVmOC3JyRxzyar2NutvEYr2GJgrHaQvyge386ALV/oYaVrq0uklyxZd67uPwPbtWReWVw+1PNQsCF+RT69OB096treyW6yJFcSIN5IG3AxjsPb/GrMGt31jGDDMzSMeCRyAen8J9P1oAZaCDTEka8ulWSbB2H6YB5qlegMGimvI5ZD8uXPJBwemep9RWnc39rqaKb22ja8X5/MbjcQO3H61hXCxT3dtBDBueWVQTnJJLdDg0AHxDIOsWeCCBYW4yOn3BRWn8ZNObSvFVraPGYyum2p2kYxmMdqKAPs79nA/8AFlPCo/6YSf8Ao169K+teYfs6tt+C/hVuuLeTj/ttJXp2c8jpQBwHxb8GxeJNHkljTdcRLnHqBXyLq+izaVfy2kkPllRlNxHPXgc+36199V518UfhlZeMIftFsy2upoMrJg7X44BA/nQB8cPIIX2qPlb5SQe/5e9JBAZZAEYrxxkcD68VreKvDV/4e1GWz1O3myh+VzHgH+fpWXBFcSkZKRDONxBXv16UAS21n5TK87kFcEAkDPufaoXeSa+LiZpEU/dDAqB6dePpUl21wsg3mN1T5eGxxntz+lNtz9mVvKxzjDHr6e/H1oAu3VwI7SZYY1RJGXLjhhz+tZGlyrp+uQX0HmjqgUDkZq9dQNdQIk8EUiuAwDA/L+lVIt9sEXauIx03YA/CgCDXbb/irZbhOEKhsDofl5zk9Mk/56SaXrEFsJ47KxSG9kULE6nO0jknH0p2r2FzM9nPKS0dwrMu09O2evOP61UuI4rP5Ij2y2Rk/Uf57UASyXk2p3ES3ELS3KkHIUgNkHjBH86dcWP2W2P22KSG7dsnDfdXtgY6Cm6BarqWuWXnyrGDlyq5HGMjt7n9Kvavdy3OorcbMLwn3gAdvSgDJtbXybvzIu0e4uT8o55xz+Vdfr1vJcxWE0BtJAsQDHvnuP5ViJHLqF9sGVjBGWjbjGOfp3FbMkkexY4Q8ahccrzkfhQBJYx/ZYmzFulJym3kdOMnHFQ3UrOr+f8Af9ByCfU9OalR5p1ighVmk4B2jv69K9X+G3wtm1Vo77XQEgXBGRnd36cUAY/wa+HMviTVUvdURfsEJyQVB3nGR3r6phEFpEltboFSNQqovRR6VS0u0j06zis9NtxFbxjAxV+2g8oZY7m9fSgCSINyX60+iigBrMR0FNyR0OaH/Ee9IT60AOVvX86fUGctxyamXO35utADWfa4B4B7+9P6imyIsilWGRUQfycLIeOgY8fhQB5p8a9QuLC1s1UYgOSWz6EV5db+OCkWY5Q5PDAdj/SvpLX9Hs9e0uWxv498Mg9cFT2INfKvxD8GXvhDVWE+57V/9XcBcK/A9+PpQBLqnjyePdHDE0jt1yc4rkLvU57qRGuVJaQ56dKUXBEZUorIMD7nzc/hVC5YZJEqnHQA4xQBcs4bvzJd5iVBjO7IyPz+lTW3iD/hHL57u0wZ0UGNx1Ddh14rIEt1MpiS4cA/Ltc4DfX2qRbD5UbUGjbBIC4zn/IoATUjc+JLx9SvRGJMFml3nLZ+o5qKVUu9Ax5jOsEm4p0yB29+/FTa3cQX9oLe0MdssfJVFIz7jimSTJarbrHGHiKKko3Yz65oAwxtadZHlMqdFjzj8M1ajjguJRGsXlqrAlgxwozVifSj9ne4tm3ROxOAdxUelVkkuFil8pUaMAgnaB+Z9PzoA2Ncvl1ia10u1nAt4jtZlJGTn6fhXN63psdpqM9jJLKvkvtGGyTwMY7+nNavheMnV0cwrtWPeGCgfN6HipPEMUl1rb3ZWM7nBc9Dx6e/WgDp9M8XL4Y8LafpMsX2uCVDuDr5hUZz61j66+larMHMUluzNwqrgA1maheJNqCtsRoo1yFx7Dpz3xVq4f8AtXSRf21lGskKgPGqkA56flQBlXlncWjvMu2SNRkEct+VP0bV7ae5+yaxlIpMIGcfMnf1plpdTwTedtYJn5o+QMe3HT/69PlnsJsT3UDLK3U7jyOaAJ9V0yx0e+EUl+bh3O9A0eCc9Mdf85qsUhmaURlfMwTuAOc+mMelXXi0/VQs8A33MajKjOcDpWbfsICFW28sck7j79vSgCPLFQWZCIxnkdR+ldx8GvBUni3xVFezRgQW5J5J6g54NcxplhJq14sEIkbcQHYH7o78Cvrj4U6BbaF4et1RB5jY+YDnJ75oA+V/2rlCfGG7RVKKtnbBVPYeWOKKf+1n/wAllvu3+iW//osUUAfUP7Opx8FPC3Bx9nk5/wC20lejo2w42naa84/Z0Uf8KV8KnBz5EnT/AK6vXo5U5yQeaAJwQelGagXcpyMke9ShucEigDg/il4Kj8SaY7QRR/aQOpHJ9O1fLHivwteaZJIssm2MHnjr+lfcTFxkL+prmdY8PafrUckd9apubjdt6UAfEF61u6IBKP3eFAPGPfrxUKrbSeWPtO0Mu0hV7/16da+iPGPwNDs1zo+xsfMEwBj8zXkGteDNT0ecpNYCFhn95w2OeuPXgUAZdjH5Vg7PIhdWwsZPVMcduKzltXnupH8yNY0O4JkH8M1ZNtcQtI5McjHptTHHuMU2SOfzl8y2WTcvJTjB46jP1oAju9TnvII7S7RfscWFiRcbl6Y5B9az3sCkrQyWzuY84kJ655P+TWjHYvd3SwWNgzyKMscZqO/tdQ0+7AvtPKySdirYx6jjigCiIHtkja0hO8DG9wBjOMnpntVu1tbj7BGLjyyx/iJ5HQk/jnpUo097l0CW84kwfljVsfyrd0nwXqWsyCFLWYQkbdhyo6e/egDGFpNbRuQ5BbvEckjsMc/5Nbvhjw1qniC+SC3ikcthS0ilR+or1LwX8DUS5S41OIqDyV8wEdP8/nXumgeHLHQYUWxjAC8ZxzQByPw6+Fth4fiinvYY5LoYJ74NemiNQAFAGOmO1VrIYRxyWBzzUwl28MpH1oAk2ndnNOqJZ0JwTg+9Sgg9CDQAUUUUAR3GfLJCg4qsuTgBj9Ku0wRoH3BQG9aACOMIPUmn0UUAFNdQ6kHoadRQBURZbYkAmSHsO4rO1/SdO8TaXNZajAZIezEDcD6qa3KYIkDEgAA9QBwaAPjjx/4HvvCmoS/Ikums+Y5NxJUds8da4kxsXUlQuRncv+fSvtPxz4Zt9Y0yQGESBV5i7H3r5X8U6C+lXMqJDILbdwOm32+lAHMCY8gsxIHbHB/OmRJsaSbPmY7Y2hqdFauzqPs8smeRjnNU7kwRM/m+cr/3SvJ9e1AEiF0LBhvQ8AEbcH34qO5Qs6BHA3gA5PA/DvVW3vbFtzRTuojbDK64x+dW5JlMqDzo3yCAFXPYZz6f5FADoblVVoZmmlic7QU4x7nn9akgupNMhMEKpIshKSNIucD1HFRTXO6QkGHccfwfzpkqpPsdpQFByfkwGP5e/SgCxZ7rSOSSFzkqUTjt2NOsv3sxWaWUZO7aT198VE10pTy45I/l6E5wD6YqZJ4ipDSRtxk/Nn60AVNS0+C4u32M+7O8hmwD/nHSp9Mu7nSAZIolRBhSN2cj8ulRyQwuA0UqHbzgHGBUIto2bLSxoCQTg8fgfegCXWrWW2ht7mBBJaTguMNjH9c5qlbybT85KKpxhhwO/ritVLl0cwhVNvGPl+ccjB6fp+dVpraTh4dhTGfm5oAr25ljll8ufzEBGdvQdOnFaD300lpGjRRsjkgnGSPfnvVS48x4w/kFWz82ABnHcD161o6bbyanqMdvbxPlzyoU5/DAoA7X4U6a811HNtkBLbcEe/XrX1VoEBjsYx3C4A/rXC/CrwNNp9hFdagnk71yIuQw7cgivUlVVUKi4UccUAfCf7WYI+Mt9uOT9kt//RYopf2tf+Sz3/8A162//oAooA+of2dMf8KU8Kg9fIk7/wDTV69HHYHNeb/s7Y/4Up4VzwPIk/8ARz16OOD2HFADiv8Atc0BADng03HBFAIwM0AKyf3Tg1FukXIJ+X3qQYJxjH0ppB/vAj2oAaDz9081XvrS0vojFeQLIp7Y61Y+Xk85+vBoO08HFAHG6j8NdEvslIXib1Df/Wrnb/4L6dclvKu3jPbDdK9UYDoS30BqRFUc7mPHQmgDy7SvhBp1jKspu5fMAwWjxk/pWrqfw00DUprea58x3hG0FkByM9+K74bAfugD6U/Izx+VAHOaf4N8P2e02+k2yuv8YXBrct7KCAfuYhGPQVN5qjvzSecucDmgBduBjjB7U1kVegOaa0xPO0j3qPduJYDJoAGUrkrwO4phZmCoFOBxUxXdnJP0oYDd3zQA1BG6lyAQOpIxUwG3BXA+lRzxJNbyRTRpJE6lWRhkMMdCPSktgFtYVjXYqoFAxjAA6c0ASs7KoJGfXHNSKwbODnHWouezHFG0bxJ/GowD7HFAE1FIpyM0pOBzQAUZpo3Fj/dpHUHqSPegB2aaGO47sBe3PNHGOp5oKKQcjAxzQA5WDdCDS1RWNoZcxDAJ5HrVnzWHBXBxQA2eXyzgdxXD+N/CceuWzvCSs+M4Hf3rt2XPJHP50mCBg4IHQY5oA+PfEnhLUdBuZZoR82eR1yPXrXJK62HmanKvmO+V8nGSCeO4/GvtjXNAstWgK3EcZJGOVHNeQ+Mvg/HLG7WqblJzhF/pigD55018QTSGFXUkALxuOai1SwvrERzySRjzeUVOCuPUfSuq8ReBr/SXG0SoE4ATPXqO1c5JaX5mY3bTSYIB35I/CgClaw6tdSyRW8MZxjDL0/HioRqVxDc+XOgdWOMsMYwcelb0Vzeadk2EeAxGe2frVbUEW7mil+xoDzllb+lAFKI3UvlGSAIznkMP0NTG3ukEhTTkm8sFt27+lXdcZZ7zNmweHy1XKtjbxVPSLi5sJJWtbhXkUYMeA+M4xle1ADLGKa7iZFs/3wPGEyD0x2qEZgOy5siGDYYYx+HvWyyXs7+fDGfObqUUjH0GKdB4c1+9l/0ezfLnO5lY8mgDDj8mZmDxbV7AE8c+g60ycIFJjDqQQdoY569elepeHPgp4i1iUSXjG3jwR8pK5/T3r1bwx8DNNsJRNqk8lwQMbCFYfqKAPn7wN4C1bxdfqlrbsik4LyblAX/vnHSvqj4dfCvRfB1tG2wXV994yy87W9q67QtKsNHgFvp1rHCmMZRNua0pH2AEhmyQvyjOKAFkyRgZ/DrSNgKTz+FKWAyM/gaiY5xuU/hQB8LftZMz/GbUCyFMW1uBznPyDkUUv7WhB+M18R0Npb4/79iigD6l/ZxUH4KeFif+feQf+RXr0dlweBxXzD8Hvjz4N8J/DfQ9E1ZtSF7ZxOkvlWwZcmRm4O7ngiuzH7TXw+H8er/+An/2VAHtAYEnJzScZOea8VP7S3w+JyH1YE/9Of8A9lTT+0t4BOMy6qf+3L/7KgD2rjHJOKQbQOTx9a8W/wCGlvh93fVj/wBug/8AiqUftL/D7+9q342Y/wDiqAPaSwVc5GB7U0g5+YAY9OteMf8ADS3w/wAAF9W/8Ax/8VQv7S/w+U536uf+3Qf/ABVAHsbcdBz34qVHRhkZ98ivF2/aX+H55D6sD/16f/ZU0ftK+AM5aXVz7GzH/wAVQB7Yc7sdqCq5GBivFf8Ahpb4ekYLat9fsn/2VH/DS3w+4w2rj/t0H/xVAHstzMtvGZJJFVFxuZuAMnFPBAPP4814uf2l/h/03atj3swf/ZqD+0v8P8/f1X/wDH/xVAHtRUFTtIJ6+tOAHbge1eKf8NL/AA99dW/8Ax/8VTT+0v8AD/P+s1fHp9kH/wAVQB7aAc9eKASDyB9a8T/4aX+H/wDf1f8A8BB/8VS/8NMfD/8Av6t/4Bj/AOKoA9qGCRnjPtS5GTnnjjivFP8Ahpf4fE8tq3/gGP8A4qk/4aX+H/8Az01b/wAAx/8AFUAe2gbu4FOH1H1rxD/hpf4f/wDPTVv/AADH/wAVTh+0x8P+u/V89f8Aj0H/AMVQB7QXET9Rj0pwfe4Ofl7D1rxJ/wBpf4fsM7tWz/15j/4qki/aV+H6g7pNXJ/69Bx/49QB7mSMcmmttJ614l/w0z8Pufn1b/wE/wDsqP8Ahpn4ff3tW/8AAQf/ABVAHtnToTily2TgCvEv+Gmfh9/e1f8A8BP/ALKj/hpn4fnq2r/+An/2VAHthyTnr7YpGJ9ga8T/AOGl/h9136uP+3T/AOyo/wCGl/h9/e1f/wABB/8AFUAe1HPGTmjPYcfWvE/+Glfh90D6uMf9Og/+Kpf+Gl/h9x8+rf8AgJ/9lQB7UeB0X1OKbnkYOBj7vY14s37S/wAPiMbtW/8AAMf/ABVJ/wANK/D7n5tW/wDAMf8AxVAHq2q6BZamn7yNN5/2a838R/DBXdpLe3jI6jBFUT+0r8Pz/wAtNW/8Ax/8VS/8NLfD/GC+rHnP/HmP/iqAMU/DaMHbNaAHoQp4qKX4PyXbH7JIIHx98jNbUn7R/wAPHOWfVjj/AKch/wDFVKn7Svw7U5H9rA/9eY/+KoA5y2+CGsW7/fSWPOT0H9a6bSvhIkR8ye0IkHALMDx6fSnf8NN/D7+9q3/gJ/8AZUf8NN/D7+/q3/gJ/wDZUAdPYfDnT7dgTbjPfKj8e1dZYeHtPswCtrDuHRvLGa8s/wCGm/h9/f1b/wABP/sqP+Gm/h//AH9W/wDAT/7KgD2kAqmIlAFRLISCX/KvG/8Ahpv4f/39W/8AAT/7KmH9pj4f4+/q2e+LP/7KgD2rzCBleg7CmtL8vzMDXif/AA0p8PucPq4J/wCnQf8AxVKv7Svw/BP7zVuf+nP/AOyoA9sDjjJ5xRuCuu0jk9P614p/w0t8PwPv6t/4Bj/4qj/hpb4ff3tV/wDAMf8AxVAHgn7Wn/JZ7/8A69bf/wBFiiue+PXi3TPG3xFuda0MzGykghjBmj2NlVweMmigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scan shows critical narrowing of the lower trachea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29412=[""].join("\n");
var outline_f28_46_29412=null;
var title_f28_46_29413="Lidocaine (topical): Patient drug information";
var content_f28_46_29413=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lidocaine (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=see_link\">",
"     see \"Lidocaine (topical): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/50/33574?source=see_link\">",
"     see \"Lidocaine (topical): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8768584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      AneCream&reg; [OTC];",
"     </li>",
"     <li>",
"      Anestafoam&trade; [OTC] [DSC];",
"     </li>",
"     <li>",
"      Band-Aid&reg; Hurt Free&trade; Antiseptic Wash [OTC];",
"     </li>",
"     <li>",
"      Burn Jel Plus [OTC];",
"     </li>",
"     <li>",
"      Burn Jel&reg; [OTC];",
"     </li>",
"     <li>",
"      L-M-X&reg; 4 [OTC];",
"     </li>",
"     <li>",
"      L-M-X&reg; 5 [OTC];",
"     </li>",
"     <li>",
"      LidaMantle&reg; [DSC];",
"     </li>",
"     <li>",
"      Lidoderm&reg;;",
"     </li>",
"     <li>",
"      LidoPatch&trade; [OTC];",
"     </li>",
"     <li>",
"      LTA&reg; 360;",
"     </li>",
"     <li>",
"      Premjact&reg;;",
"     </li>",
"     <li>",
"      RectiCare&trade; [OTC];",
"     </li>",
"     <li>",
"      Regenecare&reg;;",
"     </li>",
"     <li>",
"      Regenecare&reg; HA [OTC];",
"     </li>",
"     <li>",
"      Solarcaine&reg; cool aloe Burn Relief [OTC];",
"     </li>",
"     <li>",
"      Topicaine&reg; [OTC];",
"     </li>",
"     <li>",
"      Unburn&reg; [OTC];",
"     </li>",
"     <li>",
"      Xylocaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8768585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Betacaine&reg;;",
"     </li>",
"     <li>",
"      Lidodan&trade;;",
"     </li>",
"     <li>",
"      Lidoderm&reg;;",
"     </li>",
"     <li>",
"      Maxilene&reg;;",
"     </li>",
"     <li>",
"      Xylocaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691542",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat painful nerve diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat signs of hemorrhoids or rectal irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease long-term pain problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691606",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain from skin irritations.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691601",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain caused by shingles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702388",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lidocaine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697759",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care when a large part of the skin is involved or where there are open wounds.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696692",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid use of heat sources (such as sunlamps, tanning beds, heating pads, electric blankets, heat lamps, saunas, hot tubs, heated waterbeds). Avoid long, hot baths or sunbathing. Your temperature may rise and cause too much drug to pass into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad mouth irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad numbness and tingling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry, healthy skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694529",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on hemorrhoids with a cotton swab.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696190",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use rectal cream rectally.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Skin patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694518",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on the most painful parts of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694470",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put patch on at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on for 12 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take off the patch right away if it burns.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3484615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Mouth solution:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3484616",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swish drug in mouth and then spit the drug out.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away all patches in a sealed container away from children and pets.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12242 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-EBA391572F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29413=[""].join("\n");
var outline_f28_46_29413=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768584\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768585\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024220\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024222\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024221\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024226\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024227\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024229\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024224\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024225\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024230\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024231\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/30/4579?source=related_link\">",
"      Lidocaine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/39/12915?source=related_link\">",
"      Lidocaine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=related_link\">",
"      Lidocaine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=related_link\">",
"      Lidocaine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=related_link\">",
"      Lidocaine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/11/20663?source=related_link\">",
"      Lidocaine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=related_link\">",
"      Lidocaine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/50/33574?source=related_link\">",
"      Lidocaine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29414="Cisapride (United States - available via limited-access protocol only): Drug information";
var content_f28_46_29414=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cisapride (United States - available via limited-access protocol only): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?37/22/38244?source=see_link\">",
"    see \"Cisapride (United States - available via limited-access protocol only): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/51/32565?source=see_link\">",
"    see \"Cisapride (United States - available via limited-access protocol only): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F152071\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Propulsid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F152119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Gastrointestinal Agent, Prokinetic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F152075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     GERD or gastrointestinal dysmotility: Oral: Initial: 5-10 mg 4 times/day at least 15 minutes before meals and at bedtime; in some patients the dosage will need to be increased to 20 mg to obtain a satisfactory result.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F152096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/51/32565?source=see_link\">",
"      see \"Cisapride (United States - available via limited-access protocol only): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Gastrointestinal dysmotility: Oral: Children: 0.15-0.3 mg/kg/dose 3-4 times/day; maximum: 10 mg/dose",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F152076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682665\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F152077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Initiate at 50% usual dose.",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F152042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11217380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In U.S., available via limited-access protocol only. Call  877-795-4247 for more information.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F8104790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088994.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088994.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F152056\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of nocturnal symptoms of gastroesophageal reflux disease (GERD); has demonstrated effectiveness for gastroparesis, refractory constipation, and nonulcer dyspepsia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F152124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Propulsid&reg; may be confused with propranolol",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F152117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (dose dependent)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Extrapyramidal effects, somnolence, fatigue, insomnia, anxiety",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramping, constipation, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Sinusitis, rhinitis, cough, upper respiratory tract infection, increased incidence of viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Apnea, bronchospasm, gynecomastia, hyperprolactinemia, methemoglobinemia, photosensitivity, psychiatric disturbances, seizure (have been reported only in patients with a history of seizure)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F152059\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hypersensitivity to cisapride or any component of the formulations; GI hemorrhage, mechanical obstruction, GI perforation, or other situations when GI motility stimulation is dangerous",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Serious cardiac arrhythmias including ventricular tachycardia, ventricular fibrillation, torsade de pointes, and QT prolongation have been reported in patients taking cisapride with other drugs that inhibit CYP3A4. Some of these events have been fatal. Concomitant oral or intravenous administration of the following drugs with cisapride may lead to elevated cisapride blood levels and is contraindicated:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Antibiotics: Oral or I.V. erythromycin, clarithromycin, troleandomycin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Antidepressants: Nefazodone",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Antifungals: Oral or I.V. fluconazole, itraconazole, miconazole, oral ketoconazole",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Protease inhibitors: Indinavir, ritonavir, amprenavir, atazanavir",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cisapride is also contraindicated for patients with a prolonged electrocardiographic QT intervals (QT",
"     <sub>",
"      c",
"     </sub>",
"     &gt;450 msec), a history of QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation, or known family history of congenital long QT syndrome; clinically significant bradycardia, renal failure, history of ventricular arrhythmias, ischemic heart disease, and congestive heart failure; uncorrected electrolyte disorders (hypokalemia, hypomagnesemia); respiratory failure; and concomitant medications known to prolong the QT interval and increase the risk of arrhythmia, such as certain antiarrhythmics, certain antipsychotics, certain antidepressants, bepridil, sparfloxacin, and terodiline. The preceding lists of drugs are not comprehensive. Cisapride should not be used in patients with uncorrected hypokalemia or hypomagnesemia or who might experience rapid reduction of plasma potassium such as those administered potassium-wasting diuretics and/or insulin in acute settings.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F152046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special note:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      On March 24, 2000, the FDA announced that the manufacturer of cisapride would voluntarily withdraw its product from the U.S. market on July 14, 2000. This decision was based on 341 reports of heart rhythm abnormalities including 80 reports of deaths. The company will continue to make the drug available to patients who meet specific clinical eligibility criteria for a limited-access protocol (contact 1-800-JANSSEN).",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias:",
"     <b>",
"      [U.S. Boxed Warning]: Serious cardiac arrhythmias including ventricular tachycardia, ventricular fibrillation, torsade de pointes, and QT prolongation have been reported in patients taking this drug.",
"     </b>",
"     Many of these patients also took drugs expected to increase cisapride blood levels by inhibiting the cytochrome P450 3A4 enzymes that metabolize cisapride. These drugs include clarithromycin, erythromycin, troleandomycin, nefazodone, fluconazole, itraconazole, ketoconazole, indinavir and ritonavir. Some of these events have been fatal. Cisapride is contraindicated in patients taking any of these drugs.",
"     <b>",
"      QT prolongation, torsade de pointes (sometimes with syncope), cardiac arrest and sudden death have been reported in patients taking cisapride without the above-mentioned contraindicated drugs.",
"     </b>",
"     Most patients had disorders that may have predisposed them to arrhythmias with cisapride. Cisapride is contraindicated for those patients with: history of prolonged electrocardiographic QT intervals; renal failure; history of ventricular arrhythmias, ischemic heart disease, and HF; uncorrected electrolyte disorders (hypokalemia, hypomagnesemia); respiratory failure; and concomitant medications known to prolong the QT interval and increase the risk of arrhythmia, such as certain antiarrhythmics, including those of Class Ia (such as quinidine and procainamide) and Class III (such as sotalol); tricyclic antidepressants (such as amitriptyline); certain tetracyclic antidepressants (such as maprotiline); certain antipsychotic medications (such as certain phenothiazines and sertindole), protease inhibitors, bepridil, sparfloxacin and terodiline. (The preceding lists of drugs are not comprehensive.) Recommended doses of cisapride should not be exceeded.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: Should not be used in patients with uncorrected hypokalemia or hypomagnesemia, such as those with severe dehydration, vomiting or malnutrition, or those taking potassium-wasting diuretics; should also not be used in patients who might experience rapid reduction of plasma potassium, such as those administered potassium-wasting diuretics and/or insulin in acute settings.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Risk vs. benefit: Potential benefits should be weighed against risks prior administration of cisapride to patients who have or may develop prolongation of cardiac conduction intervals, particularly QT",
"     <sub>",
"      c",
"     </sub>",
"     . These include patients with conditions that could predispose them to the development of serious arrhythmias, such as multiple organ failure, COPD, apnea and advanced cancer. Patients should have a baseline ECG and an electrolyte panel (magnesium, calcium, potassium) prior to initiating cisapride (see Contraindications).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F152114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2A6 (minor), CYP2B6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F152050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amitriptyline: May enhance the arrhythmogenic effect of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bepridil [Off Market]: Cisapride may enhance the QTc-prolonging effect of Bepridil [Off Market].",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of Cisapride. Management: Consider alternatives to cimetidine. If this combination cannot be avoided, monitor for toxic effects of cisapride if cimetidine is initiated/dose increased, or decreased efficacy if cimetidine is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Efavirenz: May enhance the QTc-prolonging effect of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May increase the serum concentration of Cisapride. The active metabolite aprepitant is likely responsible for this effect.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Cisapride. Management: Minimize consumption of grapefruit/grapefruit juice during cisapride therapy. Monitor for toxic effects of cisapride (eg, QT interval prolongation, ventricular arrhythmia) if grapefruit/grapefruit juice is added/increased in the diet.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Cisapride.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nefazodone: May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NIFEdipine: Cisapride may increase the serum concentration of NIFEdipine. Reported with sustained release nifedipine product.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May increase the serum concentration of Cisapride. This may result in QTc prolongation and malignant cardiac arrhythmias.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protriptyline: May enhance the arrhythmogenic effect of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Cisapride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F152068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Ethanol may increase CNS depression. Management: Avoid ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Coadministration of grapefruit juice with cisapride increases the bioavailability of cisapride. Management: Avoid consumption of grapefruit/grapefruit juice during cisapride therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease cisapride levels. Management: Avoid St John&rsquo;s wort.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F152051\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10912627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F152080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F15577065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 12-lead ECG should be performed prior to administration of cisapride. Treatment with cisapride should not be initiated if the QT",
"     <sub>",
"      c",
"     </sub>",
"     value exceeds 450 milliseconds. Serum electrolytes (potassium, calcium, and magnesium) and creatinine should be assessed prior to administration of cisapride and whenever conditions develop that may affect electrolyte balance or renal function.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F152061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acenalin (JP);",
"     </li>",
"     <li>",
"      Acpulsif (ID);",
"     </li>",
"     <li>",
"      Alimix (GR);",
"     </li>",
"     <li>",
"      Alimix Forte (CZ);",
"     </li>",
"     <li>",
"      Alipride (IN);",
"     </li>",
"     <li>",
"      Cipasid (TH);",
"     </li>",
"     <li>",
"      Cisamod (VE);",
"     </li>",
"     <li>",
"      Cisaride (TH);",
"     </li>",
"     <li>",
"      Cisawal (IN);",
"     </li>",
"     <li>",
"      Coordinax (HU);",
"     </li>",
"     <li>",
"      Cyprid (LU);",
"     </li>",
"     <li>",
"      Digenol (HR);",
"     </li>",
"     <li>",
"      Disflux (ID);",
"     </li>",
"     <li>",
"      Enteropride (MX);",
"     </li>",
"     <li>",
"      Esorid (IN);",
"     </li>",
"     <li>",
"      Gasprid (PL);",
"     </li>",
"     <li>",
"      Gastromet (CN, PE);",
"     </li>",
"     <li>",
"      Kinestase (MX);",
"     </li>",
"     <li>",
"      Lornakin (MX);",
"     </li>",
"     <li>",
"      Peptax (UY);",
"     </li>",
"     <li>",
"      Prepulsid (AE, AT, AU, BE, BF, BG, BH, BJ, BR, CH, CI, CL, CO, CY, DE, DK, EG, ES, ET, FI, FR, GB, GH, GM, GN, IE, IL, IQ, IR, IT, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MY, NE, NG, NL, NO, NZ, OM, PH, PT, PY, QA, RU, SA, SC, SD, SE, SL, SN, SY, TN, TR, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Presistin (MX);",
"     </li>",
"     <li>",
"      Prider (TW);",
"     </li>",
"     <li>",
"      Pridesia (ID);",
"     </li>",
"     <li>",
"      Profercol (MX);",
"     </li>",
"     <li>",
"      Pulsar (AR);",
"     </li>",
"     <li>",
"      Refluxin (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Risamol (JP);",
"     </li>",
"     <li>",
"      Stimulit (ID);",
"     </li>",
"     <li>",
"      Tadasil (MX);",
"     </li>",
"     <li>",
"      Unamol (DO, HN, MX, PA);",
"     </li>",
"     <li>",
"      Viprasen (GY);",
"     </li>",
"     <li>",
"      Vomipride (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IL, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZA, ZM, ZW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F152045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enhances the release of acetylcholine at the myenteric plexus.",
"     <i>",
"      In vitro",
"     </i>",
"     studies have shown cisapride to have serotonin-4 receptor agonistic properties which may increase gastrointestinal motility and cardiac rate; increases lower esophageal sphincter pressure and lower esophageal peristalsis; accelerates gastric emptying of both liquids and solids.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F152058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 0.5-1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 97.5% to 98%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic to norcisapride",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 35% to 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 6-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine and feces (&lt;10%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, &ldquo;Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3): 776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?28/46/29414/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barone JA, Huang YC, Bierman RH, et al, &ldquo;Bioavailability of Three Oral Dosage Forms of Cisapride, a Gastrointestinal Stimulant Agent,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1987, 6(8):640-5.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bran S, Murray WA, Hirsch IB, et al, &ldquo;Long QT Syndrome During High-Dose Cisapride,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1995, 155(7):765-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bucci KK, Haverstick DE, and Abercrombie SA, &ldquo;Dystonic-like Reaction Following Cisapride Therapy,&rdquo;",
"      <i>",
"       J Fam Pract",
"      </i>",
"      , 1995, 40(1):86-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cucchiara S, Staiano A, Boccieri A, et al, &ldquo;Effects of Cisapride on Parameters of Oesophageal Motility and on the Prolonged Intraoesophageal pH Test in Infants With Gastro-oesophageal Reflux Disease,&rdquo;",
"      <i>",
"       Gut",
"      </i>",
"      , 1990, 31(1):21-5.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hill SL, Evangelista KJ, Pizzi AM, et al, &ldquo;Proarrhythmia Associated With Cisapride in Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1998, 101(6):1053-6.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Khongphatthanayothin A, Lane J, Thomas D, et al, &ldquo;Effects of Cisapride on QT Interval in Children,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1998, 133(1):51-6.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koelz HR, &ldquo;Treatment of Reflux Esophagitis With H",
"      <sub>",
"       2",
"      </sub>",
"      -Blockers, Antacids, and Prokinetic Drugs,&rdquo;",
"      <i>",
"       Scand J Gastroenterol Suppl",
"      </i>",
"      , 1989, 156:25-36.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lander A, &ldquo;The Risks and Benefits of Cisapride in Premature Neonates, Infants and Children,&rdquo;",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 1998, 79:469-71.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lewin MB, Bryant RM, Fenrich AL, et al, &ldquo;Cisapride-Induced QT Interval,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1996, 128(2):279-81.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Olsson S and Edwards IR, &ldquo;Tachycardia During Cisapride Treatment,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 1992, 305(6856):748-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rizwanuddin S and Wolfe SM, &ldquo;Cisapride and Torsade de Pointes,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1995, 345:508.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sempere AP, Duarte J, Cabezas C, et al, &ldquo;Aggravation of Parkinsonian Tremor by Cisapride,&rdquo;",
"      <i>",
"       Clin Neuropharmacol",
"      </i>",
"      , 1995, 18:76-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tack J, Coremans G, and Janssens J, &ldquo;A Risk-Benefit Assessment of Cisapride in the Treatment of Gastrointestinal Disorders,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1995, 12(6):384-92.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tolia V, &ldquo;Long-Term Use of Cisapride in Premature Neonates of &lt;34 Weeks Gestational Age,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1990, 11:420-2.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Van Eygen M and Van Ravensteyn H, &ldquo;Effect of Cisapride on Excessive Regurgitation in Infants,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 1989, 11(5):669-77.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wax PM and Reiser JR, &ldquo;Extrapyramidal Reaction Associated With Cisapride Therapy,&rdquo;",
"      <i>",
"       Clin Toxicol",
"      </i>",
"      , 1995, 33(5):515.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Woodard-Jenkins J and Woolf A, &ldquo;Spectrum of Toxicity Seen in Cisapride Poisoning,&rdquo;",
"      <i>",
"       Clin Toxicol",
"      </i>",
"      , 1995, 33(5):490.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9269 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.102.30.19-5FA4BE6EBB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29414=[""].join("\n");
var outline_f28_46_29414=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708667\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152071\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152119\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152075\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152096\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152076\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682665\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152077\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152042\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217380\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8104790\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152056\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152124\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152117\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152059\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152046\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152114\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152050\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152068\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152051\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10912627\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152080\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15577065\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152061\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152045\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152058\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9269\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9269|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/22/38244?source=related_link\">",
"      Cisapride (United States - available via limited-access protocol only): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/51/32565?source=related_link\">",
"      Cisapride (United States - available via limited-access protocol only): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29415="Pressure ulcer sites";
var content_f28_46_29415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F80206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F80206&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 590px\">",
"   <div class=\"ttl\">",
"    Pressure ulcer sites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 570px; height: 444px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG8AjoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKCQDgkZNABRVLVtVsdItTc6lcx28WdoLnlj2CjqT7Dms/QvE1nrF3Laxw3lrcovmLHdw+W0iZxuUdwDjPcZGRzS5lew+V2ubtFFFMQUUUUAFFFFABRRRQAUVQvdZ0uxlEV7qVlbSnok06IfyJq3BPFcRCW3lSWNujowYH8RRcLElFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyWr+N7bTr6WAadf3Mcc62rSwhMGUgHaoLAnGeT0HPoa6xmCqWYgKBkk9hXhZ26/cQWfmh0muZrl/mwAJnkYu3+7BkY9ZV9KyqzcVoa0oKV7mzpd5Z+NPEOs6hb32rJbQtDHCkV9NAIzsG4bUcL94dec16R4WmkuPDOkTTu0kslnC7uxyWYoCST61514Int7rXvEtxZxNFbSSW5jBTZuXyQAwHoQMj2xXoXg//AJFLRP8Arxg/9FrVx1in3FUVm0a9FFFUZhRRRQAUUUUAFFFFABRRRQAUUUUAcd8SddutM0z7FpllPeXt9HIiiE4aNRtDP9QG49wPwqWuoeJbLTo8XNjdjYGL3wMbxcZO4pw2PoD6k9aS11aPWdb1W9hJFrat9hXfgfNGz72+hyv4AVc0y1/tTbe3a5tOtvCw4Yf89G9c9h2ByeenHUqS5tDrjCMYe8jIl1DUb/5n1HVLuBxny9NtPJjYe0pGfxDiol8NfalUxaLbxfKSZtSlMk2f9kgsw+u4Eehruqo63BLdaTdwQDc8kZXaG27h3XPbIyM9s1m23uHPbZHA6bFbT3ZGnXOjxaioZIpJrx7ySSQfwKz4IXI5wScdh1rQ1a4gv5LBPsr/ANrLP5Yi+0tbzQEqWYhl5IITj+FuOa22SXUoLewtdOewsI2QytMirhVIOyNQTzxjd0A6ZPTeMUbSLIUUyLwGI5H0NIfOzhZH8Q2Tt5N9rtvEPnt4ZraO7GeNwkdS7le+CVPJwTwBsaZ4svl1G0h1L+z57S5m+y+da70eKYgkK8bE4BxjrkEjiumrh/EqvPqdzfWETTNp720jIi8zPFJ5jKPUhDge7Y7VpGpJPcmynpY9KorO0rXNM1a3WbT763nQjkLINy+xHUEehrQLAKWJAUDOe1dl7nLawtFcteeMLeRmh8PwNq04yDJEwW3Qj+9L0/BQx9qwdQkvdVkNtrN5JcuwGdL03KIM93fIYj3Yqp9KzlVjE1jSk9XodHqniu3iuJbPSIjqeoRnDpE4EcJ/6aSdF+gy3tXP6mJriLzfFGsbIGIAtreU20IPpkEO5+pwf7oq3p2kIy/ZLqeC3RFH+gWD+UIweRllwx6dto68GoFuLfT7zzbTTbKDT4ZxbSTMoWUktsLg+gYjryeT6Z55VZSNoxjHZXGW+mxtGV0rQbZUBxvukECt6nG0ufxUZ9arXWhC2D3M+hxxsvPmaRcOsp5/2QjH8Cas+JNR1C3ub+W1uHX7GYPKt0C4lLMMg5GctnaBn0703U2ksb/WdShluXltZUlMfnMUMQjQsgXOORvI44JzWZd5Ml06fU3jE2keIZpLcZXyb2BZthHVSflkBHcM2av/AG/xKv8Ay9aRJj1tJFz/AORTWcdt34smgv0hAcZtLi2LRS7dgYByD8wOHwDx8nTnhLDUg4aW1uJdRsuCzGLbPED91igA3IRnDAfnyRXtJLZk2g90aDav4nX7tvosg95JUz+hxT4vEevRH/S9CtZVHU2l9lj9FdFH5tTra4huoFmtpUliblXRgwP4ipaftp9yvZQ7Elv410c4XUZZdKlJwE1BPJB+jn5D+DGt+3u7e5QNb3EUqnoY3DA/lXNOiyKVdQynqCMg1kzeGNCmm82TR7Ay8/N5Cg/yrRYh9UZvDroz0E8VmX3iDRtPJF9q2n2zDqJbhEP6muQHhjRAf+QXaN7NGGH5GtC3sLO2ULb2lvEo6BIwo/QU3iOyEsP3Zpf8Jn4axka5pxX1E6kfnUtt4s8O3TBbfXdLkY9FW6TP5Zqj2qKW3hlH72KN+3zKDS+sPsP6uu51cM0c8YeGRJEPRkYEH8RT64Cfw9pMz7/sMMUuc+ZADC+f95MH9azbm/1SyJjtJvE8KqcDCQXSn8X3Nj8QapYhdUS8O+jPUaK8rXxD4iJws2sE/wC1pcQ/XcBUsd/4llyzXXiDnnakFhGPp82TVe3iL2Ej0+ivNGm8SFf3NxqgYjG6We2B/IRMKn0rVfF9lLILq3ttRgYfKLi7WORD/vJCAR/wHPvQq8WJ0JHolFcj/wAJDr2M/wBh6efYak3/AMZqWLxHqYGbjQunaC7Vz+G4LVe1h3J9jPsdTRXMjxfEjhbvSdXtx/e8gTAf9+2Y/pVmLxdoDuqPqlvbyN0juSYGP/AXwapTi9mS4SW6N2imxyJKgeN1dDyGU5Bp1USFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcr8QL0JpsemK+x7/cJSOq26jMx9uCFz2LiuPu7GK08Pae72jYvVkMrQYEjiZgwtk9M/KpbssZ5Ha7cSN4m8WTqS406eOS3RhwWgiKiTB7CR5MZH8KDGDgh3xH06Wf7DNDeRW0cUUsKRmQhpJJAqIqKOCeSM9QG4riqy5pHVBcqSK3hBrpvEXiX7dFBDMJLceXAxKKPJGACcZ/IV3vg/8A5FLRP+vGD/0WtebfDy2msta8UWtw29obiCNWzklBCoUn324zXpPg/wD5FLRP+vGD/wBFrXXD4ImNX4ma9FFFUZhRRRQAUUUUAFFFFABRRRQAVieNZLiLwpqj2UhiuvJIicHG1jwD+dbdc78Qp5Lbwbqc0ULTvGgbYp5PzDP5Dn8KUtmOO6OV0fRY7G0tNFRpC14z3N4zYJYDaZPb5iVX6Ma7kcDArB0xjJ4kugekVpEVz/tvJn/0AVv1551VHrYKKKKCAooprsqIzuwVVGSScACgCjrV29lpzvDs+0ORFCH6GRjhc+wJyfYGqNjbJZ2scEfKoOSerE8lj7kkk/WoTcrq2pLcQMHsLXIicEFZZDwzg+ijKg9yW9Aau0jenGyKN3pGm3knmXen2c7/AN6WFWP5kVjT+H9EjuPs1vps9w7EMbOGV/JXPQshYRqOD1HOOAa0tXmuCLhLfcEgiEj+WwDysxKpGp/hyQct1HGOuQzTLebR7rT4opnmNzOyzJj5cFGYt6nBUfMxJ7Z5FCHJ9hLmSK1dbfWL+20+LgLa2bsXZSdoywUFQScDaAc4AbtVvT9RWz1VNOh06ODT5Jmt4ZImyWkVCzFlxwDtcZyTleevFHTIILq/hSDAjnvJr9yR/rUR8Kc/7xjI9lp+gzm41GS9k+SzgjnuAzdCJJW2MPT5EJ/4HTM35jtMtLca7DNtVrn7VdN5rD5zyRjJ5wAFH/ARUNwBNLPbyLuS51VUQHncFKs3/oD/AJVRgfVbVlv7QWh+x2j3F1HduyAtM5kcBgDgrsPUH71QaDqd8NTtY9R0HUfOthLcymPy5AskrHBGHzjBlHTPt1oHtc2bx2bxaluBlJbyLf8ARYHkH/jyLUeqyTPZ6+0I+e5uPs1ucfxFY4QfpvzWZpuvae2tPqlyLtY5PPvtxtJSEjVUiQ5CkYKgnPTk0lhrunwrosF/fpBIjNd3ZmVkG7aSRyP+ejg/hQNaa+RsSxrc+O7Z4mx9kYIyj0WF/wD5IWoPD8U0ep6QLYgKouo5sjkxK+FHPPDbf19aZ4Q1K21DWLe5t5oHaa1uLmUJIGKmSSMqDg9Qq4/4DTvB8pEJv5iPKj01LjjoDKzyOPyVKCdkyCHV0e+S+FqtsZ085xGSyz2+4KJD0AdCy7s/wt1OML1FczaQva6Rcx3owtnoiREYzudwwYfXMa/nVu1uJJNclfe5g3SwgbjswixHdjpkO0i5/DsKRpF20NuiqOl34v1kZYikYIMbE53oRlW9sjnHoR64F6goKZLIkUTySsERAWZmOAAOpNPqk0I1PVFs3G61tws9wCOHbPyJ9Mgsfoo6GgTdlcWztbjVx507TWunsP3cakpLKP7zEcoO4Aw3qR0qZtCkt3VtLvpYlwQ8d0XuVPoQWbcD/wACwcnjPNbtFMwcne5zdw95pr7tR8qa0I5uII2URH/bUlsL/tZ+uOtT291b3IzbTxTDGcxuG49eK3azrvRtOu+ZrOHfnIkRdjg+oYYIP0NIpVO5k3zTz6hZ6faztbtOHkeVFVmVEx0DAjqyjkHrTrVrq3v5rG/aORlQSwzIu3zUJIIK5+8pAzjj5l6ZxV9LbTdCjnvJZPK3gCSe4mLEgZwMsfc8D1rAt9Zj8SSW72iJa6hEpktvMcOrhly0T45RsAEjHYEbsEUDU3e/Q3qKq2N0LlHDo0NxE2yaFj80benuO4PcEGrVBqFFFFABTZI0kXbIiup7MMinUUAZR0DTlm862gazm6+ZZyNbk/XYRn8c1ZibXLRibbWftKdo763V8fRk2H881copqTWzE4p7ojTxLqtqhOo6KLgD+LT5w5Pvsk2Y+gJq5F4y0MhRdXy2EjcBL5TbnP8AwMAH8M1XqOeKOeF4pkDxuCrKehBrVV5LcydCL2Ontbq3u4hLazxTxno8bhgfxFTV5zH4R8Px58rSLOPPdIwp/Sqtva2SFX0b+2kt1bmaxnlMR7YxuIYe6g9K0WIXYzeHt1PUKK4Czm1EEzaTrs0/lko9veoJEDDs3AdW+p/A1p/8Je1kq/25pdzbLxvuLb/SIV/LD/mmPerjWiyJUZI6yisGz8Y+G7z/AI99d00t02tcKrfkSDWiurac6hkv7RlPQiZTn9a0ujOzLtFVo7+zkbbHd27N6LID/Wp1dW+6yn6GmIdRRRQAUUUUAFFFFABXP+Nb2S30oWdo5W91B/ssTKeUBHzyD/dQMR74HeugrzbVZl8R69byRTD7LKzWlsVyCYR808gPo+xUBHQYIPzVnVlyxNKceZ6mn4Os4I4ri6t1KxEi1tweiwxfKAPYtvOe+R7U24Bv/EkskgUR6aPJjXqS7ojMx+gIA+re1dFDEkMSRQoqRooVVUYCgdAK560G7V9ZlPDm4VNvoBEmPzzn8a4TohrK5zXgO7F/4i8XXKf6trxEQ+oRNmf/AB016L4P/wCRS0T/AK8YP/Ra15t8MVSOXxLHGAEj1SZQAMYG48V6R4M/5E/Qv+vCD/0WtehD4InPU+JmxRRRVGYUUUUAFFFFABRRRQAUUUUAFZ/iK0fUPD+p2cX+suLaSJfqykD+dWru5hs7aW4upUigiUu7ucBQO5rmJrrVdZj86KaXSdObBjCoPtMo9W3AiMH+7gtjqVPALX0Gu5k+EdVXUJtNuyGV7+xO/cCMPGy5X65d/wAq7GvPUt5dBvIbWHfJELg3Nk8jZ3M2fNhLHoxDOVzwSf8AZ57fTr+HUIDJAWDKdskbjDxtj7rDsef6jIrgnFwdmdMnze8i3RRRUkhVe9tLa/tnt72CKeBxho5FDA/gaZJfW0ep2+nvJi8nhkuI49p+ZI2jVznoMGWMYJyd3HQ45PxN4wh0y5d21GCztIX8lS8JmNxL/EAqnO1ehI/iyO3JYaV9jbPhy2hAfT5rm1mGPn855QQP4Srkgj8iOxFRSQ6nay7PJF/EwG2SLbGynvuDNjHTBHPt3PPab4ovZo5Jbe+a7jK7y0ulThUbrtBQDC47tkj37T2XxF01bqW01CWJroLvjWzDybx3XaQCGGO/BHPqAWZa5kCXEl/qBDwTQJ9shililG1l2RSSjPY/Pt6Eg/Sp3mN04mhbD3qtBbMDtMduCPNm/wCBHaAR/sHucbtxHp+vacZIAl1HuLL5cpjy+0qQWXkHBIP1rANvdMtxca7AthajH2gl1ZDCo+WGMAk7SepIBOSAORtBqV9xVJkh22uYpb9RFAU+VoLRer+xYnj/AHl9DUcrRDRr2IOFh1KdoVwcCK2jUJIfYYR+fV1qKyu7zVbSa5061u5J7tgJZ49qrAgOPLQyEAsoyOARvJJ9Kpx3SvfSre6dfwQWca5tBbMx2Kf3cIIBUgkbmbODwMkA4AZsLG0tosEibZ9Tm+1XEcnWO3XAVSOxIVAQf7z+lJHPLNZStbyMLjV3IhdRgxWyjHmfqWB9ZF7Vnf2pp9zJcx3uowbmHmXY80RvOccQxhyMKBwTx+ZYifR2PiB2ku2t4BcACdVuYpD5Y+7DHsY/L1yTgnJwORtA06kqxR3NqipGvlai6RRKnGLOL5sn/ZY5H0kWnXKreQXTsDnUZRYxEHObdMmQ+2f3gz3+SrsOi6ncXU8l7NBB5vyl7dy7iMdI0yqhB1yfmJyTxxgl8O3F1cSSXMluttHH5FtZQ7hH5Q6K7ejYXcAB90DJGcguZGNqi6fPYXd1Pa27NfgRW8jxK5WBAd0wB93bbjqTH61WfRo7TT/skNzcacH/ANK1BBLvjhjx8kRDZGcBQcY4B7Fa6JPC9y07XV3qfn3rMMSCAKsYHI2qSeV/hySB1wTyYG8N3NuBBYSyTShzL9t1Bw4Rjn5hGgAdx1y/Tjk9ABzI524vdXguDDf2iXPnSJcFYF+feFzFE0eSRt2eawUsR6Y63ob2y1O8tdH0y9WeOOFo7i4UgMcsHnZh2PCj2Mv+ycaUHhS7tA6WV+UnlyZtRmHmTnJBYIowq5x94knoOwxND4J01TFFLDFPboFLvMgeacjszHomQDtXGTnPBIIDkh+nJqE7XF3BaxNBdSmWMyS7MR7QqYAU9VUHnGN1W007VpFQy3tnDuB3rFbs5X2VywBx6lfw7VSh0TTNZ0q1utE1HUrGznAmR7K4eIOhHA2t90fQA1cj8LackRWebUrkY+Y3GoTvn6jfj9KBc7toSx6CMEXWpajcrjoZFiwfXMaqf1png+COHTbny3kdmvbkM0jl2O2VkAJJJOFRRz6VQWy8Hx2U90lvplzDGyrI6qtwQzEADuckkVn2dl4eGuCH+x4Fhvc4Saw2eTKAOMkYwwHAHcHruoFqzvKK4zQtLsLvVvEdvHbmy/s++S2iNlPJASjWsE2WCtgndK46YwBx1J1/7N1W1LtYaw0wPSK/iWRR7Bk2sPqd1DVidzcorz+DU9YuzNPqMV40azSQmLTJU2R7HKnIO2TPHUE56jFSTa5DZv5lvrE8c6DK2eofu1l/2cyANk9iD78jigv2bOmtbdbjWru6uCsj27CCBCP9UNoZiP8AabdyfRR75XWtCsdXaB7pJFmgcOk0LmNxjtuHOKbHDHqK2+raZcNC88SMH2hllTBKh1743HoQfeln0n7e4OrTC5iUfLAimOPPqRklj9TgemeaCSJPC2hoc/2ZbuxxlpF3lsepOc/jUg8OaOoAXTbZQOgVMYrDefVFuDp2iXyPZxyFXuZoS7QgMcorlsOw+6PlOMfMcjm42mJNGFvbi7u/XzZiA31VcL+lBag2XZPD+hR7nm0+yweS0qA9PrVaSPwnAcyJoUZBxlhEMUsem2MXEVlbJ/uxKP6VMLeEDAhjA9NopFez8ymZ/BgkwZfDwkf1aHLf41J5/hGdf9boMgB/vQnBq4BgcdKCAeoBoD2fmUhZeE7hj5cWiu2MHy/Lzj8Ksx+HtGkCvBDgAYBhuHUY/wCAtQ1vC5y8MbH1Kg1BJpenyZ8yxtXzwd0KnP6UXD2b7lyPQLGPGw3ox0H22cj/ANDpy6HaKxIe8Oexu5T/AOzVlf2FpwbMduYSM48mR48Z9NpGKZfJqthA02jXbSlE/wCPS7zMr/RiQwb0y2Pp1AJwl3Lmo+HpJIWNhqN3FKqnbHK4kic+j7gWx64IPJ9qyNOl1eRnh0JmQ2qrHPbai+Y4Wx9wEKXY45zuAwV6547Cxu4b6zhurWQSQSqHRwMZB9u30qgF8vxYzKABNZDce5KPx/6GaZHM+pjtZaxfXtveXFpBDc25JB+WIOCCNrMDIxHOcYHIHpV9rXWlAZV06U90LvHj/gWGz+VdBTSQBkkD60BztbHN3K3EbD7Xo7y54aSApKo/PDH8FqpMdCWULd29pBI3T7VbiIt9N4Ga7GmsoZSrAFTwQe9IpVH1OaGj6U4BGnWLA9D5CHP6VCfDmiH/AJg+nc+lsg/pW1PoelztuewtxJ/z0RAj/wDfQwaQaJaKpCPdr7/a5Wx+bGgr2qMRPDmmRPvt4Zrdv+ne4ki/9BYVOdPuY1xaa1q1v6HzxL/6NDVoPonJMWpX8X0ZG/8AQlNNOizYwNYvwfXbB/8AG6abXUOeL3II5vEEC4i1a3uD/wBPdmCT+MbJ/KnR614kjOJbDSLhfVLqSI/kY2/nUd1Y/Y8NceIZYlxz54gA/wDQRUEd3anCxa2l03rBD5p/8czVqpNdSWqb6GoPE18n+u0G4Y/9MLmJvy3Faa3i+VT/AMi1rZ+htv8A49VCd5do8qa+c+iaewz+LYFVjZatcKBE2pI3/TxJbwxkfVFd8+3H1qvbTJ5KZZ1jUdU12E2iWkul6dIpE5kkQ3Eo/uIFJVQRkFt2cHjHUTeEbFF0+31Bgvm3ECeWijCwRYBWNB6dMnufYACCHR9KupXsdT0tVvGUyB5ZTMXA4JjlJ3YG4D+EjPTvWp4bk3aRFHjH2dpLXpjPluyA/iFB/Gs5SctWGiVol+4mjtreWeZtsUal2PoAMmuc0gSSm6v5kEbX0iziIHOxdiqoJ9cKCfQnAz1rpZEWSNkcBkYEEHoQa5aI3OiwxWt5ayvaxsIo7uIhkCZwm8Z3A4wCcEd8+klU7X1Oe+GmPP8AE7A5D6rMw+hY16P4M/5E/Qv+vCD/ANFrXnfw0C+VquzvOhP18tc/rmvRPBn/ACJ+hf8AXhB/6LWvQh8ETmqfEzYoooqiAooooAKKKKACiiigArnvEWt3VpfRadpcEL3skfnGS4YiONM4zgcsc9hj3I4z0Ncx4m1DQJbn+z9UE813AFmUW1vNJJBuyAwaNSVJwe9A0UbfSLi+1WG/13VZL3yW3w2iRLFbo3ZtvJYjsSxxXTyosqYzXm15qep6TqUQsf7Q1fS2IDLJpsq3EY/3tqqw+oz9etb3/CRwRD97FqMZxk7rGbj8QmP1q426A0yfV/BGl6tBLFcJMiSHcRDO8Y3ZznaDgnPPIqhceD9XicS2GtCSdF2pLdRESgdgZI2XcPZlap4vGeljObzbg4IeN1P5EU8eO9E4/wCJraZzjaX5z9OtTKnGW44ylHYgs7HxtbIVe60q6OeGnZun/AI1/rTzH463EKvhsDsSZ/5Vaj8baU5AiuTMx7QxPIf/AB0GnP4viyvladq0yE4LpZSAD8GAP5Cs/YQK55HE3nh/xD4g8Yy2OqavDa3FtYI8smnxsoME0rDysk5BJtyc56DGOtdjpfgbRNL2ta6fAZQAPNlHmvwP7zZP5VjaX4ht08Z+JL6SC+O5LSzASymdlEcbSYYKpK/8fGecdfxrePi/T1fa63ysOxsJx/7JVxio7EtyY+/8OWNyVeW0i81DlJUGyRD6q64YH6GsTWbYwW+dcgOsabb/ALxZ2YR3lrjncsgxuA+ob3atZ/G+gquZr9YR6yo0Y/NgKz7zxjoj7ha3YvnAz5dkjXDH8EBx+NW0pbiV0YMVzb7Zr7QNZGqwsm43EMhFxb46NcQqR5iDpu27gMZB6119hq0euadNFbSRQaiYSyAMJAuQQsqH+JOeCPocHIrA0jWLa+1iy1PUo7uwjtNzQW/2GdpmZlKnzGCbQuD90E5OCTximeIk0Oe4N5otxc2d3uMpiNhciJ3PVwVTMb/7S9e4auOpR6xN1O+kjrPDs9rLpMEdoFj8hFikg/ihYDlGHUH69etMu9cjhv2srW0u764Rdzi2VSsZ7KzMQoYjnBPT8M+b/wDCZwrME8RaDcX5iG1J5LE+YR7NtAYe+E+laWgePoIY7tF0e7Wy+0yLZrbWwEccaERsCR1PmJK2QMYYdax5H2G0dsdWu1JzoWp4HcNbn/2rmkfUbW4QreafeAd1ls2kH/joIrnpPG7y8Wlsq8cl4blyP+AiL+tNXxPqG3csvmISSWGi3ZK+wA6/jj8aXK+w+U0HbwlG5EiWNjIf4mj+yt+eFNaNvZ2tzAG0vVboL/z0huvP/wDQ94rkbjxxqkb+WNMvnQH/AF0Ok3GWH+4+Av13N9KgutQtNcOzWraYw5DYGhTpI3sXIbA/3cH37UcsuwW8zvBbanFGVi1GKU9muLbJ/HYyj9KSN9ZUgS2+nyj+8s7p+mw/zrjrSfRbOBYLOXXbeMdAq3mB+BBFSJrSRH93rmubeyyacXH5mHP60cr7D5fM697u/jPOmGT3inUj/wAe21malrWrW6RyRaLPDCgaSeWZ4WVFUZ7Sg/jzjHQ1it4s+zqSdRvJTno2kTH8OFFY/iLxxPJ4a10GXb5dhcN+80q4hJ2xMSQSSO3emou+wnGxN4Nt9Vu/CXhzT/scqQ22mW8Su7PHExESZkfBBY8cKM8nkjqNa+0nVbSa0sZbwXlhev5P2cO0a7gjPhi3mNtIQjAYDoMYJqLTPGcENrHplqtkLi0VYGM16qou0YwQRvzx/dxnvVDWPFYvNQtZRqFkn2Ji/lWTvOd5UruL+WV6EjaV/iPI4wNNsaUrG9fwmaZTqGi3xZPl3wsHRwDkAhWyy5GcMv4VYuZbe+t5Lae1vjG45zZyj6EHb1B5B9q5Ofx7cPPkXnlxjgKlvMmfrm3fn6GnN8SCisolDFf4jbzcj/v0P5UuV9iuaRp+FNUWw1vxGNQa6kaSaB/ONq6k/uUjG9dvysSnoAc8elbV94z0yyuhbSxag1wV3eVHZyM4HuoGRXncPixDrmr3Et15cV3bWrOPLbDczryDA3ZMcqPu960rHxfplnb+Tbak9rFuyIoIgqr7gC0FVJO5momnrGuXVnOutWGjamNLcg6ks8BRo1GAJ1T7xwPvDH3QCOVw2zHqctxbxTRaTfTW86B0kjMMiOpHBBWQ5BBrlT4+0oSFXvr+fB6+bLGDj6RLWLpnivS9BvpP7NFy3hyQNLJardMjWMhyWdOQTEx5YH7hO7IXdtFHmW2pXNKPoddc6Lp8skkltp2q6VdMwbzrOOSMk+p8s4I9c1FJcaxZo2LvVNq/daKJxn6iaJ/z3/hWFqXxIlsQw0q31B7gHCwXNxBLGDnncVJcfnWrp/xUhSADV7QfaAoLC0LNnPYbgF4/3vpU8rG230CxleytLWCTxVFCqIFZWtkDFu+CwHGfUZqcXUMgZ5fFOqRqrbS/2aOKNT9WhxjkdTTm+LOjYBW0vsf7YUH/ANCNQyfF7R0LOLW48sDG0j94zeoABXb7lgf9mizK532NBbjV7W3FxDf2OqWRI2uYXDsO+Wi3Dt1C0WnitJpzCbKV5B977NLHLt+q5D/+O1y2seKdE1WQXVvPJZXJbcWt5J1WQ4Ay37oHPAHGMgDJ6VhyeK7qFjb3Gp22pWj5+S/093jX23Ll/wAwaOVlKXc9Wj17TXnSCS5+zzv9yK5RoWb6BwM/hWmK8j0rxXHJbRG8mSygeQQvAlx567TgbjFIpITnnDAjB4qZfE0WjavbLpEmnzWjb/NSB5LeEjH91gyhs45U9Acj0XKx3R6vRXCr4489Ny3WgWa8ZM95JIefZY8frVyDxPYSKPtHi7SU9RbWMrf+PFyP0qlTkyXUijrqK5Max4VLb77xpfTIP+WcYEK/+ORhv1p6ar8M2n8xr5XmI2+ZLNcFiPdmNWqL6sl1l2NmOG+0+eV9LkgaCVzI9rcZChj1KMPu5PJGCM88ZNVZW122urvUo4rG7uZINiW25kEe3cQFbB3ZJ5yFzxyKqJrXw3LbYtQVWP8AcluFP4EGnSar4BKrt1m7iZejLeXQI/M4P45p+xfcj2kX0NTT54NSuvJutTvzcFd4tWVrTA7lcAM2P94iqureHdLW8a6vNXkjcgALevFMqj0XzFJA47HnFYV9qvhl4DAPGFrdR5BWLVLYSgHthlCEfU5qC08T6JpK4gOgyM5yzafeRqzE9yJAn/oRqHTkhqz2Zqmy8MZdf7R8PyOeT+4hY5/4CaEs9McDybqDBxn7NYTrn/vl6jXx/oK7RcTyQlhkfJ5o/OMsP1qyPG2gNnbfMwBxlYJCP/Qamz7GlvMVLGBIyE1TV16D93FdjA9gWxUU1qGZSuq+KXZT0hDIDz/tjH50Dx34bL7f7SG708qTP/oNI/jzw4gOdQY44+W3lPP4LSsw5V3LFhZlSRLF4guMnO691LaP++Y3/mKtPYQ4z/YGlzse9xOXP5mMmuZm+J2jCYR29vfyjvIYhGo/76IP6U//AITu1nxs1HSbNSeTN58rD/gKxgf+PU1GT6Caijqbb7dbDbZ2GkWa+ke5v5KtWFn1jOXudPA9Bav/AD8yuYGu6BckG/8AGk4AG4x2Vo0CkeuWV2x/wKrg1fwGY9r65fuRyWN5dqf0Iq1RkyHOC6GxcjVZ4iE1Rbd+zQ2y4/Ji1Zxh8TwSb4tahugOkc1usQ/EqpJ/DFQDV/AMR3f21fcet9eH9N1QSar4RkYC08WatbOcEY3yDH0kjbin7GXcOeHY07Q6jbXSXd9ZpfXQBjSRLkZjDEZwpRQF4HPLcd6dpx1ixtfKii0/mead8u53+ZIX2g4G37xG7B6dKxLjxJY2wAtPFlncn+7eWMgLfR4wB/46aqS/EawtNouBBdAjO6wlL8eu2RUP5ZqHTkilyM7d/EMCw6NIIXYajdfZMZGYXCSMQ3rgxlTim+L2b+z7WJc5mvbdeO4Egc/op/DNeZ6l4p0u+msZtP1S5gWG/W7aJ7XaYcoUZwSpDfePHPLd6t6h4y0omIW2s3l/fv8Auobm5i2xWpb5TIQEUHAPYE9uM0crsiVH3i98LmBfxIFOVXVJQpxwRnIx7YIr0rwZ/wAifoX/AF4Qf+i1rzDw7r/hzSdS1mG21BfsfmQLC+xzvC28alunXcDz611fhLxv4ch8NaTbT6rDFPDZwpIsgZdrBACOR1zXbGyikYTu5NneUVU0zUrPVLb7Rp86Tw7ipZex9COo6g/iKt1RmFFFFABRRRQAUUUUAFckyqfEOssqnzC8QY+o8sYH6n8662udt4xJ4g1kD7waInjt5Y/wNOLswBY2Io8tq14rcFOlO+zD0q+YVjG8tqPLatn7MPSk+zD0o5gsY/ltR5bVs/Zh6Un2YelHMFjhPByNNP4kugD+/wBWl59THHFB/wC0f89T0fltUPgfR7nTtA8rUYvKu5by7upE3BsedcySjkcdHH8q3/sw9KFILGN5bUeW1bP2YelH2YelHMFjG8tqPLatn7MPSj7MPSjmCxyfijUG0Tw7qWp7d7Wtu8qJjO9wPlUe5bAH1pfDWjtovh7TdN3b2tbdInf++4A3MfcnJP1q14w0a51X+xrOCHfZtqMM96xYALFFmVeM5OZI4lwM8Mc8V0P2YelHNqFjG8tqPLatn7MPSj7MPSjmCxjeW1HltWz9mHpSfZh6UcwWMfy2o8tq2fsw9KPsw9KOYLGN5bVzfxHjJ8Da1Eelxbm3OTx+8ITn/vrp3rvfsw9KwfG2kXOpaElrYReZK19ZM43AYiW6iaRuSOiK5x3x0J4ocgsPntlmOZY0fnPzKDSrCVACgADsK2vsw9KPsw9KOYLGN5bUeW1bP2YelH2YelHMFjhLVGT4i6qP+emkWWfbZNd//F/pXReW1Q/2Rcjx4dQEP+hNpvkGXcP9YJdwUjOehJzjHWt/7MPSjmCxjeW1I0JZSrDKkYIPetr7MPSj7MPSjmCx5nGr+BrhIZSR4SlIWKQ8/wBmOTwjHtAc/Kf4DwcKRt7MRtWpc6fBdW8tvcxRzQSqUkjkUMrqRggg8EEVzfhrSNT0HU5NIKveeHvL8yxuXkBktMYBt5MnLLzlG5OAVboCTmCxoeW1HltWz9mHpR9mHpRzBYxvLajy2rZ+zD0pPsw9KOYLGP5bUeW1bP2YelH2YelHMFjG8tqPLatn7MPSj7MPSjmCxjeW1HltWz9mHpSfZh6UcwWMfy2o8tq2fsw9KPsw9KOYLGN5TUeU3pWz9mHpR9mHpRzhYxvLajy2rZ+zD0o+zD0o5gsY3ltR5bVsfZh6Uv2YelHMFjG8tqPLatn7MPSj7MPSjmCxjeW1HltWz9mHpR9mHpRzBYxvLajy2rZ+zD0o+zD0o5gsY3ltR5bVs/Zh6UfZh6UcwWOE8dIyaXp8h+6mracD/wACu4kH6sK6Ly2qLxtpFzqOgiHT4vMuUvLO4VdwX/VXUUhOTxwEJx3xit77MPSjmCxj+W1DROBzWwLYelEluCOBRzBYwPCXmDWvESkr5YmhIA67vJXJP4BfyrqKytF01rG91W4dlb7ZcLKoHVVESJg/ipP41q1mUwooooEFFFFABRRRQAVUhsVi1G7uw7FrhUUoei7c9Prn9Kt0UAIowKWiigArh7nWvEmr+J9d0zww+j2sOjCKOWTUIJJjcTvGsoQbHTy0CumW+c5J+XjnuK5XV/BkV7rF3qVhrOsaPc3sSw3f9nyRgXAUYUkOj7XA4DptbGOeBQBlaN8SodTsLF7bQtWvL57WO6vbexWOT7EGdk+Ys67/AJo5MBAzELnbTNZ+IVq2h6peQ2HiK30uBJtmsWsEDKzRNtbyxIzc5BAMiBTg4J4qxJ4H0bT7ywg0jWL/AECV7RLEQWVxGrXkMJLAHzFZiV3vl0Ib5zk0lz8NLGfT7/TTrWuJo12JgNOSaIQwmVtzFP3e88kkB2YDJwBxgAnf4h2KaxcWcmlastrb6imlTaiUi+zpcPs2Kf3m/BMiDOzAJGcVj+G/Hl5e+INP06007VNT0yfTmuzezC1jmVhcNGS4EiLsAXGFQnp15q5pnw/lOvate6vqdxJYz6yNVg06Fk8gsqRiN5CY/M3Bo87Q+35VOM5qdfhtpsUNrFbajqsEUVpNYTKjxH7TBI5dkcmMkck4KbWGetAGDqvxVttT0DxAmgGWy1jTY4ZTvltbkBXmCHmGSVARggqxBGQcd69XPT1rgLf4X6clrcQXOr6xdrLZQ6eplMC+VDFJ5iKgSJQOR1IOR7813zDcpGSMjGQcGgDyzwr8QdQvNSh/t/UNF04CGae80ieyuLe8tAilsLI7FZtoGW2ouV+YZHXdf4hQxaLNql1oGs2lmkcc0cl29rbrNG5OGV5Jwi9MlXZWAI+Wnx/D61mktRreta1rlpa+YYLXUZYmRC6NGSWSNXc7HZQXZsZ9earSfDWGW1sYZ/EviGZtPlhmsJJZIGNo0auq7VMOxjh2BaRXbpzkA0ANtPihpuo2ejTaNpWranLqv2oQwWnkMym3YLJucyiPHPBVyG7E5GbEPxM0SbR9T1KKG/a30/SU1iYeUobym80bAC3+sBhcEHAzjk1mP8NLi11LQ20fxBqVrBZtqM1xdl4nu5JLp0c43RMhGQ2eARxg1Y1P4U6Rd6e9jaalrGm2k2mrpVzHaSx/6TCpcrvMkbHdmRzlSM7jnI4oAiXx4+kSeLbvVw9zY2WrxWluomtbbyY2tIZeXmkjU/MzdWLfNxwOOy8K69ZeJ/D9lrOmFzZ3aF034yMEgg4JHBBHBI9CRXP3vw606fUn1G31HU7PUDe/b0uITCxjf7OkBCrJGy4KRjqCQckEVveFNBt/DOgWukWU1zPBb7yJLlg0jFnZyWIAB5Y9qANeud8Z63c+H49KvI44X097+K2vmcHdFFKSiupBwMSNHnII2k9OtdFWd4h0i11/Qr/SdQDm1vYWgkKHDKGGMqexHUHsQKAOE1P4rWOjapqa6r5H2MXr2Gnqk8MEk7QopuHaSeVIwqu4QDIOVPB7Wk+J9lqVhNL4c0rU9TmGmx6kvlpEqLG/mgbmeRRkNCwIBycjbuGSLyfD2wt9O0SDT9T1WyvNJ87yNQheJp3845m8zfGyPvYBjlOoBGK0dL8I2dhe3l1Jd397Pd2MVhO91KHLpG0rBiQAdxMzZ7YAwBigDjovjDY6d4Y0G98TafcWWpalZrdC3NxaQrImxGaVDJcBdhL4VS3mcH5eM0WPxPRdW1i+lttRvPDKwWNzFdQxRBLOKaMHdJllcglgTtDlQD0FbNp8OIrODTRZ+JPEEF1p9u1nbXaNbeYtsQgEBBh2Mo2AgspcHPzU66+G9ldXM7T6zrT2t0ltHe2jyxMl4IAAvmMYzJzj5trjdk5oAnufH1tFFrE0WkanNbaVM9vc3Be2giDqyggPNMg/iznpgHOCQDpeCPFmneMtHfUdJ3iKOd7eRWeN9rrjI3Rs6MMEHKsRz1qlqHgTTb3TLyzNzexG41P+1hMhjLxT7gwKhkKlQR0ZW981o+E/DkPhu1vYor29vpLy6e8nnvGQu0jBQfuKoA+UcAcfTigDO+Iuv6joFjp8umxxpFPc+Vc30tpLdR2cexj5jRREMwLBVzkAbsk4FY8fxEi0vwpHq+r3WmatDJcyQLc6XPBaRgL0DrdTrtfOQUDMRXX+INHl1dLf7Pq+p6VNA+9ZbF0BbjGGWRHRh9VNcz/wrOwW4tr2DWNZh1aKe4uH1FHhM0zTqiybg0RRcrFGoKKpULgEc0ATWfxG0/UhaNoml6xqsU1rb3kslpCmLaOb7hcM6kngkqgYgDOOmX2HxCsr2Oynj0vVksru9/s+K5kSJUM3mPGVx5m7AKE7gCMEc5yBX0v4a2OjxWUej61rlhHBawWcwgmiH2uOEnZ5hMZIOCQTHsJBx6VfbwLYf8Iza6LBeahbraXpv7e6jaMzRTGZpcjchQjLsMFSMdc9aAK958QbOK8Szs9I1fULx724sUgtkhBZ4VVnOXkVQuG4JI6duKPCnxDsPEl9p9vDpmrWSajbyXNlPeRRqlwsZUSABXZgVLj7wGecEiptD8B2Gk31peC/1K7ure5ubvzbl0JkknUK5bagGPlGAMY/Sp9H8FadpL6A9vNdsdFgnt7fzHU71mKli+FGSNgxjHfrQA3xbrepWus6LoehLaLqOp+dJ9ovFZ4oIogu9tispdsyIAu5epOeKqzeJtU0J4dO1qyOt63cedPBDoUIj3W0ewGR1mlAQhnAxvbJIxnnGv4m8NW+vSWE7Xd5YX9hIZLW8s3VZYiwwwwysrKR1VlIOBxxWPN4BWVobn/hJfEK6tH5y/2kJoTMY5dm+LBiMYTMaEBUGCMjBJoAS2+Imn6g9v8A2Hpmr6vHJbwXU0lnCmLZJSQm8O6sW4YlUDMMHIqOX4k2MenXGqHRtbOiRBnXUxDH5EiLIqO4/eb1Ubi2WVcqrFd2MF9t8OtP0+S3OiaprGkRR20FrNFZzJtuUiJKby6MwblgWQqSCcmn23ghdLsb6DTtQv7qya3uIrbSL2ZRZR+bklSUj8wrngbmbaCcCgB+pfELSNNmvWu4bxNNsb1bG61LYptoZDGHyx3bgo3KpbbgMcHuR0GgamNZ0i21BLS7tI7hd6RXSBJNvYlQTjIwcHnnkA8VyWj/AA106DwJonhnVJ57qzs8S3sQf93fzHLMZsjcy7yWAyOgzkDFdZ4f0tdF0e106O7u7uK2Xy45bpw8m0fdBYAZwMDJ5OOSTzQBo0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyniTWtVPibT/Dvh77FDez20l9Pd3sTSxwxIyoAI1dC7Mzj+IAAE88CurrA8R+GINavbG/jvr7TNUsg6Q3tiyCQI+N6EOrIykqpwynkAjFAGB4j8dy+BdJgl8aRW88z+YTPp88EEZVeRiO4nVyxHOxPMPGMnjNe18efZ9b8Qi4+06hbm+s7XSbS2iQSyNNaJLtUsVH99yXYAAHkYxVjUPhna37PJP4h8QG7mtJbG5uTLC0k8MjFih3REIMk48sJ6dMVal+HWmMJXhvdSt7prm2u4rmJ4/Mt5YIBAjJlCpygIYMGB3Nx2oApa38UtM0EWB1zS9R04XQ5W6mtI5Ij5rRkGIz+Y/K7sxq4KsCCecXG+IliuvS6c2lauIItSTSZNQMcX2dbhwpRf9ZvIO5RkIcEjOOtUL34V2V6t4LjxD4hdr+NI76QywF7oI7Ou5jESoBbG1Nq4AGOK3JPBOmyfaN095+/1iLW2w68Tx+XhR8v3P3a5HXk80Ac5D8aPCs95eQQPNMIILmdHilt3MwgRnkCxrKZEOEbHmKgOOD0rY134i6Roqym7gvWKWVtfAKqAMs8pijXczgK24cliFAOS1JafD2ztoJ7FdX1l9DljuIhpLTRi3jSYMHUEIJCBuO0M5C9ugqrB8NIImuJX8S+IpbqW1hshcPJbhkiiYlUCiEIQdxBDKwYHkHrQB1XhvWF13Skvks7qzVmZfKudhbg9QyMyMp6hlYg+talYfg/w1Z+FdJawsJJZUeaS4kklCKzyOcsdqKqL9FUD2rcoAKKKKACiiigAooooAKKKKACiiigAooooA8y+LF1b2fizwZNeeIF8PQB7wNfloV2ful4BmVkBPTkH25rjrjx74hXRfP1bxCdEu49IW70xfscR/tucyzKo2upJ3KkB8uPa377OcYr36igDxu68R+J01LV9SfV5beCx1/TdO/sr7PC0XlzpaiVWfZvJBnYghhgjnI4EXgnxj4k1Xx9Ba6jrWlRK97dwXGiNODcRRxiTYRCLYOn3Ube8zKwPHJAHtNFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVFc3ENtEZbmWOGJeryMFUfiaxvEfiAaZLHZWUH2zVZl3R24baEXON8jfwr+p6AGuRktf7QvQdRYa5qqsG8onbbWx9QvKpj1O5z2zWU6qjoawpOSu9EdTJ410JZNkV3Ncn1tbWadT9GRSP1pR4ss3/ANTZ6pLxn/jzePP/AH3tqmtpqoxn7Dj0Bfj9Of0oTTNRkY/aNQhSM9Bb2+GH/AmZh/47WPt5F+zh3LLeKpQcL4f1dhjOd1sP5zUg8XwxIXvtL1a0QdWMKzfpEzn9Kg/4R6EYaO+1FZxz5n2hmz9UOU/8dqtcDUdOjL3USXluuS0tspDqPUx85x32kn0Wl7eQ1Tps6LTfEGkamoNjqVrKx42CQBwfQqeQfYitSvKb1PDOvNa319ZgpJjyru4tmjSUDnaWYAEegbr2rR0/TtFkUjSnVAuM/Yrp48en3GFWsR3QPD9mei0VxEFtqFpuNjrV8PRLkrcJ+O4b/wAmFWode1i0CC/0+G+To0tk/lv9fLc4/wDHz9KtVosh0ZI62isjTfEWl6jN5ENz5d13t50MUn4KwBP1GRWvWqd9jJprcKKKKYgooooAKKKKACiq1xqFlbPsuLu3if8AuySqp/U0kGpWNxII4L22lc9FSVSfyBoAtUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFU9U1Kz0q1NxqFwkEWcAt1Y+igck+w5o1jUINJ0u6v7xttvbRtI5AycAdB71w9vEXn/tzxDJGL51wiucJaIekaZ7+p6k+2BWdSooGlOnzm1P4g1G7yNLsEt4yPlnvicn6RLzj/AHmU+1Yuql1hSfxBrF7LuOwQ2heBHbB+VY4zvbgE4JbvV37VeTxhtP0y4lVujzkQL+Ib5/8Ax2sq6N7q1/aQWcMBubKb7Q8sUzmFcKymMybACx3YwAcDJOCBnllUlLqdMYwiVhFoaSCX7PqVg5+X7SFuICPq4xgfU4rRnvPEVrbRS6BqEepwHnF2ySEj/ZKhc/UvU0+rNZSxQ6nYXkEshIUwwtcRsR6MgJ/MA+1Zlstmj37x3NzaLdTCULb27x7cLgkgr1PU8en1MqTWxbUZblXWPHPi/Tdv2qw0i3hIz5szDe2Ou2MSkn8CauJ8V4Lmw8mzs0l1+d/LtrGOUyDkcNI+AE6ElckgDnHOHXa6aLRbq71W+u42bZGsVywMjf3VWLbuPtz/ADp3h/RPs922oXFtDaPtKQWkIG2BTgsSR96RiOT+HPU2q0kQ6MWPt7DE8dnJO9zqV7IJdQuEJVygBJ5ByicBAPQ8dzVjw9pJvdOt9QF5dWUc6+bb2tmwihhjblRtAwxxgktnkngDiqfhnOtW4tJYZ7eBoVub5tpia4lkJ+TPDbV2kHpkBR93r11+ws9KuGgMcAhgYoSvyJhTjj0GKzJk9bEGmT3AvLuyun89oFR0nChdytuwrY43Dac4wMFeBRfa5ptk/lz3cfnbtvlR5kkz6bFyf0rk9OivZrW2hh1ZhHqSGZ5ZE/evOFBKF1xgFVYYABATAI4qzFbwiKIQwCztrofZpo48L9nmDHY4xxkPleOuV7CgOQ249ca9MiaVZXE8iMEYzqYEQkA5O75sYPZTTYLT+0rcTXOsSTxjIYWUnkxAg4PKndx7tVCK5khW31VkCSRjyr2NOflBIbnvsbJHtuA61St7WPRdSl0tsJp16PKO07RtfKxv/vA/uzjrmM0A422Outbe0gsYoIEiFqAAi9VIP885696j1DSbO/kjkuI38xBgNHK8ZI67SVIyPY8Vxmn2X9p6XPoF6Q1zav51uzDCeZG2GXb2XOGA7LKMYwMWIfEWoWOjuqQfabi2O/y5n/ePCpxKm7P+sjzyTwwAPOeAVn0NyTRbuCZjpl+kVu53GK5iabYf9g7wQPY59sDiqzXl1a5jv7C5MoJw9rE0yOB/EMAkZ/unn0z1qwninTt8KyOY/PBEJfADSAZMZOcK444JAORgmpYPEmnzmdIzP58B2yQtCyuDgEgAj5iAckLnj8KBqckVWSx1ixQyxRXNs/IEqZwQfQjIIP4gj1ptuuq6WR/Zd8Z7cNk2t+xkGPRJPvL+O4DsBSPB4eu70GSBXW4YlH+Y28rk8kYOzzM55OGyKIdP1uCGOzhezZI1CLeTyPI7KBwWTAyx4z8/qfanGTjsU5RlpI0YfGVrC8cWtWtzpkz5wzr5sLY9JEyB/wAC2n2rUi8Q6LNjytW09iewuUz+Wa5hru6sZDbalA81wceU9rCxSfPYDJ2kdwxxjnOM4gutRjiljh16yWyjlVmje5kjZDjGQSCQDyOO9aqu+qIdGL2Z38Mscy7oZEkX1VgRTbq5gtIGmu5ooIV+9JI4VR9Sa81h0/w5e3HlJpMUEsysySfY2tzKARkq+AT1HQ9805NM0Kzu1hisXvbqP5gCr3TQ+nLbtntyM9qr6x5E/V/M6C48XNeZTw3ZtejO03cxMVuvuCfmk/4CMH+8KwJp0v5U/tDVbzVZ3BBt7AusI9cpGen++TWxbaRNqMBk1aS4iWRj/ocbhVCdgxHJJHJ5xzj66moXkGlWSsUOMiKGGMDLseFRR0/oACTgAmspVJSKSjH4UcjAvhaFTi0063cnDxy2yxyA/wC0rAEfU1pS6Bo8oAl0nT3A6brZDj9KmuLjV72IqYNOto2BEkUu648xT/CfugcZz97r+dbSYL23uZI5QEslTCIZ/Owc/wAJKhsYzwxPbBrM2TfVD49JFpIH0q9vbBh/BFKWi/79tlfyAPvVyLX9Z0/H9pWUOowA/NPZZSRR6mJic/8AAWz6Cp6KuNSUdmKVOMt0bmk6pZ6vaLc6fOs0RODjgqe4YHlT7HmrtcLc6b/pRvdOnew1EjBniAIkA6CRejj68jsRUqeML7TpEh1vRbqbI4utMQzRt7lPvJ16fN9a6YVlLc5p0WttTtaK5j/hN9JVN0sWrRjOPm0u5/8AiKfH410RwCJbxc/37Cdf5pWnPHuRyS7HSUVg/wDCX6CDiTU4Yj6TAx/+hAVInivw85AXXdLz6G6QH8s01JPqTytdDaoqG1ure7j32s8U6H+KNww/MVNTEFFFFABRRRQAUUE4GTwKyp/EeiW7lJ9X06OQHBVrlAR+GaAtc1aKwm8W6IPu3vmcZ/dRPJ/6CppF8XaKet1Io9XtpVH5laXMu5XK+xvUVjR+KdAkbamtabv/ALpuUDfkTmthHV0DIwZWGQQcg073FawtFFFAgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKo67enTdE1C+ClzbW8kwUdyqk4/SgDifFV2viCeVXn2eHdMk8yfaARdyxnJU5/5ZoRz6sPaqtpY6nfanJFd3Nva3bwrcwyiEyvChyNqBjtRl4BbBzn8BLHYrp/hvTNNdS26S3hlB53lpF8wn65bP1rSimF58QJVhOV06w8uYjs8zqwU/RY8/8CrglJydzsa5FyouJoYaKGO9v766jjAXy2kCK2Bj5toBYeoYkHvTrXVtMilisrbMcQPlROkDLBu/uK+Nue2AevHXitK5R5LaVIn2SMhCt6HHBrlLy5E+gjQY7G6t9SeAQxxmFtkRAAEvmL8mFOGyGzwBweKkg7Cuf13xTZ6TqtvphinuNQuIWmjhhAPAYKoJJ43EnHsjk4CmtTU7+30nSrm/v5fLtbWJpZZD2VRkn6+1cl4U06Yi41zVodms6m3nSK3Jto8YjgH+4uM9txc96aWl2EVzOxc03ShHezanfLBJqlx9+SNAFjX+4vfHAyTycemANC6uIrW3eadtsa+xJPoABySegA5NJdXCW6ruDO7nakaDLOfQD/IHU1BJHJaGG4vES41OQkW1srExwnHLE47d3x3wBzgybt8uiJLSf+yoHluo5JNRvW8wWseGYAAAL6AAAZYnGSeeQKyb1r3Wikd1OIYp4fOtUjBKLIjfMsoIy+Dt4OAeeARmte0tfILySOZrmTmSZurew9FGTgdvzNc7qU/m3dzZafeQQLFMs73kvzLYynggDPzFgeV4A3MSeQKCeW2rH6pqUVlHHdbo7c3RNzFDI43R3MZ/eRD2bBGR33f3hV2Oe01W4v4rVJhaXsK3EckkbJvYgqWQMAcDbG2fVs1laVpiRX2oWRtdmsvB9rSeb55DKjDOHIGY2JQ4GBy4wOQL+l3CSWGmz2isILe4e1ZSMbIpF3oPbGYlx26UwT1LmnSF5h5sIQXsIndM5CzDCSrjsM7fqSxqnfW/2rQoYXkKNZTtYOzHLBWAERz65MDZqcr9ngkmfcFsdR+U5+9HMF3Z/wBkNKT/AMAqxOizQ69ZrwzW6XIYdnIZQfw8paAe3oZd3dSfabXV44wjSQreGM9Ukj+SdD6ny22geqe1WtciaDVpbi2VG3quoQ4Gd7IAkq/8CjKD/gWarXLRW9yx2sI4biK8Qdik+YpB9Ax8w+5qZcW9hZlyVbSbwWvXJaGTCIPph4yT6oaBWsZ0tpbiKWMPH9iDRxh1G4eQ4/cS4/2d2wk/eQNnjimi2kE4TbIsysbcp5hBWVRkRhzzgg7o2PTO3owAveQIklWYL9mjkbT52HBEL4eEj2UyeWPrntT4tl4YBeMzm8ia1ueNo+0wnG8ehYBmB9EU0DRRhuGYSX0K+bDIfK1KyY7EdicLMF/5ZsTw3TDDB+6WHRWGtmCPypYrq6iEYljnRQW8vJGHUncXUgggAnj1OK5yUmJoLwZm89LiG/jAwJBE3lzPgdNwG7H97bj7zZ2fDtrBFaC5icySzKFkl3krIVJy4HQbiS3HXOaGJRudBa6rp93IsdrfWs0jZwiSqWOOvGc1bdEfbvVW2nIyM4PrWJc2sVzHslU4DbgyMVZW9QwwQfcVBHYPDI0lvqGoRyMMEtcGUH/gMm5R9QBSB0+xs6jp1tqKRrdK58ttyNHK0bKcY4ZSD096fZWdvYweTaQpFHksQo6k9ST3J7k8msvQLi9l1HUYLif7Ra2/lokjoFfeQWYEjAICsmOB1rdoM3daBXL2UcVzf3t5IokuFuJIUkbkoqnbtX+6OOQOp611FYUujXcd1PLp9/FFHPIZWint/MCsQM7SrLgHGec8k0yoNJ6iXd1BZwmW5kCJnA7kk9AAOST2A5NVI57nVXWLTorm3hLfvbqeBo9q+iK4BZj0zjA5znodGw0cx3Md1qFwbu6jz5eE8uKPIxlUyeccZJJ5OMAkVFYWzavBHfX8s3lyjfFbRyMiKh6bsY3kjk5yBnAHcop1OxFd2F5pqJNaTz3sKn97DLhn2n+JCAMkf3TnI6YOMzwSpPDHNCwaORQysO4PINJPpFxb3MUmhXMNjHtKywyRNJG3TBVAy7WHPI655BwKqwaVfaPbpFZsL+1TgRuRHKg/2T91h6A7cepoCE+jL9FVLfULeaXydzRXHP7mZTG/HXAPUe4yKt0GoUUUUAFMkjSVdsiK6+jDIp9FAGXJ4f0d5DKdMs1mP/LVIVV/++gM/rUkOnS2rlrHVdUtyf4TcmZR9Fl3AfhWhRTUmthOKe5Xiv8AxDau376w1CLssqNA4/4Eu4H/AL5FKfE+tKSP+EcRiO6364P5qD+lVruSW41K2020l8uSQGWd1xujiHGRnjJYgDPue1Ra1ph0a0W9027ulZZI0lW5me4RlZwpbazZBG7d8pGcYrRVp9zKUKd7NFl/FWvjOzwsremdRQf+y0gv/El/taaa00mIjmK3Xz5R/wBtGG3/AMcP1qHU9L14W2+21GGSQOmYoLUIWTPzbS7sA2M4J44/GowmgJGok1K5srpOT9ovHSbPujnDD04I9KHVm+ouWmtkSPotvcbjqUtzqO45K3kxkj/79/cH/fNXLW0t7SIR2lvFBGOixIFH5CqIks3AWLxHKjnn98kQ/QotMkuVidV/4SfRh3ImjBY/TEo/lWbu9zRSSNiisibU/JYIuoaFMxxgvfeST/wHDfzqWC7v5BlbCC4XubO8ST/0LbSHzIuzwQ3CFJ4o5UPBV1DD9aoR6HaWzBtMM2mODnNi5iUn3QfI3/AgatGe5RQZNMvVHtsbH/fLGoTqsC/6yC/T13WMwA/HbihNrYd0yxb6vrmn8XUMOrQ5+/DiCYD3UnYx/FfpWzpfiPTNRmEEc5huzkfZrlDFKcdcK2Nw9xkVgNqtgihpbqKIHgea2z/0LFMmOlavH5Ej2d4gbIXcr7WHQj0I9a2jXktzKVGL2O6orh7ZNW00j+zdSae3GT9mv8y/gsud4/Hd9KnTxZqsO77d4ZuGwcbrK7ilB/77KH9K3jWizCVGSOxormV8YQqm640nWIO+Ps4k/wDRbNTF8d6LzvGpRsOz6bcA/wDoFVzx7k+zl2Oporlk8b6dMCbWz1if6WEqZ/Fwopq+NIjKY20fVlK8sAsLFR2JVZC2Pwo9pHuHs5djq6KzNF1yw1lJDZSt5sRxJDKjRyR+m5GAIBxwehrTq077ENW3CiiigAooooAKKKKACiiigAooooAKKhu7q3s4GnvJ4reBfvSSuEUfUmuZufFTahenT/DsTSuVy1/NE/2aMeqnGJG9gQD60Dsber6zY6Uqi7mPnOMxwRKZJZP91FyT9cYrifFvi2efTdS09LbT7JpLd0Av9QSOXLLwPLUHGc92HUV1OjaXbacjuGM93LzNdS8ySn3Pp6AcDoAKreIrzSdFsp9U1AKgXA+RN0krnAVEA5Z2OAAOScU+W+4XSOL8QeKtPOj2N/Yzi5nS4hlitIz+9mOc+WB/exuPPAALHABNReCfFNgl5q1xezLcX900ckw06znkTfgjYDtJO0YGTjPXA6Df8O6HJdzya94qSMahPGY4LJmDx6fA2MxZ6M7YG9+/3R8oGdd9X8P6egjbUNOt1XgIZkQD8M1j9Xjbc1dVyexCNfmkXNvompyA9Cwij/RnB/SoZNZ1vLeVoUIA6NNfBR/46jUs/jHw/ErMuqWUmOdsUokY/QLkn8K57xdrE93osl1Lay2+lLtCWpGLjUZGIEcOP4FZiqkHk552jOVKlTjuKPM+hRj1e78c6/FYzQRQaPprrdXQilMqXMgOYFyVXK5HmYx0SM8hxjtLy4Fui4RpZpG2RRL9529B/MnsATWH4etP+Ef0qGyfF3rFyxuLhYRgyzN95h/dQYCgngKqj0FbtvEukwtfam4mvpPkAjHTPSKMH6cnvjJwAAOaTTdlsdC9xebEVY9Hj+1XhFzqc/7tFQYJ7+Wmei8ZJPpk9gG20DLJJcXDCS6l++46AdlX0Uf4nqTVeaSO2L6pq8kUc23YDn5YlJH7tTjJycc4yxx7AN0RG8VST75JLTT7d/LltuUuJSQCN/eNSCDxyfUcgqMHJ2QXUFzS3JYI7nXp3t9Pke3sEO2e9Ucse6RZ6n1fkDpyemzP4O8OT2ot5tEsHjA25MI3/Xd97PvnNac01jpNiGmktrKziAUFisaIOw7AVhy+ILzUsx6Ba7YjkfbbtCqD3SPhn/HaPQmuyFNRVjmnUlJ3ITot54fiQ6K8l7p8S7fsEz5kRf8AplIeeB/CxwfUVzVzqOjQ6Rfppl1NJd6pPLdQQbDuW5jRGMWMDa3yBth5IDYziuiPhqK5Pmaq8mpztjc12dyfhH9xfwFYfizwTZ3eluNPsxa3iFXiks9sLKwIKtnplT8wz0I9CQVLDp6oFUsWZrq3utH8R3UMqy262vkkA8eYEZj+PzqPXirUzeVqN44/j09yw/3Dx/6GawrHxObuzvtF8TaTdnULdVS+exj3LID92ZVU79rAZGAcEMucqasQ3umyLe+Z4ig3y2slvAl2n2aVQ/8Ae343EEDHyj3zXLKDjubqakmWtQtdxW1UZd9OuIR9QIyDj6ikijj1R3ERwdV0zeuegKEFG+v739BTIdUuH83UIrQSS29oyRxJNHKZJHZc42McqNo564JwO1S+GrdooreW0imeDTrE2kLTqYTcOdmeGAIH7tRk8ZY+lSVJ7j9FEep3UjzoVi1LTozLCT90gnP4/vMf8BrHS6kTQNUkHmTXlrfRIuxfmluEKxsB/vbefZj2rT0CeDRomuddvbW0dIEhWKSZN3y5LvgE8sx+6CeFHc4GdbeJbWK1a18PWOoRQSMZWuBZSyyOzHJYDbjJ9Wbj+7imk3sJvXQ09Et5EvJzI6v5KlG2nKiZ3aSUKe4BKL/wH1zWwqqihUUKoGAAMACsnRtT0x44rS2laKVRgQXKtHMfUlXwxJOSTznrmtipZqtgooooGVdMufsWrXFrcALHeOJbeTsW2hWjPv8AKCPUE/3a6GsK7toru3aGddyN6HBB7EEcgg8gjkGjSdQmhnTTtTYNOc/Z7jGBcADOD6OB1HfBI7hQxnHqjdoorLvNat4Lk20Mc13cKMvHbgHy/wDeJIVT6AnJ9KZna5qVhywX2kWV02mmG4gjV5YbaRWDA8ttDgnIz0GOOmelR3OsXdxEYrGwuIJmO3zrjYEjHdsBiWI7AcH1FN0nVTb3NzZard75FmjSCWRVVpBIp2jCgDO5XHQdPxIVytK7Kg8S6nNcLHZ6bp848vzpGF+wESYBBc+VhSQRgd+vQE1dsvE8E1vHNcWd/ao4yrPCXUj1ymcDuCwHFUUit7+WS2tIlh0a2kKeUi7VuJAfmJ9VUjGOhIPUAZ16RagnqSifStYUweZZ3oXDGIlXKnsSvY1AfD9qsm+2nvbY56JcMy/98vlR+AqG6srW7Km6toJin3TJGGx9M1CmmRxSb7ae8gPoly+3/vgkr+lAeza2ZYl0nUFbNrqox6XNsJP/AEApTjZ6pGvDWVw3/AoR/wCz1BJFqIOYdXuAfSSKJh+ig/rSpJrSnm+sGX3s2z+Yl/pQO00NKa2p+bT7Fhz9y9Yn26xChX1TaN2ksG7gXCGo7rxDJYgi6n0gMMY8268nP4ENiqw8ZK2fL/smQDqUv2YfmIsU7CvMvINYkb5dOt41zz513g49flRqlGj3c5b7bqLLGRjy7SPyuPQsSzfiNtZ9n4rN7N5Ns+ivIeipqJdv++fLBq3KdXmk+bUYYIuwt7YB/wDvp2Yf+O0g99mvp+n2mnxlLOBIw3LN1Zz6sx5Y+5JrL8U3Nu6WmmGeMXV1cw7Ytw3FFkVmJHptVhn1wOpqE6exkEn9oaj5o/i+0Nj/AL4+7+lUrmC1if8Asu3tY7u+vMyuJ+jAMMySN3wSMAc9AMAcAvZ9WdlVW+sbW+RUvLeKYKcrvXJU+oPUH3FcpJoepaZE06atFAVHzXBuJY40+scjSJ/L8Kdopv8AUbDzL7UrtiXZB5RREcA4DqyorEHGQf6c0xKN9mbI0ERKVtNQvoV7K0gmA/Fwx/Wol0rVkJ26rauv/TWyJP8A47IP5VWbSY2ABvNU6YyL+Yfyasie80CzmkjufEc0ckR2ukmsSAqfQjfnNItRl3OgfTNYZCo1LT+f71g5H5edVKXwxcyMrvLojS55ZtKJz6/8taxzqmiTR/uLvXblW6NbSXsgP0ZTj9amja3mbdHpviCXrgyzSr+kkgqlGT2Qndbs0ZPDF84OzUreA8j/AEeGeHH4LOKdb+G9XhlRh4nvFVeqrEHB9f8AWF6zxbhmYf2FqwA6H7XHz/5GqRYUVCG0C/cdMSSxSfzlNV7OfYm6/mR0JttShUkatEw9bi2Bx/3yy1VhUatbrOZNI1KNgdmbcqDyQeSzfyrJCWasjzeGpFRCGLtFAdoHf75PFc74MSwh8H+HzeeHpprltPt2kmWyWTc5iUnBGTjJ4o9nK17Csr2uduNNaL/V+H9G2DoElwfy8oD9ajOnQuCX0a+jbuLe7Cj9JFrE+3aC5xMl3pmOcyxzWa/99fKv61r2kUhtkk0rWLkwnlGaQXKN+L5JH0YVDuty+R9GNhTQkYpeW9+mP+WeoefIh+m8shP0yapzWEgmOoeHLS4tokJkkW5maKKdQPuLE33M9mIXHXkVspqeoWo/0y0S6jAy0todrf8Afpj0+jE+1YvjbXUvtIh0vR50a61dJIY2x0xhWUjqrZYA5xtG49RghPvJljSZLTxPcmSO6kk0+OCKUJDJtDO5fIcrzkBV+XOOeQeK2bjQNMe32RWsVqy5KTW6iN0PqGA9uc8HvmtK3iWGFI40VFUABUGAPpVPxBayXuj3NvCodnAzGxwJACCUJ7bgCPxpCcm2ckl3NHY6JrxZBdxTRRyyIABLBJIEYH2IYPj1Ar1CvNfEEq3fhDUjaQsklvCxEDpsZHjG4KR26DHbGCMgivRbSZbm1hnjOUkQOD7EZrqw73ROIWzJaKKK6DnCiiigAooJA6muU1rxvY6ZJdItvcXH2eQQySKUSMSEA7QWYFjyBhQeeKTaW41Fy2OroryHUvijq586Oz0uytJVG4fapJGYL6mParke4BFc/J4r1u+SKS81PUL2KTIC2uywtwTxtMgJkJGfu8H2rN1oo1VGXXQ92vb20sYjLe3MFvGOrzSBB+ZrIfxhoWMwX4vB62UT3P8A6LDV5xpk2nSFF+z6Fa3aH95c3c6SyRj6FjIzdfvFMV06vpkLvDdeKFeRR80SywoR9Aq7v1rN130RXsordkHizWtOvprLUIJgzWQf/Q9Qt5bZZCxXDK0igBxtOMg/ePIzmls/FVvewxvZWOqTu4+4LVlA/wCBthPyaop7jSreWJbfxX9lgziWKWVZZF9DukyUGSM7gR06dw3Uaq+3xMGtQC5uTZblVQMkiUYjwO5wcULETWw/ZQ63HalqurQ6fcXl1JYaLZwKXeadjcMFHqo2gH6FvpWRo+iX3iHy9U8UzXo2kmwtGbyZLdTn96+zGJWBxjqinbnJcnPt7mLXJxf6xJrNxo0Egk023SyZnuTwVuX2RhQP+eankZ3nnbt1l1KweVTDpmsYP3n1GO8cD6RqrA/T5amdWdrN6jjGN7pGhc6X4ctNo1BLMkdPt0vmH/yITU9q2iwqG0+2gdfWztTIP/HFPtWbG8ygtp9/a6eWOcweHJlb8dx/pUok1Qqd/iy+BPQpoZGPzQ1jvuac/ZGsNRBA8iw1KT/t0eP/ANDC1zU66j4m1ua60+DbaaEzRRpKwy94Vw7KBlSY0baMnG6R84KVBr99qen2sU2n+KLq41K6mFvbxS2exGYgkswYYCIoZzgAkIQDk1qWP2XRdHt9L0fXxO0S7IbWLy/OmZjks5IYjJJZmx3JqkuVXIcnJ2OksJtM07Sftlu7PHINzSHLzStnGD3LZ429jxgdKybzUGW8jkuYmn1OUf6NYxtkxJ3JPQe7njnAzxnmtQ055Li0tbG7D65Yf6i5t02pZKxywmyT5gfjKHlsBvlI3jW8I6pbW7Xlrq0a2WvQr51600mRMmcCWOQgbovYY2Z2kA9daVDns3sRKfI/M2NP0iR7lb7WHS4u15jRR+6g/wBwHv8A7Z5PsOKzddbzPE+m22m3aWOoMrySXMeDL5a4Hl4PB3biRuBA2EgZFaUMWoeIr+NbOaS10JVJluVQpJcN2WJj0XByXA+h7joT4Z0Y6aLE2EX2fdvzzv34xv353bv9rOfeuy8UuWK0MW23dmJb+GrBr2G9uvtF3dxHMct1cSSlD/shjgfgBXTRIiqMYrlbrTtW8PTPNBPc6tpJ6wld9xbDnlSBmUex+b61c03VYL+2W4sbmO4gbo8bBh9PrTVnsS7nQ7gKaxUjBrN+1NjmmNcMarlYrmT4w0OaZrfWNBVf7csATGjNtW6iP37dz6NgFSfusFPTIN/RbrTfEWjQX1qN9vMDmOVMNGwOGR1PRlIKkHoQamFw1cjqsreFNZm12AY0W9ZRqsQ6QPwFugOwxhZPYK/8LZGmgudO/hfRXOW0uwY+9sh/pVe78F6BdxCOfSrIpkNhIgnI91xWkt3kAjkHuKeLod6XKPmZBYeHtJ0/H2HT7S3IGMxQqp/MCtD7PEKg+1CmNdelNJiuN1PRNP1OIR3trBcIpyolQNg+oz0Nc2/h660yfOjapPDFnLW11m4iP0yQy/g2Paty81KO0gaa6njghX7zyOFUfUmqFpBf+JJA0bz2Gkd59uya59kBGUT/AG+p/hx1qJxi/iKjKS2ZnWGuXk0l5BPot481pIIpXs9s0ZJUMMchuhBwRxmtGG8vJ8eToeqnOPvxpH/6GwrrNL0600q0W1sIFhhHOByWPdmJ5YnuTyat1zewibe3kcJe/wDCSgA2Hh9HyP8Al4vkjI/BQw/Wq19dS/Z1i1rQNViViMmOH7QqkdGDQliuOoPBHtXolFDoRBV5dTy7+2LdgYP+EpdbcjBiZVE4HTbuI3D643e+au22p2dtBHDp2nanLGPuiDT5ivPfcVAz6kmvRKKX1ddx+3tsjzLWfEl1p6xouh3r3Uv+pt5HjV5PcKrMwHqxUAdzXPeJrLWb2Gy1LV1tbBBf2MC29uTLIPMuokDM5wpILnjaeGPPJB9B1bw3epq97q2jXEDXFyFMttcp8rlVCgLIPmTgDqGGcnHJrlfGWrRHQJLS/glsNSiurSYQTcFvLuYpC0bdJAAucqT05APFaQowjq9yZVZSVkbVt4ddYki/tPUTGgwqp5cQA9tiLUo8IWzsGkutUc++ozj9A4roVmT+HApTMB3rb2ceiM/aS7nPHwXp/wApDX6lehXULgH/ANDpG8I2w6XGq/8Agzuf/i66EXIz1qZJwaOSPZC55dzkl8JWSMWYX8jHqZL+dv5vUv8AwjOmfx6dBJ/11Tf/ADzXVh1NL8h9KaUV0Dmk+pzlnoNjbNuttPtIT6xwqv8AIVpLZvitLCimPMqjrTv2JMXUNHtryPZe2kFyg/hljDj9a5+6gufDpNxZpc3emY/e2u4ySRf7ceSSR2KfiPQ9o04bvWRrOqQWjRwRobi/m4gtYiDJIfX2Ud2PA71M4qatIuEpRehQs7jV9Tgin0rSF+zygMk91doiMp6MPL3kj8BSXugeIbkH7TBoV0qnMaGSWJkPqH2tg+4Arf8ACOl3emWVydQlQz3M5nMMTExwZA+RSevILE4GSx4rdrnVCJo68jx/wlpWr3D38Uen2ksttqE6vJe3rutvIzeZhU2ncf3g+f5SwINdlF4WvHV5NY1+5ZfvFLONbaNR9Tuf8d1P8Hfu/EfjeDnA1WOVfQB7K2z/AOPBz+NdXVeyje5PtZWsjx9dJfxBbLcadLdW2nzDMUtzqNxO8idmMQZVGfQlvcdq2NB8FaHpDCWCxjmue80yhmz6gY2r/wABAro9R8J2xZrjRH/su9znMS/uZD33xfdOfUYb3rKTXRprGHxDCNNnTgySE/Z5PdJSApz6HDDuK1goLpqTKUpdTbS2d+2BTzZt61Xttc0+4UeRe2smemyVWz+Rq0t6D0II9RWl2QM+yNnrUqWY/iNKbpcdaqXeqwWykzzRRKO8jhR+tGoFDx0U0/wT4hvM822nXE3PP3YmP9K0dJ0tLPSrO1PBggSPHHG1QO30rjvH+s2V94O1S0hvrWVrqMW2xJVYkSMI+gP+19PXiuhGu2TvhdQtSSeAJl/xo6ga0lmMcH8K5PXvC8gVrnQLl9MvQ28iAhY5/Z1IK5P97aSPfpXQQajHL9yaN8ddrA1U1TW4IZVtYQ11fv8A6u0g+aRvcj+FfVjgDuaUopq0hxbTujm9I1PWobn7LfWs91NsaUwsiLOEBAJQqdkwGRkDY3I+U1flis75YdY0qGCW7glE2RGA8hUFWjbPIbBZefunGeldDoGh3UeoLqusSRm8WIxxW8JJjgViC3zHl2O0c4A44HUmPxNo0kLyaxosQ+2opa4tkXi8UDpx/wAtAB8rfgeDxx1KK3gdMK3SRoWlxHd2sVxA26KVQ6n2NT1zfhS7iZ5oLd0a1mH2y1xwdrn51x7Pk+28DtXSVzA1Z2ObtArXmrxuAx+1EMDz1jQj9CK0PhtK8ngzT45CS9t5lqSf+mUjR/8AstZmlx+RdarbruMcV2djMck70SQ5Pf5nYfQAdq0fhyQ3h6YrjyzqF5tx6faJP/r1tQ+Idb4EdRRRRXWcoVneI5Xt/D+pzRlleO1ldSpIIIQkYI6Vo1leKwT4W1gKcN9jmwcZ/gNDGtzmItG8tFDajq7vtAYvfSnJ7nBPFZs/grSZ743kpvWuiwcSfanBDDgNweTjjJzxxXaNb7pOnenGxJPFaWjs0Lml0Zw8/gfSLlpmujezmYKJfMuXIcL93Izg47ZFNi8BaHCMRR3MfGD5c7R5Hp8pFd4LAg0GyPpS5Ydh88+5xUXg/ToY0jhl1BEQEKBducA9RyTQPB2mbY1Muo7Y23Kq3sqgH1AVgBXafYz6UfYz6UcsOwc8+5x3/CJ2O7d9q1bdjGf7Rnzj/vquZ03Q7TxRfPNBJfP4XjO0ebeSyjUpATk4ZiPJUgY4+dh/dHz9fr+kah4g1Q6O0UtroCIHvbgHDXhPIt0wchMffbuDtHViOmi09IokiijWONFCoiLgKBwAAOgHpRywvsLml3OUTwvp6jBl1Nvc6lc//F0v/CMafuz5mp/T+0rj/wCLrrPsR9KX7F7UcsOwc0u5yDeFdOYgmTU+P+olcf8AxdH/AAielM+WjvHJ4O6+nbP5vXYfY/auf8aafqF5p0Ol6WkqNqMotp7pOPssBBMj5/vFQUXHRnU9jRaHYOaXc43w54e0zXbu91RoHOkgtaacnnSfMgYebNu3Z+d0AHP3YlI++a3o/B+mRqUjk1NIT1iXUZwuPTG+uvtNKhs7WC2tYlit4I1iijUYCKowFHsAAKmFpjtRywtqg5pLZnB23w/8P2wYQwXiZbcdt7MvPrw1JqHgPSbuIYkv47qM7re5a7kle3f+8ockexBGGHBBFd99l9qPsvtT93sF2zzjQmb7f/Y3iOfUodYVS0Useo3KQXqDq8P7zgjI3RnLLnuuGPR/2NB2utWH/cUuf/jlaWveHLPXbA2l/GxUMJIpY22yQSD7skbDlXHYj+WRVHw0utQ3E2l6/C1xJAu+HVIkCxXSZx8yg/JKO4xtPVe6qvd7BdkEmhwSABrzWMdeNUuB/wCz1lSeAtBkned4rwzP96Q3s25vqd3Nd59l9qPsvtTtHsF33OFHgbRgMD+0QPQX83/xVM/4QHRP7t//AOB03/xVd79l9qPsvtRaPYLvucIPAmiDtf8A/gdN/wDFVKvgvSVUKG1Ep0Km/mKkehBbBHtXbfZfaj7L7Ue72C77nlFnoFrpPiBNG1G41IWNyCdJljv5o1AUZNqwVgNyKCVPVkB7oSenHhTTwMedqv1/tO5/+Lre8QeHrfXNKlsbougYh45ojiSGRTlJEPZlYAg+3pUPhYapPphj162EOpW0hglkQYjuNuMTR+isCDg8qcr2yTQLsyP+EWsQCBcasAf+oncf/F0n/CK2BPzz6q4/unU7jH/oddh9l9qPsvtRoK7OJ/4QnQhcpcfZrr7Qhykhvpyyn1BL8VqJpMK5/wBK1U5451K4P/s9dF9l9qPsvtR7vYd33Oa/sS2/5+NV/wDBpc//ABylXRrdWBFxqvHrqlyf/aldJ9l9qPsvtR7vYLs599MjdSpudTA9tQnB/PfTJNHgkILXGp8ccalcj+UldH9l9qPsvtR7vYLs5r+xLb/n41X/AMGl1/8AHKX+xrftc6sP+4pc/wDxyuk+y+1H2X2o93sF2c3/AGND2u9XH/cTuP8A4usP4hWKQ+CtZujcXrta2slwvm3MkiqUUtuIJIOMV6B9l9qxPHOkS6j4J8Q2NvG0k11p1zAiJ95meJlAHvk0PlC7MKHwPo9q5+zf2hBg4Aiv5lx+TVZ/4Ri0/wCfzWP/AAZT/wDxddZBBJJBG8ybZWUFlHY45FP+y+1HuhdnFnwjYYI+16xg/wDUTn/+LpjeCtJd90rahKTx+9vpX/m1dv8AZfaj7L7Ue6F2cR/whGh5JW2kVj1ZZmUn8QaangbRFGNl8frfz/0eu5+y+1H2X2otHsHNLucO3gfRD/yzvv8AwPn/APi6F8DaGDkw3jexvp//AIuu4+y+1H2X2otHsF5dzjB4N0UdIb0fTULj/wCOVJY+FdN095H0/wC22skn33jvJdz/AFJYk11/2X2o+y+1Hu9gu+5z39m8D/TtU/8AA2T/ABpBpUWQXutUc5zk6jOP0DgV0X2X2o+y+1Huhdnn2labAnjPXbYveAJbWlwuLuYMQ5mT5mDZb/VHGc45rek0a0lIMhvGI6ZvZjj/AMfqSHS7mPx7eXfkt9kuNMghMvbfHLMQp98TE/nW/wDZfahcvYLs5xdGs1CgC64OR/pc3/xVI+i2boVY3u09QL6cZ/8AH66T7L7UfZfaj3ewXZxUvgnQJQwlsZHDdc3Uxz/4/TLfwJ4btgRDpgQHsJ5f/iq7j7L7UfZfai0ewXl3OQj8JaHGCF08c+srn+bVC3gfw0z720a2ZvVsn+tdr9l9qPsvtR7vYLvueZeK/C+h2dpp4stLtYJptTsU3ImCVFzG7D6FUIPtmt7/AIQ/w3jH9had/wB+FrQ8UaXc3eoeGlghZ4Y9T824YdERbecgn23+WPqwNb/2X2pe72C77nIp4Q8OIcroOm597dT/AEqVPDOhRljHo2noW6lYFGfyFdT9l9qPsvtT93sF2c7HoekxjC6XZc+sKn+Yok0PSJMF9I09iPW2Q/0roxa+1JJa4AwKPd7Bdnm8M8Xh7xjJBFAy2UUZmjSNfljjk5lRQOuGjEgX0L4HAFejRuskavGwZGGVYHII9a5y60h9TvtchhIS8iS2mtZGzhZVEm0n2OSp9iaPAmoC60l7VgyS2jmPY/VVycL/AMBIaP6xmvPrR5ZXR0J8yHQo1pq17aEh0b/Slf8Ai/eM2VP0K8H0wO3Nj4VQCz8HR2QOTa3d1CT64nkwfyIrJ8X6gLbVLY21uTeQhZDKWCrJESysjEZOAec4wrFM4BzV74bT7JNXsVEhhEqX0LSZ37Jxuw2e4YN+GKKDtIqprTO2ooorsOUKZNGk0LxSoHjdSrKwyCDwQafRQBF5Y9KkAFLRQBjeLPEEPhvS47ye0urwy3MNpFBa7PMkklkWNAN7Ko+ZhyWAqvD4psobVpvEMY8OSfMyw6rdWyO0YKAyAxyuu3dIq9c5I45GYfiF4bbxVotpp2y1khXUbS5uIroZjkhinR5EIwQcqpGCMHODgVVh8E2dh4z0PUdHsNMsdL06yvIfs9vCItsszwkOiqu0cRuCcg8jrk0AbUPiPQp768sodZ0yS8slZ7qBLqMyQKv3i65yoHcnGKx9Y+IvhTTdFutUXW9Ovba1lhimFndxSNGZHCLu+bA6knJ6Kx5xXJ23w7137PZadM+kR2WlQ6glrdRSSGe7a4R0HnLsAQfPuYhn3Mqniptb+HOpXVjBHYyadHLBotnYqGZlVpoLlJuSEOEOwjOCRuztoA7dPGPhd7qztk8RaK1zeKrW0Qvoi84Y4UoN2WBIIGM5p/hXXBr9vqMv2b7P9k1C5sMb9+/ypCm/oMZxnHb1NcB4y8F+L/FF7LJdTWKW0ptZI7ddYuVitDG6tIvlJEqz7iuQ0mMcYUYzXceCtEudDtdVju3hdrvVLu9TyiSAkspdQcgc4PPb3NACePPF2neCdFTVdXiupLVp0gP2ZA7Juz8xBI+UAEnGTgdDVdfHmhf8JVqOhvOY30+yF/c3shRbWNDt4Mhb7wV0Y8YwwOaseNdBl8QQ6RFH5BjtdRhup1mzh413BlAAOSc9Dx71xp+GN7occsfgvUfshGlyWkdxdTM05ladHyXCnA2JsDYJUbcA4oA7hfF/hhtL/tNfEWjHTfMMP2sX0XlbwpYrv3Y3YBOM5wM0+48U+HbbSrfU7jXtJi025O2C7e8jWGU88K5OD0PQ9q880b4b6vFqkd5fGyVP7btdTaKTUbi/cJFbPEQZZk3M25lIzgADjGAKtWfgfxBouvJrGlLo13MtzqhW2u5pI40jup0lV1ZY2w42YZcYIYjcOpALkPxLVvBEPiWWxsEiktLG6a1Go5miFxMI8uPLG1BkkN/FtYYXGa3ZvGmly3Ph9dFuLLVrXVb97A3NpdLIkTLBJKTlcgn92BjI+9n2Pn9t8LNcg8JTaaZtJmuW0jSbAK8sgjaS0uHlk3HyydjKwAOCeuQK2JfAOs6nri6xqMmnWNxPqRuriC0meRYoxYy2ylXKKXkJkDElVGBjnHIB32la/our3VzbaTq2nX1zbHE8VtcpK8Rzj5gpJXn1pItatpPFFzoSxzfa7ezivWcgeWUkeRFAOc5zE2eMYI59OG+GPgPUPDOo2cup29kxstONhHdx6te3Tyjch4hm/dwKQmSq7ucYIAwdnVPAena34/utb1/S9I1SxbTILOCO8t1meORJZncgMpABEicg5ODxwKANXw/4t0fW9BtdWiuo7aGexXUTFdSIkkMDA/PINxCrw3OccHnin3fi/wAMWd4LO88RaNBdkAiCW+iVyCoYHaWzypB+hBrzVPhz4o0/wxBp2mvos9xN4YXw/dNcXEsaxMpf94mIiXB8xhg7cYB56VqXvw3vbqw16GQ6a8moXekzIX3EbLXyBIrfL3EUm0cg7ucZOADuR4p8OnRjrA17STpIfy/tv2yPyN2cY8zO3PtmnP4m0BIreV9b0tYrhVeFzdxgSKzbVKnPILcAjqeK8/8AEPw41S81q91Kzmtm3a3/AGnFai/uLLzI2s44GBmhG+N9yswIDAg89TjV8C+BZ9C1qyv7i30+FIbCa38qC4muTHLJctKSskw3tlW5YkEkngDigDsk1rSXit5U1OxaK4ieaFxcIRLGmC7qc8quRkjgZGaNF1rSddtmuNE1Ox1K3RtjS2dwkyhvQlSRn2ryqD4c+JW07S9LvYvD0+naXpd7psYe5nJuxNsAMiqimMbUwQrEgnIJrtfhzoOs6JFqTa7PDI1xKhhRbg3TxoqAYadoo2k5zgMvyjgE0AWte8Wx6Zq76XZ6PqmsX8VqLyaGwEOYomZlUkyyICSUcBVyeOnSotN8feH73xFcaE92llqsFvDcm2vJEikIkjaTaELbtyIu5wQNoIPSsz4geFb7X9Vjli0Pw9qMCW5jjuLu7ntLqByTnEkSMWTkHbleRnPTGJefDzxFLY6xpsmpWt7HrGi22n3Wo3E0iTpPAkg37AhEiuzrnLqQMn5j1AO/s/Ffhy9tGurPXtIuLZZBCZoryN0DkZCbg2N2ATjrxUcPjLwvPd21rB4j0WS5uSoghS+iLylgCoVQ2WyGBGOuR61wen/DjUJLiK4v7LTIZBfWM827VrzUTNHB5u4FrgccyfKgGBzljxjV8QeBL3UpfF0kL2Ik1e/066t3ctlEt/J3Bjt4P7t9uM9R0yaAO4Gq6a2zbf2Z33DWi4mX5pxnMQ55cbWyvXg+lY58feDQsjHxZ4f2x4Ln+0ocLnpn5uM1ysfgvxFHrtpGp0k6Lb+Iptc883En2hxIJP3fl+XtBBkPO85AHTpTvDHw6udLXwaLpdNc6Npd7ZXOwE75JzFhkyoyMLJknB+bocmgD0uJ45okliZXjcBldTkMD0IPcU/A9KwfAWj3Hh/wRoOj3zxSXVhYw2srRElCyIFJUkA444yBW9QAYHpRgelFFABgelGB6UUUAcz4z8VHwrai6m0LVdQsxtDz2bW+2NmcIqkSSoxJLDoCOetW9O8RWk9lcT6io0mW2kWK4t724g3wM+NgcxyOqlty7Ruydw45qLx5otx4g8L3Om2TxJPLJC4aUkLhJkc5wCeint1rj/FvgvxFf6pr6aUdJOnazd2F3LLc3EiSw/ZzFuRUWNg2RECGLDqRjvQB0nhfxxpOu6lf6Y13Y22rW17c2i2Bu0aeRYXZfMCcNghSehx6mtK38VeHbk3Ytte0mY2ZAuRHeRt5GTtG/B+XnjnvXBL8P9bubuayu/7JttLbXLrWVvbed3uiZPMCJsMaqpw4y288DGO9Y9h8J9XTQn0+5h0zz4tNXT4rt9XvbnzQJonP7qUFIEIiyVXdzjBAHIB6lJ4v8MxeR5viHRk+0SNDDuvoh5kittKL83LA8EDnPFS3XiTRYdSl0v8AtfShrCRmQWMl4iS4C7slclgMck4OBzXHeNfBWrX+oa22hx6NJa61pMekyi/Z1NkqGT54lVGDgiUnYSnKKc1n/wDCv9fj8QSyWk1hDpzySySu11JKbgm3MSs0DxkRyn5N0qSDhT8vzNkA6XT/AIj+GpdVl0nUNX0qz1KC2t7iQG/jMMnmxl8QuSpkAUZztX5WU45rrEu7WS9ms47iBruFFkkgVwXRWztZl6gHa2CeuD6V5xoHgbUNKSay1SHT77Rb/QbTS9R2TSCWNoIZEby0EZ8wNvHUoR1wTxWn8G9G1HT/AAquoeIXmk1vU9ktw08ZjkWNEEcSMuflYIoLDszNQB3mB6UYHpRRQAYHpRgelFFABgelGB6UUUAcZ4j8fWehapqVpPpOq3EGl20V5f3lusJitopC4DMGkDtjy3J2K2AK05PGXhof2ksWu6XcT6dFLNdW8N5G8kKxg79y7srjBBzjHesa+8A2useN9Y1bXFNxp11aWcEVql3Miu0TTM3nRKQki/OmA27o3A787aeAPE1x4qtdQ1q/guI4TfK9ydSuJWkSZGSMJbFRFDtBUEKTnHXtQB2GmfEHwnf+HbPW/wC39KtrG62qGuL2JPLkKBzE53YEgDDK5yKp6l47jtNXuLKKwWeOK/0+yWZbjhxdEYcfKeFz0zz6iuRk+HniWaz8ONdQ6ZLPpOmNpDW8GuXlok0e2PbN5sMasCShDRFWXGPmz00bT4c6jbLAkL6dDDFdaPMsUckpVEtAokVdwLdvlySTxkigDvtM8R6FquoXFhpms6Ze31vnzra3uo5JI8HB3KpJGDwc961sD0ry3wt4I8S2vjXTNa1+8guzZpdpJcHUriZp/NK7SkDIIoAAoBVM9uTXqVABgelGB6UUUAGB6Vxsnja4TxGNE/4RHxAbwxNOpEllsMIcIZM/aM4yRxjdz0rsq599FuG8fQ64Hi+yJpj2RTJ37zKrg4xjGFPf8KAMZviHpllrVnY65daNYwXNrPci+Gpq0G6OcRCMMyqCxByR/CVZecZrcufEmm6fJfyavqWjWVhbGICeS/UEb1yPMDABM/w/M24c8dK4Cw8B+JNImsprKHQb6SOy1CykW7uZI1T7RdGZXGIW3YXgqduckZxySP4deItJ0/7LouqRPEo06Jx9sltJLqG3t2idGmjRmi3MVbKZOFxkZzQB6np17Z6nZRXmnXMF3aTDdHPBIJEceoYHB/CrOB6VyXwv8OXvhfwu+n6m8DXDXt1c/uZ5JlVZZmkUb5BvYgNyWySe5611tABgUEA9qKKAIIrSGK6muUUiaVVRzk8hc446D7xrgvLfSfi3PCPls9WsTOg7ecjAMB+HzH3JPevRK4n4pgWWn6VrwVi2k30crsoy3kufLkA+oYflWdWN4lwep594ivrQ3NxdaY9xE0s37qQgxbvNJVt24gEBiWBPVQy8bMr3/wALrfZDrU5keZnvBEJXk35VI0G0HuFbcM9Tg55rzkagbu7huL/TXu0naOWH7ImI5ZZPmSPDcbWKgsQeGB/vMK9m8H6U2ieGNM019nmW8Co+wYXd1bH45rCiryub1XaNjYooorrOUKKKKACiiigArzjxZrut6T8QpP7ItE1C2h0J7qW1nvmt4xtlOWX5HBcgYGQB6sK9HrnfEXgzRPEV6LvVYLp5/INqxgvZ7cPCTkxuI3UOpPUMCDQBy8XxPe6t31Ww0bzfDlvPa211eSXWyeNp0icFYdh3Konj3ZdTycA45Wx+JN097byahoUdto9xqF9p0V1HfebKZLYTEs0XlgBWED4+YkHjGOa6S58DeHbnV49Sk07FwkkUuyOeRIWeIARu0KsI3ZQBtLKSMDHQVZi8J6JEloiWI22l5NfwqZHIWebzPMbk8586Tg5A3cAYGADnPh/8QLzxZqKRS+HL6wsp7T7XBePFcBCMrhHaSCNd5DZGxpFIB56Z7+ud8O+DND8OXQuNItp4XWI28aveTSxwxlgxSNHcrGuVXhQBwPSuioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiio5pooIy88iRoOrOwAH4mgCSisKbxh4bhcpJr2lh+6i6Qn8gaT/hMfDucf21Yj6yilzIfK+xvUVhQ+L/Dcz7I9e0svnG37UgOfpmti3uIbmMSW8scqHo0bBh+YoumDTW5LXB3nj25ttUuyNHRtBs9Th0me+N3iYTSFFDLDsIKBpUUneD1IUgV3lc5P4K0CfX/7ZlsWN6ZkuSBcSiFpkGFlaEN5bOABhypYYHPApiOe+C8mrahot9rGubjc3t5cAMNTmuUwk8q7VidVSELgKNg+YAFsHis6z+LM8Wh2mta9oC2Wl3unXOoWzW179olPkqGZHQxoFJBJUhmHrtzXpGjaVZ6Lp6WWmQ+Taq8kgTczYZ3Z2OSSeWZj+Ncn4O+Gei+H9Fgs7pZNUnWzaykmupZZEaJ/vqkTuyxK3GQmM4GaAOXv/Her6wmnQy6PqWiFdZ00CdVuo4545JwrxFpoYSTgfMoDKQw5PNad98Rxc6Ndwto8v2yCx1KbU7aO9aJrMW2UIEqqDl227WG04JYdMV0tn4B8O2nlmO0uZDHJBLGbi/uJzGYW3RBS7naqnkKML7VabwfoJutfuf7OjE+vRCDUXDsDOgQpjg/L8pI+XGevXmgDmrD4gTHxVY6G+kx2tvMIUjmvL50lmDwh98QaPbKoJ2n95vJVvl4r0SuZt/A3h+31WLUIrScTxSLMiG8nMIkC7BJ5Jfy94Xjdtz7101ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZ/iDTV1jRb3T3kaIXMTRiRRkoSOG/A4NaFFAHG6H4MMOrDVNauVubpCrRQQb0t42VdofYWOXwevQeneuyooqYxUdEVKTk7sKKKKokKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiqup6haaXZvd6hcR29unV3OB7Aep9hzQBaorh73xlfSRPLYWFvY2aEZutWm8rj1EY5/76Kms2fX9Xu7fztO1lb5gwVo9JggynufNc+nr36Vk60UaqjJnpVFeVpqmvK483UfEqAH+KxtHH47UJP4VZfxddWKbp9dijAGf+Jlpjx5/EFP60vbxH7CR6XRXllp8UGLlfO0K+wMjyLmWFj/wFkYf+PVqW3xHhm2q9rZRyHqp1SEkfrVe1j3J9jPsd/RXFweNJ7g4gsbGX/rnqSN/7LV1fEl6ozLoc7e0NxG3/AKEVo9rDuHsp9jp6K5qLxbFuAutJ1e292hWUD/v2zVMvjDQA4SfUorVz/Ddq1uf/AB8CqU4vqS4SXQ36KpXOq6fbaeb6e9t0swM+cZBsPpg965+78QX+oHZotv8AZrcnBvLxCCR6xxcE/V9v0NEpxjuEYSlsdJqN/aabatc6hcw21uvWSVwo/Xv7Vz1z4pnudyaHp0s3pc3mYIfwBG9v++QD61ltZ2Vixv8AUp2uLlQAbu7fc30XsuT2UD6VZRNQ1Hi3RrG2PBnmX96R6oh6fVv++TXNKu38J0KjGOsihe3t5JdNHqWsXsjgAvaaZAyKgOcFigaQdDyWGcVJY6Po8ix3cFrDcGQb1nlzM5B77myf1rpNPsbfT4DFbIVDMXZiSWdj1ZieSaxb+1k0q8kurSFpNPnJeeKMZaJyeZFUDkH+IDnPIByaycm92XGUU7JFqOOOMYjRVHoBin1lf29pz7VtLlLyd/uQWzCSRvwHT6nAHel0z7TryTzwXc2nwRSmFYxEvmFl+9vDA454AGOOc8jEmjkluNSefWJDHpMML2yNh7u4UmInkEIBy59TkD3PSq1z4VubhmaWy0NpByJEjeNyf94cr9cnHvXQ6fb23h7RylxeBbeN3dpp2VFXe5bHYAZbAH0rQt54riFZbeVJYmGVdGDKR7EUGLm76HI2/wBrinW1g1PU9MvEBIgmlFykgHUqZA25eexBGRkDpWvDrmt2ZY31lbahCozvs2Mcp/7Zudp/77H0rTvrKC+h8q6jDqCGU5IKkdCpHIPuKxJUvdLz9p33lmOk6LmRB/tqOo/2lH1A61aqSWzBck90dFo2vWGrvJFaylbqMBpbaVSksYPcqece44PY1qVxEtrY6okFzhJSvzQ3ET4ZfdXU5H4Gpre/1rTio8xNVthncJsRTgezAbG+hC+7VvCun8RE6DXwnY0Vj6Z4i0/UJ1thI1tesM/ZblfLk98A8N9VJHvWxW6aexg01uFFFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZWsa/pukMiXtxieQZjgjUySv9EUEke+MUN23BK+xq0Vx9x4zdVZl0xrSPosup3KW6ufYDe35gVDF4vuJ32xS6GW7It6XP54H8qzdWC6mipTfQ7aiuS/4SHW4ivm6LaTp3NvfHd+ToB+tWG8UTocPoOpN7xSQMP1kB/ShVYPqDpTXQ6WiuL0n4g2urXotrDR9WkcSeXI22HbGc4O4+Z27967IyIASXUAckk1aaexDTW46imxuki7o2Vl9VORTqYiC/u4NPsbi8u5BHbwRtJI56KoGSa8y1C+nuW/tfUY0OoCJ7i3t5eY9PgAyXYcZcjGT1LHaCACa3vGt8t7qEOkK2LO2xeajJ/CFX5kiP+8cMR/dX3rk7q1k1u4/sqU4ubvEl0F6xkqDk+0UbIB2MkgPWuWtO75UdNKPKuZnR+F9Js49QlmeGOe9jgg864Ybj57Bmc5PQ4ZPoNo4Fb+o6VZaiF+2WySMpyr/AHXU+qsMEfgaXTrBLH7R5bFhNL5hz2+VVx/46Ku1gDZkpoVupwbi+ZB0Q3L8fjncfxNV59GuoN7aZfMQRxBd5lT8G++M+5b6Ve1LWNO0wf6fewQNtLBXcbiB3C9T+Fcxda1d608vkSyaZoluu+6uMfv5MjIjUdUJBB6bsEdCRQNOW5CP7G1NpoL7T7aW/t5Gimjt4TOY2HcMq5APYkD065qJIbSe2Emiza40YyN9vulUYPbzgR+ApI7GO8sjNfwPb6Hatsh0y3OBO+cBWwcP8xwc8Fh6AllvoG1gK2qgy2IYxQ2Nu21JnA+4vT5FHVzzkHG0cMGnMxsjEAxSalpplJ2+VqdkI5CcZ6bl/RTSjSbiUAy6F4duEb/lpHK0ZI9QPKPv3piWpiSO3t3kgtUkEYh0/wDcLJKOsaY5IGDvdyR1AGc7aksdxgPYJboz7hFNA8zO7/7BL/vtvcsAnPXqKCuY00sbuLH2fSmiz1VNVkRFPsAMfpUI0zxLcXR36hFYWueVWQXZYenzxrj8zXTWPn/Y4ftjRNc7AJTFnZuxzjPOM1PSKMXS/DenWF0bvyvtF8etxKq7s+wUBV/ACtK+uDbW7SKhkckIiD+JmICj25I57dasVn36n+19Bk6RpeNu9BmCVR+pA/GgT0VzR07SEhlF1esLm+7SEfLFnqIx/CPfqe56Y1qKKZzN3CiiigBioisWVVDN1IHJrOurS6gvXvNMMTPLtE8EzFVfHAYMAdrAcdDkADjGa1KztU1SKwKRiOW4unGUghALMOmTkgAe5IoGjndd1YzX9vZalD9gWKVJxuYu85XkCMKDkA/ePUAdMHNW4IZI5ze6LNaRJcxr5m6EyLIBkqw2svOGPPORj0rT0/VXuL37JdWrW0zRmWP5w4dQQG6dCCy5478E1R8kafrMtrHgW90rXMSAfcYMPMH0JdW+rNSNI/ytEq3mrxSDethcx98b4Cv/AKHn9KktvEVlJCstwJbWNgGWSYDy2U9G3qSuD7kVQ8RzPBoGoPD/AK7yHWIerkYUfixAq5ZwC2s4IByIo1QH6DFBTpomn0qCdjd6dKLaaTDmSLDRy/7y9D9Rg+9UZLuaxXGrQiFQMm4jO6E89z1X/gQA9zTv7PhSSSW1L2k0nLPAdu4+pX7rH3INWFv761z9oiW7hGPmhG2QDuSpOG9eCPYUCtKJHdWttf2/l3UMU8Lc4dQw+tQwpqemqf7Jvy8YGFtr7MqD6PnePxLAelSwWVhdGWTRbj7LKr5ljRfl3H+/EcYz142k+tMee5sh/wATO3KqBk3EGXj/ABH3l9eRgetNNx2C8ZaM0IPFkEIK61azaaVA3TN+8gP0kXoPdwtdDBNFcQpLBIksTjKujBlYeoIrl4pUmiWSF1kjYZVlOQR7GqJ0mGKeS406SXTrqTlpbQhd59WUgqx92BreOIf2jOVBP4TuqK5KPWNbs2Pn29tqUAHBhbyZv++WyjH8V+laOn+KNMu5o7eWV7K8k+7b3i+U7H0XPDf8BJreNSMtmYSpyjujcoooqyAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKx/FurNo2hXF1Anm3bYitov+ekzHag+mTz7A0m7ajSu7FPXtXne6k0zS28uVR/pN1j/UAjIC54LkHPoByewOLo2mfaoHeyd7SylO43C4ae6P8Af3Nng9ick9sDGatjp08Ok2GmX9yJ7q7m/wBKlVAPMJ3SSD6EBlz712oAAAAwB2rinNzZ1W9mrLcz9N0bT9NZ3s7VEmkOXmPzSOfVnOSfxNXnRZFKuoZT1BGQafRUEGUfD+lby8djDC56tAPKJ+pXBNINAsQCE+1KT3F3Ln/0Ktaigd2citiGubvTdRC3hhCyQT3EaOzIwOM8AZDKw6dMVwet+HLjSpvPnexu4Tkx2drpBUyY9TF82enVgK9K8UGSzktNTiieSOEmK62kYSFuTIQeu0gHjsWp93cw2lu01w+yNepxkk9gAOSSeAByaL2N4u6KHwqubiSG9tZrazsEtwjLZWtm8ATfn5mLnLMdpz29zXR+JtaOmRR29mqTarc5FvCx4HrI+OQi5GfwA5Irh/CuuXs7anfaTZzSS38ow10vlW9uEAQZ/jd+MkAbc8ZGCTrQwR6WlxfX873N5MR51wy5Zzn5UVR0GThVHr3JJPQ61o2W5j7G8rvYr3dlHaaMbe4lMzXdxGl1NKcNMZJFVyf+AkjHYADoKx7C91Gy1+5u7GCGa41e43rDIDl4F3Kkm8DKAqFwCD0Y8VUvCdV8Rm41MMbLSbeS7uYU+ZU6gQ9cMxG4MeR95R0JN+IM1le6ldkNd3zSwyMmQ0cERIlC+5KhABzgKTyGrnLlq9DaPjJTazyR6TfSNEqsNhTY4ZiqFW3ZIYg4+XJ7DkVmanc6pfvtuLx41VliNtaMYlkmI3CLePmIC5LtkDHQZ6Lco1hCJJjC11Ham/EeMCWdsooH+yg2oB/tgnnFXNS0O5E0NhawzPbSWv2f7VvXERdyZ3bJyWYbSMA8+nNArJHOWGn21pDClnFE97qj+cCYwgkTOI1YDorEGUgfwxkHOK3pYDeXlvpFg7+Tbs26cn5mkB/ezH1ILbRx99icYWrmn2F3L4k1m8lSVDCojtGkUbNxU8qO4C7B9Wk9TVbTNIu4/Cd3ttJYrq5REFsXVZFhXAKbs4yf3jZJ6v2oC5Bdz29/PHHC32bR7KLcrJxthA271wM5bBRcc7d5HJFLdSiLLSn7LcPCN4jwTZW3RUQDI3E4UerE4yFAGg2h3621vLGLZ7tpvPniklZYwQuECkLyEwMDABOTwafd+HblrWCG3uVErzGe5uGJDFyAAyrgg7RwoJwMKeccgKSRzsjQQxG51CECH/j2trFD9/BwY+OTGpxuPJd89RtBfDBqOrXMucwqTsnlYYzjP7sYP3Vz9xTtH8TMdy1sT+HZ7K4vb3T445Z1hS1sEBA+yxBfmIJ6uSXx9RkjLVUMF3b2kNzFa6hbwxzxQwW0Yz5cIwXeRFyST8y9+injJNA00a2k6bb6Xa+RarhSdzMcZZsAZOMDsOAABgAACrmRkAnk9KyIdIur521UR+VepcbrVLgsn7jZsKMB93cS7dM/dyOMB02h3t3PLfvDaw6jGYRbFpC4UKxLjIXgMrMOB6E9AAiudGkZ4hOITLGJiMhNw3EeuKoS3FjqwnsEuMyrk/LkMrIw+ZSepVscjODimSaDqREN0DZG/F4bl1Zm2BfKaNVDbcnAOeg5z0q/HobjTLKMTxx31qWaOVUJQbs5XbkErg4xnsD1FAe0RLperEyx2OplIr8jCN0S4wOWT37leo9xybmo6la6f5QuncNLnYkcbSM2OpwoJwPWufvfBkN9bzm5u2W+nkLSXMMSrldoATa27gbQRkkhhkVs6fo8VnOkzXF3dTIhjR7mXeUU4zj64GT14pmTt0MXVJrDWtTska4ivNPkikCRq+UMqlSQ4HBO0nAPTDcVZispbPB0u6ktwAcQPmSE+nyk5X/gJFaep6Lp+pSJLdW6m4j/ANXOh2yJ9GHNZctrrOnqHEkOo2yYDKIyk5X+9nO1iO4AGe3pSLjKNrM1NH1Fr0TQ3EYhvYCBLGG3DBztZT3U4OPoR2rK0vDXOpyPzObt1dvZeFH0C4/WqkGqxDxdpUW2eGW4imi8uaFoy4wrhhkc42kY6jdzjNbN1oMNxeyT/abqKKYhpreJwqSNjGScbhxjOCM45oEmoyK2mj7b4gNzDnyLOGSBn7PI7ISo9doTn3YDqDht25v/ABCrRlhBp6NGTniSV9px/wABA/NvUU64vSyHTdCjWGKLML3KqAkGOCqD+Jh06bQRzkjbT7aGGxtBGnyRRgksx/EsT6k5JNBUU2+ZmZrJ+2axpmmgEoH+2zEdAsZGwH6uVP8AwE1t1h+Gg1411rDhh9uYeSrdoEyE/wC+ss//AAOtyg0CiiigCvc2cFw6PKn72P7kikq6fRhyKWGbUbQKqypexDORN8kn4MBg/Qge5qeigTinuUium3txx52l6lMe2I2dh+aSHH+9xUksWpWhYvCl7DnhoPkkA91Y4P4N+FTSxpNG0cqK8bDDKwyCPQiq8cVzZc6fP+7AwLeclo/+An7y+ncD0oJ5WvhHWt9b3MjxxSDzk5eJgVdfqpwR+VSzwxTxNFPGksbDDI6hgfqDUN7fabdIItetBAFf5JJl3Rg/3lkH3fqdpqb+xzuEthqVykbDIjciaM++W+b8moDntuZ6aU1mirot/d6YFPCQsHi+nluCoH+6BVi31jxPazbbm30vUYAP9ZE720n/AHyQ6n8xUy6bqpYh9Qswn+xaMG/AmQj9KVfDGmOjfb4F1Cd8bp7pQz8cjBwAoHYLgd6uNSUdmRLkfQiufHJsp44r3w9rKtIcI1ukc4Pr918ge5FWR4xLHCeH9bIz1KQrn85BWRq2mPYalZf8I6gN2/mSTwTXDhJYguMkndht5TBx69qk0e2u9Z06K6n1SS2Y5EkNrEimJxwyOX3ncpyDjHSr9tIjkp7mvH4uUnE2i6xCM8lo43/9AcmpD4z0RDi5uZrX3ubWWID8WUD9ay1S6imMNteWuolEy0bMqTj0PHynP0X60q6hCsqRXQe0nf7sdwNpJ9Afusf90mhV5D9lB7HUadqun6nHv06+tbtfWCVX/kau1xN/pWn6hj7dZW1wR0MkYYj6HqKiisLuxZW0jVLu2C/8sJmNxCf+AudwH+6wq1iF1Qnh+zO7ork7fxTPY4XxFaCKMDm+tcvCP95fvJ+oH96uot54rmBJreVJYZBuR0YMrD1BHWt4zUtjCUHHckoooqiQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuM8Wq83jHQI3JFvDBc3CgdDIPLQZ+iyNj6muzrnPFZ/0/RgwG3zZCDjnf5bYH5FvyrOr8DNKXxoq20QfW4ZCBiKCTGfVmTp+AP51t1zuXi1/TZQSY5Flt2HuwDg/+QyPxroq4jepuFFFFBAUUUUAYHjaWVNCeKKBpluZEtpFVQxKudpGCVHzZC9RjdnPFec69pV7cyx6h4kbUreMyqsULvD5QJ6jAbgHphgwA6swr0bxXdRWo0p7mKaWA3i5SJdxZwjlBj/fCnPqBWL4j8XWr2ix2st1GjortJFGGLFl3eTxllOMFmCnaO4OKEXFvoWYNK1e7jimj1K3SFmVAtq2YxCANzIdv3yc47AY545k0rw9qEdwtzqV/500BYQLuLIBs2q5GB8+Sx6dDj3qPRPElrDpem2VrZXBnCfZ/K+UeU6F1w/zHAJjc5GcAZpw8Zxf6dKLYNawbUgdZDuuJWAIRVKjrnOc42kN0NANyZd0fwzBY6BNp00plkuIzHcToNrODkADOcAA4H4nqSauyaFp0thFZz2yy28btKquSfmJJJJ753Nn61z+t6hq728NnbXaQX8EsaXNzDF8nmyYCxKrZyBvRiT2A7nhuo6peNr08n2iZdN02KSZoYMA3BXAAcn1fdgDAwhzndgArPc62e0tZ5IZZ7eGSSAlo3dATGfVSenTtTru6t7O2e4u54oIEGWkkYKoHuTXnjOsWm3V7eFPO1EzG88sbSYICwcDuSWIX12sB1Gas+JIJb230bQbs/vBDEHfqWlkR4zj6IJmPuF96A5TtrzULOyVWvLuCAMQFMkgXJPTGalE8P2g2/mp54Xf5e4btucZx6Zrh3ij1/UY7pUV11B/s6sSfls4iSx/4G3B9nX0p3h+Vm1aXUzEPtM1hLdtkfNKHdSi/8BVFH/AhQDjodtb3ENyrNbzRyqrFGKMGAYdQcdx6VNXntjBFbaRJbQsUiK2EblDtMiFgu84/vfdJ9BRd3lxYeHdRS1upbaO3v3jRlO5o0WIPgZ7bh0PbI6UDcDuL+/tNPiEl9cxQIeAXYDcfQDufYVWfXNNSxju2ulEEjmNSVO4sM5XbjORg5GOMVmv83im68xQXSygYE87dzy7gPQfIv5fSkTTI11Rr0SPk5bysDbvKqpfpnO1VHXFIap3Vzcsb61v4PPsriKeIHaWjYEA+h9DSx3trIZRHdQOYhmTbIDsHv6dO9c1eaVJcX2WkgbT5HWWe3eIt5jqpUc5xjG3gg/cH4GraU9ykEdm0MEWPKlXy+sRZWIGOM/JjnjBNA/ZnR2uo2V1btPbXdvLAh2tIkgKqfQn8R+dSXN3b2sYkubiKGMnAaRwoP4mubl0oz37vPKklk0nnm3MfWTYEyTnBUKOBjrznpio9s9lcWMJk+3tFE1vY2xQB8HbuLvnBChR82Bgf3iRkF7M6mXVNPhjhea+tY0mz5TNMoD467TnnrVyuPsPBSHe2sX9zdK5l/wBEjby4EWRy7INoDEZPc84HGOK2ltdQspn+wSR3Fs4yIrqVt0bf7L4YlfY9+/YMh26GvVTUb+30+3aW5kAA6KD8zknAAHck4A+tc3JqWrT6lFb219ZOiyMLn7PaswhAU4HmM20tuwCAufpVmOys7R2u5hG9z1e7mC+Y31bAwPYYA7CkVGDZU1u4n1mSx0m50/7PDdy/PK5jlKqqM3ygggNkAEkYGeDnBqWx8A6BbW7xzWgu5GkMhmnVRIDgDAKBcDjoKk0u5huZrrW3INhZxSRQyKM7wMGVx6j5ABjrhuxFMVdSkja/a5khvSTIluznyUXtGyjg8dW65yQcYFMfLd2iY+keH4IbdrOC81KxvrVtswiu2bcTyJNrllw33uncg8g1keNNC8TXNs2zWReaWCPPtTAEdkyN33CC/GTtBXOMCu1u5xdS6DqcQZFuo2jKH+68fmDPuNn6n1q9RexpF3Rxlj4WE8MN3Zaq1qJVVxNp4kQyjHBbzJH3cY61txaTeIFB1/U3wMfMlvz/AOQqboi/YtT1LTgu2FWF1Bz/AAyE7gPo4Y/8CFbVDdykrGV9i1NAPK1bef8ApvbK3/oJWo9viCJv9bpVyPTy5ID/AOhPWzVQ3M0189rYQLM8QBmd5NiRk8hScEliOcAcDrjIygbtuU5NR1G3x5+jySjubSdJAPwfYfyFRQeIoriNXt9O1VwRnmzZMf8AfWM/hmreoW+r29lc3j3un2yRI0hjMDShVVc/f3Lz17fyyZrePWZLaJ3tbBHZAzA3L8HHI/1dBPOik2v20a5ubfULf/fs5GA/FQR+tWbHV9OvzizvreZu6rINw+o6ipbG7+0rIrxmG4hbZNCxyUbr+IIwQe4NJqGnWWoxeXf2kFynYSoGx9M9KCi3VP7AsUpmsZHs5mbcxi+65/2kPBz69fcVROiyWx3aVqN1a4GBDI3nw/irfMB7KwpP7Tv7Af8AE4sg0KrlrqzzIg+sf3x+G73NANXNvTNTkeZbTUUWK8IO1kz5cwHUrnof9k8jtkDNa9cFN4k0DU7MeXq0EJ3bopn+TY6nIYbgOh/qK0bLXr1x5i3ei6hGR0gkMW0+ucvn9PxpmMqfYv6FH5mta9eSZ803CWw+YnEaRqQMduZHP41cvNG0+9maW6tUkdgFfJIDgdAwHDfjmsTQ9TNo9/NewMY7uY3KXFpm4iIKqoHyjdkBRzjB657Dfj1SwktRcpeW5tz/AMtDIAPzoIaaMe98LWwjI01IYo87hayoGgDZ6qOqH3U4HXBqpcPeacsq3BnggK7T9oH2u2PuTneB/vFRW23iHR1OP7StGPfZIGx+VNHiPSf4r2OMf3pAUB/EgCgabMOB7eKJZIzLZRKMiS0b7Rat7bcZUDrwFHvV2K5uFgSWSNLu3IJ+02J8xfqU5YZ9Bu+tWmttE1CZp7ea2Fw4wZrWYI7fUqefoc1UuPDtwk3nWd2rTHh5JAYpXHvJHtHHuppFqRatrmC6j328qSL3KnOPY+hqj/ZstjO91oNx9huGJd4tu63mY93Tsf8AaUg+uelVLu21SG4D3enm82qVF1EwWXH++mCf93y8e9QWniGEOkRu0ExyottQAt5ww7Fh8hJ7DC01daormT0Z09j4ugSRLfX4v7LumYIru2YJT/sSdOfRsH2rp1IZQykEHkEd64WbUrPasOpL9m84bfLulAV89g3KN+BNRQ6e2mFG0LUZNPB+5b5Elu3/AGzPQf7hWt417fEZSoJ6xPQKK5G31nxDGoW4s9KuD3dJ5Ic/8BKPj86fJ4l1S3O6fQRLGDz9kuw7Aeu11TP0zWqrQ7mXsZ9jq6KyNM8SaTqJKwXkaTr96Cb91Kv1RsH9K1wQRkHIrRNPYzaa3CimSyxwpvmkRFHdjgVStNa0q8nMFpqdjPMP+WcVwjN+QOadxWNCikBBJwRx1paACiiigAooooAKKKKACiiigArnvHWE8PyXKzLFcW0iTQEjO+TOBH/wPJTj+9W+7rGjO7BUUElicAD1rhRJN4kv4tSn3R6dAS2nw45fIx57j1IPyg9Acnk8HLzaDTs7kNtfQ+INK87T5DHcROG2SDa0MyEHY46jkYPqM4rodJ1KPUYWIHl3EeFngY/NE3ofUeh6EciuVPgsyaq2pf2tqiXjqEkaExRCQDpuCp82PU5qWbwlcedHcR65qyTxfcf9ySBnOCfL3EccgnBrmeGlfQ3dWMlrudpRXM7/ABFAy7bvTbqMDBEts8Tn33ByP/Haik17XoZ1ifw4swJx50F8pQe5DKG/Q1DoVF0JUk+p1dNd1RGd2CooyWJwAPWuaPiDVlbDeG7hh6pdwn+bCqmrajqGpRJA2gamsOcyx+fbhZR/dJEmdvqMc9DxkGfZT7FJruR63rElzPbXD2F7LpcLGWIQQGSSaQcKxUHIXkkcckAnAHODpGm2ereIZrmIXenyw7ZJbcNIjlWYsEfoqhiMlVznrn16LZrmoHZKINLtmGCY3824/A42Kf8Avqqfh6zi8O6rcaSBmO6LXVvO3Mkv/PRXb+JlJBBP8J/2TTdGcY8zRrGcb8qNLV4o4TBOEREM4Fw4AB2ujR7ifbeDk9hXIw24ljmTyryRJIzC81tbvKsRa3jjYgqCCVa3Tpn731rrL1LObV1GowJdQxxxhIZAGQSSSbQSp4zxwccANXWKoVQqgBQMADoKzCUrM4CLUotQ826g3tLKINQeBR84khZVlQDrnEaDH+0PWi5bC6/DBiTzLW4lXBz8wczAf8CWdTXYX2kWV7OLiWELdBdguIzskA9Nw5x7Hj2rn4/Cd5aXFu9hqabIPuieDLNycBipCnCsyDCj5TjsCAnmVjG1pDPDcQwjMu64htxj7wmiE4P/AH3E35VqeIpUTXtH1hG/0dYPtLNjI2KdpP4JcO34Vj6pDqPh+NJdUjR7K3WNkuoiWA8uTKqQeQTG8q56E7RnJxWqxSCxW3JQwadKJ1BO7fZyBlP4LuPHpGvrQVo9SOzi/s+2gt94VbG4ewnPTEMn3T+TQtn2NWdPuTFpuk6kyrCbVfJu0I+4n3ZB/wABZQfolUlkitdR/s3UXEguYjbyLIQWmjGFjl9+HEbH+9s6BhVjTpns7uSC+beJGWKdmHBkIwsmOgWRRg9t6kd6CvUihsIUmbTZ1lEADaVIwOCsZ+eB8+2QoP8Aeb2qP9/JFeW7wxS3cknnhFOBLcQgJJGM9N8agqD6sT0qS8iSMPBeOwjhRYJXL/MbcsfKlB67o3ypPbO49qcDLcXUkczpb3c5XMqLjZeRqMOAeqvGFIHorA85oEJp92kUltcNKZNkSW8krMD5tuSTBMfoWKH3Yk8YNdNXKBBKoUKsG6R4wrjekMrD95bOBjMbZ3Ke+R0woPRaZFNb6daw3UvnXEcSrJJ/fYDBP40mVEs0UUUFEF7cx2dpLcTkiONdxx1PsPc1PoNhJCkl5eqBf3IBcZz5SD7sYPoMnJ7kk9MAZfiKNJLCPzgTAtzBJLtGfkWVWJ+gxk+wNdBpV/Bqml2eoWbM1rdwpcRFlKko6hlJB5BwRwaLGVR9C3SEZBFLRTMjmbHTdU0+wgs4I7KdIEESyvMyFgBgEqEPPTOD1q3Z6FGZFuNWZL67GCu5P3UR/wBhDnH1OT744G3UN1cwWkLS3U0cMQ6vIwVR+JpFObegl3bx3VpNbTAmKVGjYA44Iwa59dE1O43Wuo31u2n8qxjiImmT0Yk7RkcNgc8421oP4h03zUitrhbuZ1LhLX97wO5I4H4kZ7Zqncy3GrNskjltbAfeRmxJP9cH5U9up74HDA4qXQJLoajfxC1H+gWZbEgAxJJgrhf9lRuB9SRjoauUxESGJURVSNFwABgKB/IVUGpRTO6WKS3sqDlbddwz6FzhAfYsKDZJRRRvC0XjDS2B+Wa0uIyPcNEw/wDZq2pHWNGeRlRFGSzHAArn5rTVNQ8W6d8sFkLa1mkfefOYB2RVBAIAY7WwcsOD1rVmtNH06RG1a6N5dbt6C5bzGyOmyJRjP+6uaCXNIbHcXGpFU0pP3LfevHGI1Gf4B/GfTHy+/Y7enWMOn2qwQbiASzOxyzserMe5NZ0utTsf9D0u4ljIyJJXWIH8Cdw/EClTX44wDqdrcWIJC+Y+HjyfVlJ2j3YKKDOXNIi8Xec40iCOVUgn1CJJwy53oAzbfxKge+cd66CuO1fxJpd9ZbI2Jng1BI9rr/qzFchGkYjhU+VjkkZHvxW/ca3pluxSS+tzL/zyRw8h+iDJJ9gKdrEdA1PSxdypcwSm3vUXasoXcGXn5XX+JcnPUEdiMms9pb21OL6ycqBnzrXMqn/gI+cH2wfrU1r4ktLuR0gguy0bbXVotjIfdGIYflUr+ILBDiQ3UfqXtJgo/Hbj9aRcXJFS01Gzuztt7mN3HVM4YfVTyPxq3UVxqfh7Uk8m6utNuFHPlzuhx+DUDSbKchtPvbiAqMD7Pcb1x/utuX9KC1U7lKXSwl013plxLp1453O8GNsp/wCmiH5W+vX0IomupJAE8Q+G7HVVJwZ7WNG49THIcj8Gark2m6on/Htf2rqOgntjuP1ZXA/8doFvqwTBisC/qJ3A/LZ/WrjOUdhS5JbmNP8A8Irbqv8AZUt/oVxnIW3sZkRj/tRFCjfUDPoazYdTng1HzptBe+LDB1G0s2iYgescmH/Imup/sa9ulJvdReAg5VLIBcemWYEt+QHqDWfolrqmsadbXN7erbW0qmRPsqbZJFJ+QsWyFBXBIHOT1HQkp83QUWo9R48Q6WJhDPdLazHGI7pTCxz6bwM/hWlHIkq7o3V19VOaifRr5QYodSjktyDkXdt5r/TKsox9Rn3rEn8KRRne/hzRrqUcmSALEWPrtK8f99H61Boppm7cW8Fwm25hilT0kUEfrVBk0u1iKx3MdmnXENwYQPwUgVQXwjBON58NaRGSeVuHDE/gFI/WrkHhxbYjyNA0SI5yfLYD/wBpUBzRE/tmK1Q+X4ktGzwou2idR/3yVJ/Emo7jxHYXMAg1JdG1GNjgpFdRtu+iSYH4bq0Dp15sKLpmm7T1BmIB/wDIdc1feE7a21F7u5tbuyikUZXSpGaFmB6uiIGyfUgjjt3aJfKy5HL4WggAtbq40dT1SN2EKezL80P6VZt9CtNSJa1uPD01sw5e309GkP8AwPeV9P4aw2udH0e5tPtot9QtZ5kt3tdUsUSdQ52hkLIrFQTk7geM4I79rf8Aw88L3g3R6VBZzA5Say/cOp9QVwPzBFaxp8yumZTfIzDvfD+m2OlsbGRrjWVuEgW/dw9xHI7rwzddqhgdh4KjHetyPw9AIGWW81CSZhzMbp1OfUKpCj6Bce1eefYdX06LX73TtQM9pZ6oxMM8qLLI0McQEjFgA2SnIBXI98Y7jwn4y0vxFZo8MyQ3OMvDIcHPfaT1H6jIyBUTg4vUFJtXTILzSb2cLbXunWGqouQk8+1Rj/aUqcH128H0HQUo/BzRKwi07RI89BGroF9uOv6V0a+JNFaXyxqtlvztx5y9fTrWn5ibwm9d5GQuecVJXPI4yHwwhuFZ/Del+ah/1s0ocfVSUJ/MCrV74Yl1eL7NqaafDZ/3IYhK+e2GdcL/AN8k+4rraKA52eTatpjaBci3tbTTLWbyy63ys1u0oydq7gynfwM/N3966Hw/41axmisL+ZdQgeeOGK6Eo80B9q/MCF3qHJG9c/LgnJBNdZq0K3Gm3Mck9xAhQ5ltyRIoHOVwCc/ga8v1LTba7WG4sdPjkKMJknWKJZTjkPvFypzx1IyM9qqE3F6BZTVme3UVwnwv166vdN+w628y6iJJHhWaNwzwAjB3tkMQWxwxOMZz1ru67oy5ldHLKLi7MKKKKYgooooAKKKKAK+o2q32n3VpIzIk8TRFkOCAwIyPfmuI1G91Tw5beZrGnvdWsYAa9sSpX/edGIKe+NwHc139Y174j0y1vrixma6e4hVTKkVnNKFDDIyVQjkds0XtsNFe1v8AzIY5E5R1DDkHg/StGGRZUya4ac2tiTL4cmvIrdjuNhc6ZdGIf9cyI8x89sMPQCorfxfdxymO48Pa0OeJILV3jP8A30Fb/wAdq+ZMXKzvZLdW7Cofsy56Vgr4oiU7XttUVvT+zrg/qEIqK58W+Tkx6VrNx/1zsZB/6EBTvbqFmdKLRT1FPFrGO1cUnjmdid3hrxInubLP8mq2niwyoT/ZetKw/haxcH+WP1pX8w5WdNMkManpmuD+I11HZWWl3ZZllh1GFkK9cZIcfTYXzU194ruEB8nw7r079B/ou1fxOc4/A1Jp39n3ZurnxLFdzTXEDWy20enXLR28TcMobywWZuMtgdAB0yVNpxaKimmmK0ZXVryWUnzI72ykQ54MTfuwv4O0jfiK6TWdWg0lLRrhJXN1dRWkaxgE73bAJyRwBkn2B4PSvP8AUv8ARjAktnqWu2kQ8tdtncQzFByokVkCSFSMhtw55xmq11rcja7oKGDWPJtGuNR8i/tZGdNqCEfdVnYf6VkZzyvXjjgVN31R0Ss9Uz1hmCqSxAHqaz7zW9Ms42e4vrdQBnarhmI9lGSfwFcMNa0K8kM2t3D31yG4E2nzLHF7IjKcfXkn17C1F4l0GzV/7OtLp3PJS002XLfjsA/Wo5X2KUF1Za8Q+KppLG4j0/SWuIXiDM9wMhomB+cRDll4wclcEjOBzVWG4W106ymSdLqKJCtrdvjZdREfNDIx+4xwBzjJUHsQMmHW7V555D4M161UNuS4gsikuTnJ+XBX8Cc5OatWus2dnLNdNc+IrWSb7/2nTZCj4GPmURYJ6c9cADOKfI+w0ktmZvim6todGsdSR0uINPdmjlmJxPZuNk0bnqGjBDkcMfIB9cbH2qG6s8XU0QmjDxJLdEBZl6PBMRwGGBnHcB1yOKqi98Nt5z3eqLGtwMTxtb+TBIMYwUZcZx/F973xxVTwRc6bDpflPrzQX9pKbR5hcrieOMDyn2tlW3RtG+cdXPPWm1ePoCun6mrDqK3VkrSOcwkrHNcDKlSPmhuMZABHG77rfKwJPFUnukliVrWZLlgqp9lZ3W7MYJKqCqsHKsCVlBC9cnkmtcv4fUtM+rRi7kP7y7W88uWT2LKRkccDoOwFT2mqeHrHzWj1Sy8x8GWWS6Du+Om5mJJx79Kgq3cpz2epX1xIqDaksXlSSXFsq/LnIEgDneRzgrtwTkMOh6e2R47eJJZDLIqgNIRgsQOTj3rNHiPRmXdHqdpIP+mcgf8AlmkXxBZyZ+zRahcEf88rGYg/8C27f1o5W+g9Ea9FcnL4n1RrjyrXwxqSoePOulZFH4Irn9Kn3393kXmsT2UZ42WOiXDOP+BupH/jtWqUn0E6kV1JvH00kPg7VVt22XFxD9jhb0lmIijP/fTrWhZXEmhKsEu6XSVwscmMvbDsGA6oOBkfd78DI5HWbHTV1PQrSDU9fn867865e6tHMojhR3V0BhDMVl8n1AzkiuinlSND9i1rWC/b7Zocsq/+ORxn9at0ZWsZe0jJ6nXxuskavGyujAMrKcgg9waZczxWsDzXEiRRIMs7nAArzo3+tacrnRh5oJ3NE2n3aR5OclY2j4z6CQD2zzT7PXbm7mSbWtG15p4zlB9hIhQ/3lUEnPu2SO2OazdOS6Akn1Oml1LU70btNjgtIOqyXkbO8g7HywylR9Tn1AqvYXfm64T4ge2iurdAbQA4jYMMMy7ur8EH0BH945pt4niDbRpWuM3oNOl/mRiojr1tfW7xXuhayIm4Mc+mu4YfQAilyy7F2hbc6PXtMOo20clkLdL2OSOWOZ17KwJGRzgrkcdjUNt4eglzPrCxXV6xyHUFREOyx85HuepPPoBy2meLpdNk0TSTpl/Dbm8e2aWazlO63W3nkTyxgNuBijUjaeCeuQRp6343it2WCzstUG8Za6l02cRxjvxt3E+2APftT5JdjO72RuNoGlrGTcwmeNfmIu5nmUd84ckU2TW4SPK0iA3hTC7kOyFf+B4wf+Ahse1cWfEem3A3T2fiHVWJ3bZLGRlyOmEwE49cZqWXxs6uEh8MeIen3pLJlUf987j+lLll2LUV9pmzb6dfz395eanesjTlUENm5jURpnaC33s5ZjwQDnpWjaWdtZoVtYI4Qxy2xQNx9T6n3Nc3H4muJk+e3NmT3ewvpiPqogUf+PVJFqdnKmNR17VlJ6iy0K4hH0y8bn8QRVKlJlc8Y7HSTzRQRmSeRI4x1Z2AA/E1njU/t6umj2U+qHoTGoWEg/8ATR8KR/ukn2qva3/gmB4pZYb+7njOVmvdOu53B9QXjOPwxW8njrQmIVJNQY+g0y6P/tOtI0O7M5Vn0Rw3h+DxHa/2rBpOkWM8FtqciXFut1tI3IkhWPKhcDf1JGTngdav6bPDpt8/9n239j3s5UzadeReSkxHGUYZG7A6oWHqPS34X8S6da+IvF7OL4x3WoRXMYTT7hmA+x26HcoQleY+4GefSt2/8S6Bf2z299a39xbvw0cujXTKfwMVXKinqiI1WlZoy76aO/dH1Dwy88seAsgeFmX/AHWLAj9KrSRjcGgsPEUB/wBm8icfk8rCh20VXL6Td+I7LAwIxp1zLF/3zJGSB7KRUK6rdxKQ1wbgjof7EvYs/X5WrF0ZI0jOBMPtxGFTWsf9NXtBx+ANV59Da7Ie4tYy553O0DMPx8g1IutXbRnbb5cd/sd6P0MH9aY2o6hIeLk247/8SK7lI/Vf5UvZT7Fc8e4xNCvYwqwXl9Ci5wsOoCMfksAFaBudctlRIzJKBwZHEc/4kfuj/OoRNBKm261XX8njFro8kWfxaNsfmKlA8NwQlrm38QT7BuL3AuyOO5zhR+gqlRl1Ic4CWniWZzby2hl1i3clZjb2ph8ohiNylzhhkY25LdwSK0vCF2h0e0sJgYb+zgjimgfAYYUDcMEgqfUEjt1Bri/CCRW3gzRZIr3XLXUXsIZJ0+wTXNuZWjBYhducbifusM/nS32tz3AVLvQPtrxE7JTZ3aDnuAYCV+mT9TSlSknoEXGS8z0RdV09pvKW+tDLnbsEy7s+mM1crzK31OS6tPs0zafFCyhFtY9HvZwq/wB0/Iv8hUT20qsJotPS6kPJkGkTxyk+8jybv50vZS7B7vc9Tory3/hIvFlpHGkekajcbAFDMofIHdgUUk/8C/xq/Z+LfFCkfbPC93Kp/wCecaxYH4yNR7OXYVvM9DrD8ZWSXvh66SQoBGPNzJO0KDbySxAbIAzwVIPcVzkvjXxANwTwTfk9ibhcfyrI1fX/ABHfPav/AMI1rKtG3zRxv5cbqSM5UMSWGOGzwTnHal7OXYF6nLxDUU+0XUWr29xA9tJHFbPHKY13kDy4ldUG45GNoxkDIAIr03XLC4sL60ttQlvG0ExRWds0V0yCNwu3EwUgsWPAbJHQYB5OV4ZsfsOqW+p39nqJkRjOkEMLPtkZChLvI5LYU44CjoTnAx12p6zZanYT2d5pOqtBMu1gLfkehBB4IOCD2IrppQcdWTUlfRHKeCvD+nPNrEzWUMssd9Jbo8q7yqLjABbP9489T3rZ13wjp+rypNcwtHcIMCaA7WI7BuzAdgQcVyvhnV9W01dTXTdHu9Vtjfz/ALx5BHKWVyhLcbScpz0rqLfxXfHAn8L60jcZ2iJh+e8V0XTVmjFXWqIprHXbdSltd2V7Bt2+XdwmNj7F0+X/AMcqjb6TdmFVk8P6IFYDcr3LMVIGAAPKPA6DBrZPiiQ/e8M67+EcP/xymHxP/wBS1r//AH5i/wDjlZulTfQ09rMyWl8Q6TPG+naPE8IO2SCG9DxsvYgOE2sPbg9DnjGnp3jKKWc299aTwTquWVFZmHr+7IDn6qrD3qVtfd0yvh3Whn1ji/8AjlZuoXaajEI73wxqkyA7lDxRHafUHfwfcVMsPB/C7Aqj+0jbvPEWnmxm8i+ENyw2Rh4HaQO3CnysBm5I6CuLv4kupC0zQ3FzIQCSYY/m7ZSWJcc49W9DU7QHflbPxckfeMXGQfxMhYfgap6nbZtporLR/FiCRGVkWUOj5GPmEjsPrx+dY/V5LqaKcUXPh5LOviuG21CWKR189sRLgpOQu4MASoBXJBXIJyScmvXa4L4dWWnWrW8cttfrrcVkhd7wPtUHAcRZ+ULuHIAHbNd7W1OPLGzMqsuaQUUUVoZhRRRQAUUUUAFcm0RGv6xKB96SJc+uIl/xrrKqTWSPK8ihVZzliB1OAMn8AKcXZ3AyBGxFHltWytooXGf0pfsq+tXzisYvltR5bVtfZV9aPsq+tHOFjE8ts0pjbFbP2RfWl+yr60c4WMQI1L5bVs/ZFz1/Sl+yr60c4WMXy2rmtLU3njzXZxkrZW1tYj/Zc75n/NZIPyrv/sq+tct8PrNpdO1TUJ43jk1DVLqfDqQSiv5MZwfWOKM/jRzBYv8AltR5bVtfZV9aPsq+tHOFjF8tqPLatr7KvrR9lX1o5wsYvltXI6nYwaf44sZp7eJ7PWYjZuHQFRcxBpIjz0LR+cCe+xBXpH2VfWsDxxoU2q+GLyLTyBqUO26sieMXETB4+fQsoB9iRScrhYrDRNPDbhp1mG65EK5/lU6afAgOy2hXPXCAVp6JNHq2jWOoxxyRJdQJMI5FKum5QdrA8gjOCKvfZV9afMgMXy2o8tq2vsq+tH2VfWjnCxi+W1HltW19lX1o+yr60c4WOAjQ3nxFnbJK6Zpixj033EpZh9QLaM/8CrpfLaqHgiyaa68S6lOjI15qsqJuXB8uBVtxj2Jidh/vZ711P2VfWhSCxi+W1HltW19lX1o+yr60c4WMXy2o8tq2vsq+tH2VfWjnCxwWvIzeLvC8eR8slzNjucQlPy/efyro/LaqWp2bP8RvDwCt5KabqEjOFOA3mWihSe2QzH/gNdP9lX1oUgsYvltR5bVtfZV9aPsq+tHOFjF8tqPLatr7KvrR9lX1o5wsYvltR5bVtfZV9aPsq+tHOFjgtJRk8c+Ioecta2Vxg/7RnTP0/dfoa6Py2qlBZtH8TL5tjiK40e3Xfj5SY55+Pr+9/U+ldP8AZV9aFILGL5bUeW1bX2VfWj7KvrRzhYxfLajy2ra+yr60fZV9aOcLGL5bVgfECSW08CeIZov9cunz+Vz/ABmNgv8A48RXc/ZV9a5f4jWTTeG0tYUd2ur+ygYKCcI11EHJ9gm4/hRzBYtW1p9ltoreP7kSCNe3AGBUnltW19lX1o+yrRzhYxfLajy2ra+yr60fZV9aOcLGL5bUeW1bX2VfWj7KvrRzhYxfLajy2ra+yr60fZV9aOcLGL5bUeW1bX2VfWj7KvrRzhY4PwQjGw1PH/QWvv8A0oeui8tqpeALNhpuptIjoG1e/K7lIJH2mQZ57cfj16V0/wBlX1oUgsYvltR5bVtfZV9aPsq+tHOFjF8tqPLatr7KvrR9lX1o5wsYvltStG4FbItV9aHtVbvj8KOcLGRpKbtfnZuTHZxge253z/6APyrfqjZ6cttqF1diQs08ccZXHChCxH/oZq9WYwooooAKKKKACiiigAooooAKKKKACiiigAooooAyNf8AEem6C9tHqEk5nud3kwW1rLczSBcbiI4lZiBkZOMDIz1qzomrWeuaXBqOmSma0nBKO0bIeCQQVYBgQQQQQCMVyvxF0ya9vtJuLbRNYvZYBKq3uj6hHa3NsG25XEjoro+0ZBJxtBxnkchc+GPEN0mnT+MPDreLY1sbi3js3ubcPayGYmJ5GZkQuYiitLHlgVJAOckA9norxCw8I+I/+Fm6drUuh/Y2h1WVprq2FkkLWRhkSPLj/SZX5TdvO3PRTgEc14O8FXuv/D61OhaAulSz+H720nv5ZIl/tOSZQIlOxmYqCM5kClcAAYoA+gPEet22gWEV3eJM8cl1BaARAE75pViU8kcBnBPtnr0rUrxrUdB8S6/rF/qEnh6409H/ALDSOO4urdnYW160szfJIwACtkc5I6c8BnhTwn4htvifZ65eaN9iLT3p1Ce2jsYbeVHDeUV8v9/KSdpJlPDc470Ae0UUUUAUNe1iy0HSZ9S1SVorOHbvdInkPzMFACoCxJJAwAetZ+m+KrHV7e4fR4b28mtp0guLVoDbTwlsHc8c/lkDad3uPugniqvxO0m91zwTfadpas15K8BTYyKV2zIxYF/lyACefToelcVd+EPEUS6tZzRTavcXOsadqK6u8sSNNBFcxExvGCoVo0Rj8ihWHT5iRQB6V4c1u21+wlu7NJkjjup7QiUAHfDK0THgngshI9sdOlaleHaP4I1W31dZrfwu9hqUOralez6uLmBGvLaUz+XArI7SfN5kR+dQE2561v8AwY8L6h4butTW50UabZvbwRpJMtutzM6l87/s7skmAV/eMFdiWyMYAAPUqKKKAKOu6taaFpF1qmpPLHZWqeZM8cLylFHVtqAsQOpwOBkngGse28Y2d9ei10yy1G8maxh1BFESwloZZWjBxMyEEbWYggfKOMkgVL8Q7a7vvAniCy02zlvb27sZraGCN0Us0iFBy7KoA3ZOT0Bxk4B871zwn4g1OISxaTLEzaPpVqY5Z4dyywXvmSKcORwnzZBwegJPFAHstFeEDwV4rn8fjVYtN/sy8e51FZtQto7KG38qSCZYH3R/6TK28xM3mdDyF4yO4+F2iDSEcHwefD9yLSGK5uTcRP8AbJV3bmxGzbuTnzHw53YI4oA7+quq6jZ6Tp09/qVxHbWcC75JZDhVH+eAO54q1XMfETRrzWtCgXTFhlvLK9tr+OCZtqTmGVX8snnGQDg4wDgmgCzoXi3SdbvjZ2T3qXYi+0CK8sLi0Zo8gb1EqLuGSBkZ61vV4/4j07xt4li1qA2WrW+lXVmuyw1CWwBS48+Jv3TwEtsCCTl3zn8Ko/ED4azXPiCU6dpF5caI1isdrBpRsIzbXO9zJIxuUJRn3IfOiPmZXnOBgA9uqlo+qWes6bDf6bN51pNnZJtK5wSp4IB6g146fBniC4+Itjq1zorI8Gpq0l5Clisctn5TJmSQAXMshyAwOE9FOAazR8OdQi8PaTp0XhaW2t7K8m/tKKxTTidSB3+TMqzbo5AgPSUKw3/LyKAPoGivKPA/gSS316wuNb0mZ7K00mGKAajPDcPFOl1PIoIjATcium0quF6KeDXq9ABRRRQBStNUs7zUL+xt5t91Ysi3CbSNhdQy8kYOQQeM0a3qtnomlXWpapN5FlbIZJZNrNtX1woJP4CuOhOt6L428UXEHhvUL+21N7Zre6gmthGu2FUO8PMrgBh2U8dM15XB8NPEl7Z63HP4eS1kv9BmguIjHp8FtNfCaGSMRpByR8r7XlJYH+73APpKivB/FngG91e9jmtvC+p2einTxDZ6VYHS4m0+cSyl2/eB1j37lbzIG3juCQMat94G1P8AsPxTONDs7/V7vVVe3a8SC6kNoyW6ymMSnyw52Pw20MVBPQUAen6nrdtp2saPps6TNPqkskULIAVUpG0h3ZOQMKegPNaleK/D3wVrmk6tpLzaZcWunWmu3l3HHcPaq0NtJYrGpKW+I1zKXG1BwSTz94+1UAFUrnVLO21Oy0+ebbeXiyNBHtJ3iMAvyBgY3DqR1q7XGeM4NTh8W+GdX07R7zVYLJLuOeO0kgR18xYwp/eyICPlPQ0AdnVLRtVs9a09L3TJvOtWeSMPtZcsjsjDBAPDKw/CvGde8M+Jtc8f2eunw3PZyxatYzwzomnKUtEMfnCaUM07PjzBtRtm3jLdDVHw61G38LQ6TZeGWshbatJNqBslsAdWti9x5QQSbkfyxJGdk6qOy8gEAHvtZfijW7bw34fv9YvkmktrOMyyLCAXIHoCQM/jXmHhH4fTw6rpp1HRpn0u2067jit9Wmt5hHK1zHJErJCBGAApYKqlUwMHIFcla/D3xU9trRXQGs7jUNAmtrmONdPtoJbwzQsojWAgldokw8pLdfu5wQD6QooooAKKKKACiiigDl38feGI9N1+/fVY1tdCna21FzE4MEgOCNu3Lc8AqCCeBmujtbiO7tYbi3bfDMgkRsEZUjIOD7V4xe/Cq81C38Q3sxkguri51KUWKshS/wBzyvZs7bsLsaRmAPdhnGKq6n8P9bufEy3V/Y6rdqI7D7DNZTWCiyMUcYkRpJkaaP51Zv3JIYMQR1yAew67rlvo0+kw3EU8smpXf2KARBTiTypJPmyRgYiYfUj3IvWU0lxaQzTW01pJIoZoJiheM/3WKMy5HsSPevGYfBmrjxPpc03hcSajb67d3t14hM1uTcWrpcCJB8/m4AkiXYVAGzjI5rA1XwB4sn8P6DanQM6hpuj2FvaXFqthvhmj5lWWeUmVQpzt8kgHJ5GTQB7xomt22szarFapMjadeNZS+YAAzhEclcE5GHHXB68VqVy/gjSr3TLzxVJfQ+Ul7rEl1bncrb4jDCobgnHKMMHB4rqKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwfEviWLRLqws47C+1PUb4SNBZ2Qj3skYBdyZHRABuUcsMlgBkmsWX4k6bCmpS3Omaxb2+mQxzX800KItqrwLMocF9xbDBdqgkN1AHzVs+JfDMWuXdhex6hf6ZqNiJFgu7Ix7wkgAdCJEdSp2qeV4KgjGKpR+A9L/ALM1yxu57+8i1mKKK6e4mzI3lwrEGDAA7iEDEnPzZPtQBztr8aPDl1aTywQ3Uk8U8Nv5EdxaSbmlDlD5qzmFRiJ87pFIwBjkZ0NG8dX+qeN4NLi8P38enTaZDe+ZIIVkgZ5JFJk/e8p8gA2BiTk8qQatT+BJLqxkt7zxZ4kuWZoyJJntmAVAwCGPyfKYHdk7kYkhTnKjD9B8AWGgX2m3OkahqNsbO2+yPGDEyXUfmNJiQGM4+d3P7vZjOOgAoA6+VikTusbSMoJCLjLewyQM/UivNvCXxMudR8OeH7nVfDupjU9XjdoIrRYSk5RdxKZmO1ecZkK++BzXpdcf4f8AAVlok2ktFqWp3EOlGX7FBOYtkKSLtKZWNWYDtuJPuaAIbb4jaZLeRJNYanbafNcTWcepzJH9meeINvjBVy+QY5BuK7SUIBPGcPxJ8RbxtF0y/wBI0XXbWG4vrExSS28J+3W8soUrGN7bWZTwH2N8wPHa/qPhPwxo2o2kuta7Lb6dJezT2elXt3DHa/apt28oCodmJkchd5ALkgDimTeE9C0NNGsda8XaiLeO6thpdpqF7AihoZA0cUY2KZDnapyWcjAzQBZvfidp1losuo3em31ube8exube5ubO3eCVQGwWknWNshlI2O3UVHd/FXSorWG6stK1nUbZ9JTW5JbaKLENq275m3yKcjYcqoJ9M84tXnw40+bWG1W11PVbHUTdT3Qnt2iJUzRxRyIoeNgARCnIG4c4bnFLYfDfR7LSZdOiub8wyaIugFmdC3kDfhvu43/vG5xjgcUAZn/CzVstS8Vyaxp80WgaQ0HlaghiCkSxRsqvul3bnaQbTtCgEbivNS6V8W9D1RIhYWl/c3Ut79gW3tnt7g+aYHmX545WjwVRhkPwfvbQCRdvfhxpt2dRRtQ1SO0v4oEnto3iCmSFUEUwbZvWRfLQjDBcqMqauweDU+26deajresandWF39sie6eIDd5MkW3bHGqhdsjHgAk4JJoA6a1kaa2ilkhkt3dAzQyFS0ZI5U7SVyOhwSPQmpKKKAKWtzyW2jX88DbZYreR0bAOCFJB5rgfD/xNtf8AhArXV7yDUNS+zWNmb67tIYyj3U3lqYk+ZdzhpAWCjavTIPy16Le2yXlnPbSlhHNG0bFeoBGDj864i0+Fuh2WktpdhPf2unyRWqy28LxhJZLd0ZJiNnEh8tQxXAYdRnBAAy/+Kui6XY3UusWl9pt7b3i2LWN49vHJ5jRCVf3hl8kKUOcmQDt1wDn3Pxu8Jw6bZ3aySSNcJLIYftNrG0axuUY7nmVH+YHAjZy3UZHNdDqvgLTr/VLvU0vdQtNSmvIr6O5t3QPbypB5A2BkIIKZBVgwOTUc3gJXmgu4vEniCDVUikt5NQSWEzTxu2/YwaIoADyu1VK54xQB1Wl30GqaZaX9k++1uoUnibGNyMoZTj6EVZqGzg+zWkEAkllESKnmStudsDGWPcnuamoA5/xV4oi8PXOlW39m6hqN3qUzw28FksZYsqFzkyOigYU8k1jeH/iRY61NZomkazaR3sU8lrLdxxIkzQ48yMYkJVhyMsApwcE4rpdT0S21HWNH1Kd5ln0uWSWFUICsXjaM7sjJGGPQjmsCb4c6NPpFpps0t89rbRXsIHmKC63QYSbiFHTecYxjvmgDmtT+Kltq3h7WP+EdeSz1XTp7ESBpbW5ASa6WM4aGSVM4DggkMMg4GQadH8VLLQLe9XxJcm4vH1bUILWIS21viCCbaPmleNOAVHLbj74ONiH4Yaf5d0t5rGsXrXEFpbb5mgXy4rabzYlQJEqgbuDxyPfmrTfDyxjuxe6dqmq6dqQubu4F3bPEXxcuHljKvGyFNyqQCpIwOc80AUx8VdEls1vrKz1O80pLeC5u76GJPKskl+75m5wxIB3NsVto5NT+FvFsk2t3el6m8s1xPq97a2jKihY44VVtrEYPQ8HBJ70X3w20+9MizavrRt7mKGLUIDOjLqAi+6ZiyFskfKxQpkcGrF14BspLgXNnqeqWF6t9Pfpc27RF1aZdsiAPGy7CAOoJGMg0AUP+FqaS8+mw2um6rdTXsPnrHGsIdE81os7WlBc7kY7Yw7Y5I5FegV55P8KNKn02x06XVtZfT7WMR/Z3eF1k/eF9xLRFkYlsFoyhIA54Feh0AFFFFABXntt8Uba7ntIrPw14jn+2TT29o6x24W4khYiQKTMMY2k5baCAecjFehVzGleCtO0z+xfImu2/sme6uIN7qdzXBcuGwvIHmHGMds5oAwta+LWhaR4f03Wrq2uxp99CZwzTWsUke04ZTHJMruwweI1fpxnis7UPGGqR+M5rWK/C6aNfs7RVMSYFvJYNM65Izy4DZ6jpnHFX7z4SaTPZvbQatrNnHNpz6XcGB4d09u0jyFWLRMV+aRvubc8A5xWxJ4A0qTUvtrzXjSG9gvihdNpeK3NuqkbfulDkjrnuBxQBz+nfGzwlftc+TLOUjtmuoijwytcKGVdqpHIzo5LqAsioTn2OLWp+OZ7m50+0tLW+0fUY9Ys7a9tL1IjIYJlYggozrtbaRkNkFSOCKt2/w3sY9IbR5dZ1yfRltzbW9jJOgjtVyCpQqgclCq7S7NtxxVi18AWSXIu73U9U1DUDeW9693cvF5jmAMI4yEjVQg3McBQSWJzzQAH4h6QulafqMkN8ttewXdwn7tSyJbqWk3AMeSFOAM59qv8AgvxXB4rs5rm1sL20ijKhWuGhdZAwyCrRSOp9xnI7gVi2vw0sraeFotb11YbZblLOBZ40W0E+d/lssYfI3fKWZiMDnHFa/g3wfZ+FpL+a2urq7ub4oZpp1hQtsBC/LFGidzztyc8k8UAdLRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVx3xP1i70bS9Le31D+yrS51GK3vdS2I32OAq5L/OCi5ZUTcwIG/JrsaKAPD/C93qXiT4jeGrmfXrue2tYNUFpeRQQKL+CO4tgHIMZGHDbCybchAU25Oeg8YxagPixa3mmXV39os/Dd3PDZxJEyzus0X7s7kLAOdoO0g/KuCOc+oUUAfPFh478U3Hh6/uIvFWlT3L29o+y3ljuZ7KWS6hjYMn2WJYxtdx5chdwQOeCa6CfV/FOk6trJk8UXd9b6Rr2m6csM9pbKLiK5+zl/MKRqdw887Sm37vIbNez0UAePWPj+8k1bRdHk1eE6y3iDUbW9tNkfmraxrdNCGXGVGEhIbgsB1PNdj8KLnVNT8EaNrOt6rNf3epWFvcMhhijjiYxgnaEUHLZyckjP3Qo4rsKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Common sites for development of pressure ulcers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Taylor CR, Lillis C, LeMone P, Lynn P. Fundamentals of Nursing: The Art And Science Of Nursing Care, Sixth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29415=[""].join("\n");
var outline_f28_46_29415=null;
var title_f28_46_29416="Dracunculiasis life cycle";
var content_f28_46_29416=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 637px\">",
"   <div class=\"ttl\">",
"    Dracunculiasis life cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 617px; height: 467px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Humans become infected by drinking unfiltered water containing copepods (small crustaceans) that are infected with larvae of",
"    <em>",
"     D. medinensis",
"    </em>",
"    <strong>",
"     (1)",
"    </strong>",
"    . Following ingestion, the copepods die and release the larvae, which penetrate the host stomach and intestinal wall and enter the abdominal cavity and retroperitoneal space",
"    <strong>",
"     (2)",
"    </strong>",
"    . After maturation into adults and copulation, the male worms die and the females (length: 70 to 120 cm) migrate in the subcutaneous tissues towards the skin surface",
"    <strong>",
"     (3)",
"    </strong>",
"    . Approximately one year after infection, the female worm induces a blister on the skin, generally on the distal lower extremity, which ruptures. When this lesion comes into contact with water, a contact that the patient seeks to relieve the local discomfort, the female worm emerges and releases larvae",
"    <strong>",
"     (4)",
"    </strong>",
"    . The larvae are ingested by a copepod",
"    <strong>",
"     (5)",
"    </strong>",
"    and after two weeks (and two molts) have developed into infective larvae",
"    <strong>",
"     (6)",
"    </strong>",
"    . Ingestion of the copepods closes the cycle",
"    <strong>",
"     (1)",
"    </strong>",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Dracunculiasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Dracunculiasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Dracunculiasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29416=[""].join("\n");
var outline_f28_46_29416=null;
var title_f28_46_29417="Placental abruption: Clinical features and diagnosis";
var content_f28_46_29417=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Placental abruption: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Cande V Ananth, PhD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Wendy L Kinzler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29417/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/46/29417/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Placental abruption (also called abruptio placentae) refers to bleeding at the decidual-placental interface that causes partial or total placental detachment prior to delivery of the fetus. The diagnosis is typically reserved for pregnancies over 20 weeks of gestation. The major clinical findings are vaginal bleeding and abdominal pain, often accompanied by hypertonic uterine contractions, uterine tenderness, and a nonreassuring fetal heart rate (FHR) pattern.",
"   </p>",
"   <p>",
"    Abruption is a significant cause of maternal and perinatal morbidity, and perinatal mortality. The perinatal death rate is approximately 12 percent (versus 0.6 percent in non-abruption births) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of perinatal deaths (up to 77 percent) occur in utero; deaths in the postnatal period are primarily related to preterm delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. However, perinatal mortality associated with abruption appears to be decreasing [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Placental abruption complicates 0.4 to 1 percent of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The incidence appears to be increasing, possibly due to increases in the prevalence of risk factors for the disorder",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to changes in ascertainment of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In one review, 40 to 60 percent of abruptions occurred before 37 weeks of gestation and 14 percent occurred before 32 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/6\">",
"     6",
"    </a>",
"    ]. However, gestational age-specific incidence rates vary considerably depending on the etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS AND PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immediate cause of the premature placental separation is rupture of maternal vessels in the decidua basalis, where it interfaces with the anchoring villi of the placenta. Rarely, the bleeding originates from the fetal-placental vessels. The accumulating blood splits the decidua, separating a thin layer of decidua with its placental attachment from the uterus. The bleed may be small and self-limited, or may continue to dissect through the placental-decidual interface, leading to complete or near complete placental separation. The detached portion of the placenta is unable to exchange gases and nutrients; when the remaining fetoplacental unit is unable to compensate for this loss of function, the fetus becomes compromised.",
"   </p>",
"   <p>",
"    The etiology of bleeding at the decidua basalis remains speculative in most cases, despite extensive clinical and epidemiologic research. A small proportion of all abruptions are related to sudden mechanical events, such as blunt abdominal trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/11\">",
"     11",
"    </a>",
"    ] or rapid uterine decompression, which cause shearing of the inelastic placenta due to sudden stretching or contraction of the underlying uterine wall [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In motor vehicle crashes, an additional factor is rapid acceleration-deceleration of the uterus, which causes uterine stretch without concomitant placental stretch, leading to a shearing force between the placenta and the uterine wall. Although even minor trauma may be associated with an increased risk of preterm birth, severe maternal trauma is associated with a six-fold increased risk of abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uterine abnormalities, cocaine use, and smoking are additional less common causes of abruption. Uterine anomalies (eg, bicornuate uterus), uterine synechiae, and leiomyoma are mechanically and biologically unstable sites for placental implantation; abruption at these sites may be due to inadequate decidualization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    shear. Suboptimal trophoblastic implantation may also explain the increased risk of abruption among women with a prior cesarean (OR 2.3, 95% CI 1.5-3.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/13\">",
"     13",
"    </a>",
"    ]. The pathophysiological effect of cocaine in the genesis of abruption is unknown, but may be related to cocaine-induced vasoconstriction leading to ischemia, reflex vasodilatation, and disruption of vascular integrity. As many as 10 percent of women using cocaine in the third trimester will have a placental abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. The mechanism underlying the relationship between smoking cigarettes and abruption is also unclear. One hypothesis is that the vasoconstrictive effects of smoking cause placental hypoperfusion, which could result in decidual ischemia, necrosis, and hemorrhage leading to placental separation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most abruptions appear to be related to a chronic placental disease process. In these cases, abnormalities in the early development of the spiral arteries lead to decidual necrosis, placental inflammation and possibly infarction, and ultimately vascular disruption and bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/9,10,19-21\">",
"     9,10,19-21",
"    </a>",
"    ]. High pressure arterial hemorrhage in the central area of the placenta leads to rapid development of potentially life-threatening clinical manifestations of abruption (eg, severe bleeding, maternal disseminated intravascular coagulation, fetal heart rate [FHR] abnormalities). Low pressure venous hemorrhage, typically at the periphery of the placenta (marginal abruption), is more likely to result in clinical manifestations that occur over time (eg, light intermittent bleeding, oligohydramnios, fetal growth restriction) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thrombin plays a key role in the clinical consequences of placental abruption, and may be important in its pathogenesis, as well. It is formed via two pathways: in one pathway, decidual bleeding leads to release of tissue factor (thromboplastin) from decidual cells, which generates thrombin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/23\">",
"     23",
"    </a>",
"    ]. In the other pathway, decidual hypoxia induces production of vascular endothelial growth factor (VEGF), which acts directly on decidual endothelial cells to induce aberrant expression of tissue factor, which then generates thrombin [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/24\">",
"     24",
"    </a>",
"    ]. The production of thrombin can lead to the following clinical sequelae:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uterine hypertonus and contractions, as thrombin is a potent, direct uterotonic agent [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Enhanced expression of matrix metalloproteinases [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/23\">",
"       23",
"      </a>",
"      ], up-regulation of genes involved in apoptosis [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/24\">",
"       24",
"      </a>",
"      ], and induced expression of inflammatory cytokines (predominantly interleukin-8), leading to tissue necrosis and degradation of extracellular matrix [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/24,26,27\">",
"       24,26,27",
"      </a>",
"      ]. A vicious cycle then ensues, resulting in further vascular disruption, and often leading to initiation of labor and rupture of membranes (",
"      <a class=\"graphic graphic_algorithm graphicRef54747 \" href=\"UTD.htm?41/26/42414\">",
"       algorithm 1",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      In women with premature rupture of membranes, the risk of placental abruption increases with increasing latency, which suggests that inflammation subsequent to membrane rupture can induce rather than result from the cascade of events leading to placental separation [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/28-32\">",
"       28-32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Triggering of coagulation. If a massive amount of tissue factor (thromboplastin) is released, a massive amount of thrombin is generated and enters the maternal circulation over a brief period of time [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/33\">",
"       33",
"      </a>",
"      ]. This overwhelms hemostatic control mechanisms, without allowing sufficient time for recovery of compensatory mechanisms. The clinical consequence is a profound systemic bleeding diathesis and, due to widespread intravascular fibrin deposition, ischemic tissue injury and microangiopathic hemolytic anemia (ie, disseminated intravascular coagulation [DIC]).",
"     </li>",
"     <li>",
"      Functional progesterone withdrawal by reduced expression of progesterone receptors in decidual cells, which initiates or contributes to uterine contractility [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9294247\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major risk factors for placental abruption in singleton and twin gestations are described in the table (",
"    <a class=\"graphic graphic_table graphicRef75801 \" href=\"UTD.htm?14/40/14989\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/5\">",
"     5",
"    </a>",
"    ]. Smoking is one of the few modifiable risk factors for abruption: it is associated with a 2.5-fold increased risk of abruption severe enough to result in fetal death and the risk increases by 40 percent for each pack per day smoked [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/35\">",
"     35",
"    </a>",
"    ]. The combination of cigarette smoking and hypertension has a synergistic effect on risk of abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/36\">",
"     36",
"    </a>",
"    ]. Hypertensive women have a five-fold increased risk of severe abruption compared to normotensive women, and antihypertensive therapy does not appear to reduce the risk of placental abruption among women with chronic hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two studies have reported an increased risk of abruption in women with elevated thyroperoxidase antibodies in early pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. However, most women with abruption do not have these antibodies, a positive value is not highly predictive of abruption, and there is no evidence that treatment will reduce the risk of abruption.",
"   </p>",
"   <p>",
"    A modest increase in the risk of abruption has also been noted in women with asthma (adjusted OR 1.22, 95% CI 1.09-1.36) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute abruption",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9295986\">",
"    <span class=\"h3\">",
"     Patient presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with an acute abruption classically present with the abrupt onset of vaginal bleeding, mild to moderate abdominal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    back pain, and uterine contractions. Back pain is prominent when the placenta is on the posterior wall of the uterus. The uterus is often firm, and may be rigid and tender.",
"   </p>",
"   <p>",
"    Contractions are usually high frequency and low amplitude, but a contraction pattern typical of labor is also possible and labor may proceed rapidly.",
"   </p>",
"   <p>",
"    Vaginal bleeding ranges from mild and clinically insignificant to severe and life-threatening. Blood loss may be underestimated because bleeding may be retained behind the placenta and thus difficult to quantify. The amount of vaginal bleeding correlates poorly with the degree of placental separation and does not serve as a useful marker of impending fetal or maternal risk. Maternal hypotension and fetal heart rate (FHR) abnormalities, however, suggest clinically significant separation that could result in fetal death and severe maternal morbidity. When placental separation exceeds 50 percent, acute disseminated intravascular coagulation and fetal death are common [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 10 to 20 percent of placental abruptions, patients present with only preterm labor, and no or scant vaginal bleeding. In these cases, termed &lsquo;concealed abruption,&rsquo; all or most of the blood is trapped between the fetal membranes and decidua, rather than escaping through the cervix and vagina [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/43\">",
"     43",
"    </a>",
"    ]. Therefore, in pregnant women with abdominal pain and uterine contractions, even a small amount of vaginal bleeding should prompt close maternal and fetal evaluation for placental abruption. In other cases, a small concealed abruption may be asymptomatic and only recognized as an incidental finding on an ultrasound.",
"   </p>",
"   <p>",
"    Occasionally, the signs and symptoms of abruption develop after rapid uterine decompression, such as after uncontrolled rupture of membranes in the setting of polyhydramnios or after delivery of a first twin. Signs and symptoms of abruption also may occur after maternal abdominal trauma or a motor vehicle crash. In these cases, placental abruption generally presents within 24 hours of the precipitating event and tends to be severe. The clinical presentation and obstetrical evaluation of pregnant trauma victims are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22569?source=see_link&amp;anchor=H9#H9\">",
"     \"Trauma in pregnancy\", section on 'Evaluation and management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H600214\">",
"    <span class=\"h3\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The degree of maternal hemorrhage correlates with the degree of hematological abnormality; fibrinogen levels have the best correlation with severity of bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/41\">",
"     41",
"    </a>",
"    ]. Initial fibrinogen values of &le;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    are reported to have 100 percent positive predictive value for severe postpartum hemorrhage, while levels of &ge;400",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    have a negative predictive value of 79 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/42\">",
"     42",
"    </a>",
"    ]. Mild",
"    <span class=\"nowrap\">",
"     separation/hemorrhage",
"    </span>",
"    may not be associated with any abnormalities of commonly used tests of hemostasis.",
"   </p>",
"   <p>",
"    Severe abruption can lead to disseminated intravascular coagulation (DIC). DIC occurs in 10 to 20 percent of severe abruptions with death of the fetus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of acute DIC is confirmed by demonstrating increased thrombin generation (eg, decreased fibrinogen) and increased fibrinolysis (eg, elevated fibrin degradation products [FDPs] and D-dimer). However, laboratory findings suggestive of mild DIC need to be interpreted with caution in pregnancy because of normal pregnancy-related increases in the concentration of almost all coagulation factors and a normal mild decrease in platelet count. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21703?source=see_link\">",
"     \"Hematologic changes in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Kleihauer-Betke test is positive in a small proportion of abruptions. There is poor correlation between the results of this test and the presence or absence of abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/43-46\">",
"     43-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even prior to clinical or sonographic findings of abruption, there may be early markers of ischemic placental disease detected during routine prenatal care. Elevations of maternal serum alpha fetal protein (AFP) that are not explained by fetal abnormalities carry up to a 10-fold risk of subsequent abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. An increased level of human chorionic gonadotropin (hCG) has also been associated with subsequent abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H600443\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identification of a retroplacental hematoma is the classic ultrasound finding of placental abruption (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83126 \" href=\"UTD.htm?16/44/17103\">",
"     image 1",
"    </a>",
"    ). Retroplacental hematomas have a variable appearance; they can appear solid, complex, and hypo-, hyper-, or iso-echoic compared to the placenta. Hypoechogenicity and sonolucency are features of resolving rather than acute hematomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83127 \" href=\"UTD.htm?16/41/17055\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Whether a hematoma is identified depends on the extent of hemorrhage, chronicity of the bleeding, and extent that blood has escaped through the cervix (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72314 graphicRef51286 \" href=\"UTD.htm?27/40/28293\">",
"     image 3A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69163 graphicRef79004 \" href=\"UTD.htm?6/63/7160\">",
"     image 4A-B",
"    </a>",
"    ). Although the worst outcomes appear to occur when there is sonographic evidence of a retroplacental hematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/51\">",
"     51",
"    </a>",
"    ], the absence of retroplacental hematoma does not exclude the possibility of severe abruption because blood may not collect behind the uterus. The sensitivity of ultrasound findings for diagnosis of abruption is only 25 to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/52-54\">",
"     52-54",
"    </a>",
"    ], but the positive predictive value is high (88 percent) when ultrasound findings suggestive of abruption are present [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/52,55\">",
"     52,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A thorough search for other findings in symptomatic patients may improve the sensitivity and specificity of ultrasound. These findings include subchorionic collections of fluid (even remote from the placental attachment site), echogenic debris in the amniotic fluid, or a thickened placenta, especially if it shimmers with maternal movement (\"Jello\" sign) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging can detect abruptions missed by ultrasound examination, but increased diagnostic certainty is unlikely to change management or be cost-effective [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H601335\">",
"    <span class=\"h3\">",
"     Consequences",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the mother, the potential consequences of abruption are primarily related to the severity of the placental separation, while the risks to the fetus are related to both the severity of the separation and the gestational age at which delivery occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/2,9,10,43,58-63\">",
"     2,9,10,43,58-63",
"    </a>",
"    ]. With mild placental separation, there may be no significant adverse effects. As the degree of placental separation increases, the maternal and perinatal risks also increase [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/2,43,58,59,64\">",
"     2,43,58,59,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excessive blood loss and DIC generally necessitate blood transfusion and can lead to hypovolemic shock, renal failure, adult respiratory distress syndrome, multiorgan failure, peripartum hysterectomy and, rarely, death [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/6,43\">",
"       6,43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Emergency cesarean delivery for fetal or maternal indications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fetal and neonatal:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perinatal morbidity and mortality related to hypoxemia, asphyxia, low birth weight,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      preterm delivery [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/1,2,58-61,64-66\">",
"       1,2,58-61,64-66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fetal growth restriction (with chronic abruption) (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Chronic abruption'",
"      </a>",
"      below) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/2,58-60,64,67\">",
"       2,58-60,64,67",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In population-based studies, the perinatal mortality rate is about 12 percent (versus 0.6 percent in births without abruption) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. More than 50 percent of abruption-related perinatal deaths are stillborns due to intrauterine asphyxia, which generally occurs when over 50 percent of the placenta detaches [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/6\">",
"     6",
"    </a>",
"    ]. Placental abruption is implicated in up to 10 percent of preterm births and perinatal death is related to preterm delivery in at least 30 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/43,58,64\">",
"     43,58,64",
"    </a>",
"    ]. Preterm birth may be iatrogenic due to the nonreassuring fetal or maternal condition, or it may be related to preterm labor or preterm premature rupture of membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fetal asphyxia, preterm birth, and growth restriction can be associated with short- and long-term sequelae. A study of 29 neonates from pregnancies complicated by abruption at a median of 29 weeks of gestation reported a 10-fold increase in periventricular leukomalacia compared with matched neonates in pregnancies without abruption; the rate of periventricular leukomalacia was 34 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/68\">",
"     68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31992?source=see_link\">",
"     \"Short-term complications of the premature infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29623?source=see_link\">",
"     \"Systemic effects of perinatal asphyxia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=see_link\">",
"     \"Small for gestational age infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13814?source=see_link\">",
"     \"Long-term complications of the premature infant\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597896\">",
"    <span class=\"h3\">",
"     Placental pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one large series, gross examination of the placenta at delivery revealed the following estimated frequencies of placental separation: less than 25 percent placental separation (54 percent); 25 to 49 percent placental separation (16 percent); 50 to 74 percent placental separation (13 percent); over 75 percent placental separation (17 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histopathological examination of the placenta shortly after an acute abruption may not reveal any abnormality. In less acute cases, an organizing retroplacental hematoma indenting the parenchyma may be noted [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/20\">",
"     20",
"    </a>",
"    ]. Recent infarcts may be present and are characterized by preservation of villous stromal architecture, eosinophilic degeneration of the syncytiotrophoblast, and villous agglutination with scattered intervillous neutrophils. These infarcts take approximately four to six hours to develop.",
"   </p>",
"   <p>",
"    Histological findings, such as diffuse retromembranous",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intradecidual hemorrhages, pigmented histiocytes, irregular basal intervillous thrombi, and recent villous stromal hemorrhage, are not specific for the diagnosis. Histologic evidence of decidual hemorrhage is noted in 2 to 4 percent of deliveries; most cases are associated with preterm premature rupture of membranes or preterm labor and delivery rather than a clinical diagnosis of abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/43,69\">",
"     43,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H599810\">",
"    <span class=\"h3\">",
"     Recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with placental abruption are at several-fold higher risk of abruption in a subsequent pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/70-75\">",
"     70-75",
"    </a>",
"    ]. The risk of recurrence has been reported to be 5 to 15 percent, compared to a baseline incidence of 0.4 to 1.3 percent in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/71,76,77\">",
"     71,76,77",
"    </a>",
"    ]. After two consecutive abruptions, the risk of a third rises to 20 to 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/75,78\">",
"     75,78",
"    </a>",
"    ]. The risk of recurrence is higher after a severe abruption than after a mild abruption, and the woman's sisters appear to be at increased risk of also having an abruption (OR 1.7-2.1) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/75\">",
"     75",
"    </a>",
"    ]. When the abruption is severe enough to kill the fetus, there is a 7 percent incidence of the same outcome in a future pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Placental abruption, preeclampsia, and intrauterine growth restriction appear to be variable clinical manifestations of uteroplacental underperfusion, chronic hypoxia, and uteroplacental ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/67,80-83\">",
"     67,80-83",
"    </a>",
"    ]. In large retrospective cohort studies, women who delivered a growth-restricted infant in their first pregnancy were at increased risk of experiencing placental abruption in the subsequent pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/67\">",
"     67",
"    </a>",
"    ], and women with preeclampsia in the first pregnancy carried an increased risk of developing placental abruption in the subsequent pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/84,85\">",
"     84,85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic abruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with chronic abruption experience relatively light, chronic, intermittent bleeding and clinical manifestations of ischemic placental disease that develop over time, such as oligohydramnios, fetal growth restriction, and preeclampsia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/29,30,67\">",
"     29,30,67",
"    </a>",
"    ]. They are also at risk of preterm premature rupture of membranes.",
"   </p>",
"   <p>",
"    Coagulation studies are usually normal. Ultrasound examination may identify a placental hematoma (retromembranous, marginal, or central), and serial examination may reveal fetal growth restriction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oligohydramnios. Abruption in the second trimester accompanied by oligohydramnios has a dismal fetal prognosis. In two small series of pregnancies with both of these diagnoses, only 2 of 15 fetuses survived [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histological examination of the placenta may show chronic lesions, such as chronic deciduitis (lymphocytes with or without plasma cells), maternal floor decidual necrosis, villitis, decidual vasculopathy (specifically, in the vessels of the extraplacental membrane roll), placental infarction, intervillous thrombosis, villous maldevelopment, and hemosiderin deposition [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of abruptio placentae is primarily clinical, but findings from imaging, laboratory, and postpartum pathologic studies can be used to support the clinical diagnosis. Women with an acute abruption classically present with the abrupt onset of mild to moderate vaginal bleeding and abdominal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    back pain, accompanied by uterine contractions. The uterus has increased",
"    <span class=\"nowrap\">",
"     tone/rigidity",
"    </span>",
"    and may be tender both during and between contractions. In patients with classic symptoms, fetal heart rate (FHR) abnormalities or intrauterine fetal demise",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    disseminated intravascular coagulation strongly support the clinical diagnosis and indicate extensive placental separation.",
"   </p>",
"   <p>",
"    Ultrasound examination is useful for identifying a retroplacental hematoma and for excluding other disorders associated with vaginal bleeding and abdominal pain (see",
"    <a class=\"local\" href=\"#H23230079\">",
"     'Differential diagnosis'",
"    </a>",
"    below). A retroplacental hematoma is the classic ultrasound finding and strongly supports the clinical diagnosis, but is absent in many patients with abruption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23230079\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pregnant women with suspected abruption, the differential diagnosis of vaginal bleeding accompanied by pain and contractions includes labor, placenta previa, uterine rupture, and subchorionic hematoma.",
"   </p>",
"   <p>",
"    The signs and symptoms of labor have a more gradual onset than those of abruption. The onset of labor (preterm or term) is characterized by mild uterine contractions at infrequent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    irregular intervals; the contractions become more regular and painful over time and are accompanied by cervical dilation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    effacement. Mucus that has accumulated in the cervix may be discharged as clear, pink, or slightly bloody secretions (ie, mucus plug, bloody show), sometimes several days before labor begins. Early labor is usually associated with less bleeding, less uterine rigidity, less abdominal pain, and fewer high frequency contractions compared with abruption; however, there is an overlap in symptoms since abruption may trigger labor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5608?source=see_link\">",
"     \"Overview of preterm labor and birth\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The characteristic clinical presentation of placenta previa is painless vaginal bleeding after 20 weeks of gestation; however, 10 to 20 percent of women present with uterine contractions associated with the bleeding. Thus, abruption and placenta previa can be difficult to distinguish clinically since abruption may not be associated with significant pain and placenta previa may not be painless. In pregnant women with vaginal bleeding, an ultrasound examination should be performed to determine whether placenta previa is the source. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=see_link\">",
"     \"Clinical features, diagnosis, and course of placenta previa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uterine rupture is most common in women with a prior hysterotomy. Signs of uterine rupture may include the sudden onset fetal heart rate (FHR) abnormalities, vaginal bleeding, constant abdominal pain, cessation of uterine contractions, recession of the presenting part, and maternal hypotension and tachycardia. Many of these symptoms are common to abruption because uterine rupture often leads to placental separation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44102?source=see_link\">",
"     \"Rupture of the unscarred uterus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"./uterine-rupture-after-previous-cesarean-delivery?source=see_link\">",
"     \"Uterine rupture after previous cesarean delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subchorionic hematoma is believed to result from partial detachment of the chorionic membranes from the uterine wall, in contrast to abruption, which is due to detachment of the placenta from the uterine wall [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/88\">",
"     88",
"    </a>",
"    ]. Patients are asymptomatic or experience light vaginal bleeding. In contrast to abruption, abdominal pain is typically absent, a minority of patients experience cramping or contractions, and the diagnosis is usually made before rather than after 20 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/89\">",
"     89",
"    </a>",
"    ]. The diagnosis is based on ultrasound findings of a hypoechoic or anechoic crescent-shape area behind the fetal membranes, which may also elevate the edge of the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/90\">",
"     90",
"    </a>",
"    ]. Women with subchorionic hematomas have a greater than five-fold increased risk of developing an abruption, as well as other pregnancy complications (eg, preterm labor, premature rupture of membranes) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16036265\">",
"    <span class=\"h1\">",
"     DETERMINING THE CAUSE OF ABRUPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of most abruptions cannot be determined with certainty. A thorough history and physical examination may identify risk factors for the disorder, such as smoking;",
"    <span class=\"nowrap\">",
"     hypertension/preeclampsia;",
"    </span>",
"    recent cocaine use, trauma, or rapid uterine decompression; premature rupture of membranes; chorioamnionitis; or a prior history of abruption, preeclampsia, or delivery of a small for gestational age neonate.",
"   </p>",
"   <p>",
"    Although use of cocaine can result in abruption, we do not routinely perform toxicology screening on all patients with unexplained placental abruption. We obtain urine toxicology tests in patients with risk factors for substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29417/abstract/91\">",
"     91",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=see_link\">",
"     \"Overview of illicit drug use in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23230291\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34663?source=see_link\">",
"     \"Placental abruption: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/29/39377?source=see_link\">",
"       \"Patient information: Placental abruption (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Placental abruption refers to partial or complete separation of the placenta prior to delivery of the fetus. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most placental abruptions are related to a chronic pathologic vascular process, but some are due to acute events, such as trauma or vasoconstriction. The immediate cause of placental separation is rupture of maternal blood vessels in the decidua basalis. The subsequent release of tissue factor and generation of thrombin lead to many of the clinical sequelae of acute abruption. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis and pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for placental abruption are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef75801 \" href=\"UTD.htm?14/40/14989\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9294247\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic symptoms and signs of acute placental abruption are vaginal bleeding, abdominal pain, contractions, uterine rigidity and tenderness, and possibly a nonreassuring fetal heart rate (FHR) tracing. In 10 to 20 percent of placental abruptions, patients present with only preterm labor, and no vaginal bleeding. Some abruptions are asymptomatic. The amount of bleeding does not correlate well with the extent of maternal hemorrhage and cannot be used as a marker to gauge the severity of premature placental separation. FHR abnormalities suggest clinically significant separation that could result in fetal death. (See",
"      <a class=\"local\" href=\"#H9295986\">",
"       'Patient presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A retroplacental clot is the classic ultrasound finding of placental abruption, but is not always present. (See",
"      <a class=\"local\" href=\"#H600443\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When placental separation exceeds 50 percent, acute disseminated intravascular coagulation and fetal death are common. (See",
"      <a class=\"local\" href=\"#H600214\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H601335\">",
"       'Consequences'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast to acute abruption, patients with chronic placental abruption experience relatively light, chronic, intermittent bleeding and exhibit clinical manifestations that develop over time, such as oligohydramnios, fetal growth restriction, and preeclampsia. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chronic abruption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of acute abruption is clinical and based on the abrupt onset of mild to moderate vaginal bleeding and abdominal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      back pain, accompanied by uterine contractions. A retroplacental clot is the classic ultrasound finding and strongly supports the clinical diagnosis, but is absent in many patients with abruption. In patients with classic symptoms, FHR abnormalities or intrauterine fetal demise",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disseminated intravascular coagulation strongly support the clinical diagnosis and indicate extensive placental separation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with placental abruption are at several-fold higher risk of abruption in a subsequent pregnancy, especially if the abruption was severe. (See",
"      <a class=\"local\" href=\"#H599810\">",
"       'Recurrence'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/1\">",
"      Tikkanen M, Luukkaala T, Gissler M, et al. Decreasing perinatal mortality in placental abruption. Acta Obstet Gynecol Scand 2013; 92:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/2\">",
"      Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001; 153:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/3\">",
"      Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011; 174:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/4\">",
"      Aliyu MH, Salihu HM, Lynch O, et al. Placental abruption, offspring sex, and birth outcomes in a large cohort of mothers. J Matern Fetal Neonatal Med 2012; 25:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/5\">",
"      Ananth CV, Smulian JC, Demissie K, et al. Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 2001; 153:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/6\">",
"      Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011; 90:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/7\">",
"      Pariente G, Wiznitzer A, Sergienko R, et al. Placental abruption: critical analysis of risk factors and perinatal outcomes. J Matern Fetal Neonatal Med 2011; 24:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/8\">",
"      Ananth CV, Oyelese Y, Yeo L, et al. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol 2005; 192:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/9\">",
"      Ananth CV, Getahun D, Peltier MR, Smulian JC. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol 2006; 107:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/10\">",
"      Ananth CV, Oyelese Y, Prasad V, et al. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol 2006; 128:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/11\">",
"      Melamed N, Aviram A, Silver M, et al. Pregnancy course and outcome following blunt trauma. J Matern Fetal Neonatal Med 2012; 25:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/12\">",
"      Cheng HT, Wang YC, Lo HC, et al. Trauma during pregnancy: a population-based analysis of maternal outcome. World J Surg 2012; 36:2767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/13\">",
"      Jackson S, Fleege L, Fridman M, et al. Morbidity following primary cesarean delivery in the Danish National Birth Cohort. Am J Obstet Gynecol 2012; 206:139.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/14\">",
"      Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002; 186:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/15\">",
"      Hoskins IA, Friedman DM, Frieden FJ, et al. Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption. Obstet Gynecol 1991; 78:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/16\">",
"      Mbah AK, Alio AP, Fombo DW, et al. Association between cocaine abuse in pregnancy and placenta-associated syndromes using propensity score matching approach. Early Hum Dev 2012; 88:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/17\">",
"      Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol 1980; 136:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/18\">",
"      Kaminsky LM, Ananth CV, Prasad V, et al. The influence of maternal cigarette smoking on placental pathology in pregnancies complicated by abruption. Am J Obstet Gynecol 2007; 197:275.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/19\">",
"      Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992; 99:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/20\">",
"      Elsasser DA, Ananth CV, Prasad V, et al. Diagnosis of placental abruption: relationship between clinical and histopathological findings. Eur J Obstet Gynecol Reprod Biol 2010; 148:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/21\">",
"      Avagliano L, Bulfamante GP, Morabito A, Marconi AM. Abnormal spiral artery remodelling in the decidual segment during pregnancy: from histology to clinical correlation. J Clin Pathol 2011; 64:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/22\">",
"      Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta 2008; 29 Suppl A:S86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/23\">",
"      Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004; 191:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/24\">",
"      Krikun G, Huang ST, Schatz F, et al. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thromb Haemost 2007; 97:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/25\">",
"      Elovitz MA, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol 2000; 183:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/26\">",
"      Lockwood CJ, Toti P, Arcuri F, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol 2005; 167:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/27\">",
"      Buhimschi CS, Schatz F, Krikun G, et al. Novel insights into molecular mechanisms of abruption-induced preterm birth. Expert Rev Mol Med 2010; 12:e35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/28\">",
"      Williams MA, Lieberman E, Mittendorf R, et al. Risk factors for abruptio placentae. Am J Epidemiol 1991; 134:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/29\">",
"      Vintzileos AM, Campbell WA, Nochimson DJ, Weinbaum PJ. Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am J Obstet Gynecol 1987; 156:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/30\">",
"      Ananth CV, Oyelese Y, Srinivas N, et al. Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: risk factors for placental abruption. Obstet Gynecol 2004; 104:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/31\">",
"      Major CA, de Veciana M, Lewis DF, Morgan MA. Preterm premature rupture of membranes and abruptio placentae: is there an association between these pregnancy complications? Am J Obstet Gynecol 1995; 172:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/32\">",
"      Suzuki S. Clinical Significance of Preterm Singleton Pregnancies Complicated by Placental Abruption following Preterm Premature Rupture of Membranes Compared with Those without p-PROM. ISRN Obstet Gynecol 2012; 2012:856971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/33\">",
"      Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009; 23:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/34\">",
"      Lockwood CJ, Kayisli UA, Stocco C, et al. Abruption-induced preterm delivery is associated with thrombin-mediated functional progesterone withdrawal in decidual cells. Am J Pathol 2012; 181:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/35\">",
"      Kramer MS, Usher RH, Pollack R, et al. Etiologic determinants of abruptio placentae. Obstet Gynecol 1997; 89:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/36\">",
"      Ananth CV, Savitz DA, Bowes WA Jr, Luther ER. Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. Br J Obstet Gynaecol 1997; 104:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/37\">",
"      Sibai BM, Mabie WC, Shamsa F, et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990; 162:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/38\">",
"      Haddow JE, McClain MR, Palomaki GE, et al. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol 2011; 117:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/39\">",
"      Abbassi-Ghanavati M, Casey BM, Spong CY, et al. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 2010; 116:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/40\">",
"      Mendola P, Laughon SK, M&auml;nnist&ouml; TI, et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol 2013; 208:127.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/41\">",
"      de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/42\">",
"      Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/43\">",
"      Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006; 108:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/44\">",
"      Emery CL, Morway LF, Chung-Park M, et al. The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use. Arch Pathol Lab Med 1995; 119:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/45\">",
"      Dhanraj D, Lambers D. The incidences of positive Kleihauer-Betke test in low-risk pregnancies and maternal trauma patients. Am J Obstet Gynecol 2004; 190:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/46\">",
"      Cahill AG, Bastek JA, Stamilio DM, et al. Minor trauma in pregnancy--is the evaluation unwarranted? Am J Obstet Gynecol 2008; 198:208.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/47\">",
"      Katz VL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv 1990; 45:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/48\">",
"      Tikkanen M, H&auml;m&auml;l&auml;inen E, Nuutila M, et al. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Prenat Diagn 2007; 27:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/49\">",
"      van Rijn M, van der Schouw YT, Hagenaars AM, et al. Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol 1999; 94:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/50\">",
"      Chandra S, Scott H, Dodds L, et al. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 2003; 189:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/51\">",
"      Nyberg DA, Mack LA, Benedetti TJ, et al. Placental abruption and placental hemorrhage: correlation of sonographic findings with fetal outcome. Radiology 1987; 164:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/52\">",
"      Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med 2002; 21:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/53\">",
"      Sholl JS. Abruptio placentae: clinical management in nonacute cases. Am J Obstet Gynecol 1987; 156:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/54\">",
"      Jaffe MH, Schoen WC, Silver TM, et al. Sonography of abruptio placentae. AJR Am J Roentgenol 1981; 137:1049.",
"     </a>",
"    </li>",
"    <li>",
"     Yeo, L, Ananth, CV, Vintzileos, AM. Placental abruption, Lippincott, Williams &amp; Wilkins, Hagerstown, Maryland 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/56\">",
"      Masselli G, Brunelli R, Di Tola M, et al. MR imaging in the evaluation of placental abruption: correlation with sonographic findings. Radiology 2011; 259:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/57\">",
"      Linduska N, Dekan S, Messerschmidt A, et al. Placental pathologies in fetal MRI with pathohistological correlation. Placenta 2009; 30:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/58\">",
"      Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH. Placental abruption and adverse perinatal outcomes. JAMA 1999; 282:1646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/59\">",
"      Ananth CV, Smulian JC, Srinivas N, et al. Risk of infant mortality among twins in relation to placental abruption: contributions of preterm birth and restricted fetal growth. Twin Res Hum Genet 2005; 8:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/60\">",
"      Raymond EG, Mills JL. Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand 1993; 72:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/61\">",
"      Rasmussen S, Irgens LM, Bergsjo P, Dalaker K. Perinatal mortality and case fatality after placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand 1996; 75:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/62\">",
"      Ananth CV, Demissie K, Hanley ML. Birth weight discordancy and adverse perinatal outcomes among twin gestations in the United States: the effect of placental abruption. Am J Obstet Gynecol 2003; 188:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/63\">",
"      Chang YL, Chang SD, Cheng PJ. Perinatal outcome in patients with placental abruption with and without antepartum hemorrhage. Int J Gynaecol Obstet 2001; 75:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/64\">",
"      Sheiner E, Shoham-Vardi I, Hadar A, et al. Incidence, obstetric risk factors and pregnancy outcome of preterm placental abruption: a retrospective analysis. J Matern Fetal Neonatal Med 2002; 11:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/65\">",
"      Faiz AS, Demissie K, Rich DQ, et al. Trends and risk factors of stillbirth in New Jersey 1997-2005. J Matern Fetal Neonatal Med 2012; 25:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/66\">",
"      Brailovschi Y, Sheiner E, Wiznitzer A, et al. Risk factors for intrapartum fetal death and trends over the years. Arch Gynecol Obstet 2012; 285:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/67\">",
"      Rasmussen S, Irgens LM, Dalaker K. A history of placental dysfunction and risk of placental abruption. Paediatr Perinat Epidemiol 1999; 13:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/68\">",
"      Gibbs JM, Weindling AM. Neonatal intracranial lesions following placental abruption. Eur J Pediatr 1994; 153:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/69\">",
"      Salafia CM, L&oacute;pez-Zeno JA, Sherer DM, et al. Histologic evidence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 1995; 173:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/70\">",
"      Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. Am J Epidemiol 2007; 166:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/71\">",
"      Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol 1996; 88:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/72\">",
"      K&aring;reg&aring;rd M, Gennser G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol 1986; 67:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/73\">",
"      Rasmussen S, Irgens LM, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynaecol 1997; 104:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/74\">",
"      Rasmussen S, Irgens LM, Dalaker K. Outcome of pregnancies subsequent to placental abruption: a risk assessment. Acta Obstet Gynecol Scand 2000; 79:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/75\">",
"      Rasmussen S, Irgens LM. Occurrence of placental abruption in relatives. BJOG 2009; 116:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/76\">",
"      Toivonen S, Heinonen S, Anttila M, et al. Obstetric prognosis after placental abruption. Fetal Diagn Ther 2004; 19:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/77\">",
"      Tikkanen M, Nuutila M, Hiilesmaa V, et al. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand 2006; 85:40.",
"     </a>",
"    </li>",
"    <li>",
"     Clark, SL. Placentae Previa and Abruptio Placentae. In: Maternal Fetal Medicine, 4th ed, Creasy, RK, Resnik, R, (Eds), WB Saunders Company, Philadelphia, Pennsylvania 1999. p. 623.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/79\">",
"      Pritchard JA, Mason R, Corley M, Pritchard S. Genesis of severe placental abruption. Am J Obstet Gynecol 1970; 108:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/80\">",
"      Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006; 19:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/81\">",
"      Ananth CV, Vintzileos AM. Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol 2008; 35:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/82\">",
"      Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am J Epidemiol 1996; 144:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/83\">",
"      Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol 1999; 93:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/84\">",
"      Ananth CV, Peltier MR, Chavez MR, et al. Recurrence of ischemic placental disease. Obstet Gynecol 2007; 110:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/85\">",
"      Melamed N, Hadar E, Peled Y, et al. Risk for recurrence of preeclampsia and outcome of subsequent pregnancy in women with preeclampsia in their first pregnancy. J Matern Fetal Neonatal Med 2012; 25:2248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/86\">",
"      Shenker L, Reed KL, Anderson CF, Borjon NA. Significance of oligohydramnios complicating pregnancy. Am J Obstet Gynecol 1991; 164:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/87\">",
"      Shipp TD, Bromley B, Pauker S, et al. Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters. Ultrasound Obstet Gynecol 1996; 7:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/88\">",
"      Maso G, D'Ottavio G, De Seta F, et al. First-trimester intrauterine hematoma and outcome of pregnancy. Obstet Gynecol 2005; 105:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/89\">",
"      Seki H, Kuromaki K, Takeda S, Kinoshita K. Persistent subchorionic hematoma with clinical symptoms until delivery. Int J Gynaecol Obstet 1998; 63:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/90\">",
"      Tuuli MG, Norman SM, Odibo AO, et al. Perinatal outcomes in women with subchorionic hematoma: a systematic review and meta-analysis. Obstet Gynecol 2011; 117:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29417/abstract/91\">",
"      Kerker BD, Horwitz SM, Leventhal JM. Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use. Child Abuse Negl 2004; 28:209.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6826 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-340D2F8564-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29417=[""].join("\n");
var outline_f28_46_29417=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS AND PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9294247\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute abruption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9295986\">",
"      - Patient presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H600214\">",
"      - Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H600443\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H601335\">",
"      - Consequences",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H597896\">",
"      - Placental pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H599810\">",
"      - Recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic abruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23230079\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16036265\">",
"      DETERMINING THE CAUSE OF ABRUPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23230291\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6826\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6826|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?41/26/42414\" title=\"algorithm 1\">",
"      Pathogenesis of abruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6826|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/44/17103\" title=\"diagnostic image 1\">",
"      Ultrasound image retroplacental hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/41/17055\" title=\"diagnostic image 2\">",
"      Organizing intrauterine hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/10/29856\" title=\"diagnostic image 3A\">",
"      Retromembranous bleed 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/19/22832\" title=\"diagnostic image 3B\">",
"      Retromembranous bleed 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/41/40594\" title=\"diagnostic image 4A\">",
"      Ultrasound image of preplacental hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/49/7955\" title=\"diagnostic image 4B\">",
"      Ultrasound image of subchorionic hematoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6826|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/40/14989\" title=\"table 1\">",
"      Risk factors for abruption",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35032?source=related_link\">",
"      Clinical features, diagnosis, and course of placenta previa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21703?source=related_link\">",
"      Hematologic changes in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13814?source=related_link\">",
"      Long-term complications of the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=related_link\">",
"      Overview of illicit drug use in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5608?source=related_link\">",
"      Overview of preterm labor and birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/29/39377?source=related_link\">",
"      Patient information: Placental abruption (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/54/34663?source=related_link\">",
"      Placental abruption: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/4/44102?source=related_link\">",
"      Rupture of the unscarred uterus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31992?source=related_link\">",
"      Short-term complications of the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/23/9593?source=related_link\">",
"      Small for gestational age infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29623?source=related_link\">",
"      Systemic effects of perinatal asphyxia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22569?source=related_link\">",
"      Trauma in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./uterine-rupture-after-previous-cesarean-delivery?source=related_link\">",
"      Uterine rupture after previous cesarean delivery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29418="Approach to the adult patient with anemia";
var content_f28_46_29418=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the adult patient with anemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29418/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29418/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29418/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29418/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/46/29418/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/46/29418/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/46/29418/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although anemia can be defined as a reduced absolute number of circulating red blood cells (ie, a reduced red blood cell mass as determined by a blood volume study), such studies are not practical, cost-effective, or generally available. As a result, anemia has been defined as a reduction in one or more of the major red blood cell (RBC) measurements obtained as a part of the complete blood count: hemoglobin concentration, hematocrit, or RBC count:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemoglobin concentration (HGB) measures the concentration of the major oxygen-carrying pigment in whole blood. Values may be expressed as grams of hemoglobin per 100 mL of whole blood",
"      <span class=\"nowrap\">",
"       (g/dL)",
"      </span>",
"      or per liter of blood",
"      <span class=\"nowrap\">",
"       (g/L).",
"      </span>",
"      Efforts are underway to determine HGB levels non-invasively, allowing continuous monitoring of this parameter [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/1,2\">",
"       1,2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hematocrit (HCT) is the percent of a sample of whole blood occupied by intact red blood cells (",
"      <a class=\"graphic graphic_picture graphicRef68024 \" href=\"UTD.htm?20/49/21265\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      RBC count is the number of red blood cells contained in a specified volume of whole blood, usually expressed as millions of red blood cells per microL or liter of whole blood.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will provide an approach to the anemic patient. The first portion is devoted to an understanding of the basic aspects of erythropoiesis and a review of the causes and clinical consequences of anemia. The second portion is devoted to the clinical and laboratory evaluation of the anemic patient.",
"   </p>",
"   <p>",
"    An introduction to the phenomenon of RBC destruction (hemolysis) and tests which may be used to provide a diagnosis of hemolytic anemia is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approaches to the older adult or child with anemia are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=see_link\">",
"     \"Anemia in the older adult\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=see_link\">",
"     \"Approach to the child with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal range",
"    </span>",
"    &nbsp;&mdash;&nbsp;One set of \"normal ranges\" (95 percent confidence limits) for HGB, HCT, and RBC count is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ). If anemia is defined as values which are more than two standard deviations (SD) below the mean, then, by using these ranges, a HGB &lt;13.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;135",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    or a HCT &lt;41.0 percent represents anemia in men and a value &lt;12.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;120",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    or &lt;36.0 percent, respectively, represents anemia in women. Normal ranges other than the above have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other authors have proposed different lower limits of normal, ranging from 13.0 to 14.2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      for men and 11.6 to 12.3",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      for women [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      WHO criteria for anemia in men and women are &lt;13 and &lt;12",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/4\">",
"       4",
"      </a>",
"      ]. These criteria were meant to be used within the context of international nutrition studies, and were not initially designed to serve as \"gold standards\" for the diagnosis of anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The revised",
"      <span class=\"nowrap\">",
"       WHO/National",
"      </span>",
"      Cancer Institute's criteria for anemia in men and women are &lt;14 and &lt;12",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/5\">",
"       5",
"      </a>",
"      ]. These values are meant to be used for evaluation of anemia in patients with malignancy.",
"     </li>",
"     <li>",
"      Other lower limits according to sex, age, and race, based on data from NHANES III and Scripps-Kaiser studies, have been proposed (",
"      <a class=\"graphic graphic_table graphicRef79757 \" href=\"UTD.htm?37/22/38251\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"       3",
"      </a>",
"      ]. These values are as low as 12.7",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      for black men &gt;60 years of age and 11.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      for black women &gt;20 years of age.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of immediate limitations to this approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The above ranges may be \"two-tailed\" to be used for defining both anemia and polycythemia. In such cases, 2.5 percent of normal adults will have values which are more than 2 standard deviations below whatever \"normal range\" has been selected, and will be considered anemic. On the other hand, some ranges are \"one-tailed\", such that 5 percent of normal subjects will have levels below the stated lower limit of normal [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The normal range for HGB and HCT is so wide that, for example, a male patient with a baseline HCT of 49 percent may lose up to 15 percent of his RBC mass and still have a HCT within the normal range.",
"     </li>",
"     <li>",
"      \"Normal\" ranges may not apply to special populations (eg, high altitude living, smokers, athletes, elderly, use of ACE inhibitors). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Special populations'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1705?source=see_link&amp;anchor=H2#H2\">",
"       \"Impact of anemia in patients with heart failure\", section on 'Etiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Setting a lower limit of normal for hemoglobin does not imply that such levels are \"optimal\" in terms of morbidity and mortality. One study has suggested that the lower limits of an optimal hemoglobin level, as assessed by all-cause mortality data, are 13.0 and 14.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      for elderly women and men, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/6\">",
"       6",
"      </a>",
"      ]. However, in one report, older black subjects classified as anemic by WHO criteria did not appear to be at risk for adverse events such as mortality and mobility disability [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/7\">",
"       7",
"      </a>",
"      ], suggesting that alternative criteria for anemia might be required for this group (",
"      <a class=\"graphic graphic_table graphicRef79757 \" href=\"UTD.htm?37/22/38251\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=see_link&amp;anchor=H2#H2\">",
"       \"Anemia in the older adult\", section on 'Defining anemia in the older adult'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Volume status",
"    </span>",
"    &nbsp;&mdash;&nbsp;HGB, HCT, and RBC count are all concentrations and dependent on the red blood cell mass (RCM) as well as the plasma volume. As a result, values will be reduced if the RCM is decreased",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if the plasma volume is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/8\">",
"     8",
"    </a>",
"    ]. Three common clinical examples will help make this point:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 70 kg adult with a bleeding peptic ulcer who had a 750 mL hematemesis (ie, 15 percent of a normal total blood volume) within the past 30 minutes may have postural hypotension due to acute volume depletion, but will have normal values for HGB and HCT. Over the ensuing 36 to 48 hours, most of the total blood volume deficit will be repaired by the movement of fluid from the extravascular into the intravascular space. Only at these later times will the HGB and HCT reflect blood loss. However, if the total blood volume deficit is not fully repaired and the patient remains hypovolemic, the HGB and HCT will underestimate the degree of blood loss [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the third trimester of pregnancy the RBC mass and plasma volume are expanded by 25 and 50 percent, respectively, resulting in reductions in HGB, HCT, and RBC count, often to anemic levels (",
"      <a class=\"graphic graphic_figure graphicRef62723 \" href=\"UTD.htm?9/55/10110\">",
"       figure 1",
"      </a>",
"      ). However, according to the RBC mass, such women are polycythemic. The terms \"physiologic\" or \"dilutional\" anemia have been applied to this setting.",
"     </li>",
"     <li>",
"      Patients admitted to the hospital in a volume depleted state may not show abnormally low",
"      <span class=\"nowrap\">",
"       HGB/HCT",
"      </span>",
"      values on initial testing. An underlying anemia may become apparent only after the volume depletion has been corrected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Special populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal ranges (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ) may not be appropriate for all populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients living at high altitude have values higher than those living at sea level [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16042?source=see_link&amp;anchor=H5#H5\">",
"       \"High altitude, air travel, and heart disease\", section on 'Long-term altitude exposure'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A study of blood donors who smoke found a significant and direct correlation between the patients' blood carboxyhemoglobin and HGB values [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/11\">",
"       11",
"      </a>",
"      ]. The same study also found a significant relationship, although of lesser magnitude, between HGB values and the degree of environmental air pollution with carbon monoxide in nonsmoking blood donors. Thus, patients who smoke or have significant exposure to secondary smoke or other sources of carbon monoxide may have hematocrits higher than normal [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/12\">",
"       12",
"      </a>",
"      ], occasionally reaching polycythemic levels. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link&amp;anchor=H23#H23\">",
"       \"Diagnostic approach to the patient with polycythemia\", section on 'Acquired secondary polycythemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Values for HGB in African-Americans of both sexes and all ages are 0.5 to 1.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      lower than values in comparable Caucasian populations [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/3,13-17\">",
"       3,13-17",
"      </a>",
"      ]. Some, but not all, of these differences may be attributable to co-existing iron deficiency anemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alpha thalassemia [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Normal values for a population with a high incidence of chronic disease may be skewed toward anemic levels. Thus, anemia may be difficult to define in countries in which malnutrition, infection (eg, tuberculosis, malaria),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      congenital hematologic disorders (eg, thalassemia) are common. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=see_link&amp;anchor=H1#H1\">",
"       \"Community public health issues and the thalassemic syndromes: Lessons from other countries\", section on 'Introduction'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Older adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia in older adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=see_link\">",
"     \"Anemia in the older adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Athletes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Values in male and female endurance athletes may vary significantly from those in otherwise normal people [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/19-24\">",
"     19-24",
"    </a>",
"    ]. Dilutional anemia secondary to an increased plasma volume [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/20,25\">",
"     20,25",
"    </a>",
"    ], gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/21\">",
"     21",
"    </a>",
"    ], intravascular hemolysis (eg, march hemoglobinuria) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/22\">",
"     22",
"    </a>",
"    ], iron deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], as well as polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/23,25\">",
"     23,25",
"    </a>",
"    ] have all been reported as a consequence of strenuous sports, or the use of performance-enhancing agents, such as androgens and erythropoietin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=see_link&amp;anchor=H22#H22\">",
"     \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Mechanical trauma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21050?source=see_link&amp;anchor=H4#H4\">",
"     \"Use of androgens and other hormones to enhance athletic performance\", section on 'Androgens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     THE RBC LIFE CYCLE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythropoiesis in the adult takes place within the bone marrow under the influence of the stromal framework, cytokines, and the erythroid specific growth factor, erythropoietin (EPO). EPO is a true endocrine hormone produced in the kidney by cells that sense the adequacy of tissue oxygenation relative to the individual's metabolic activity (",
"    <a class=\"graphic graphic_figure graphicRef53916 \" href=\"UTD.htm?34/53/35677\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=see_link\">",
"     \"Regulation of erythropoiesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    EPO enhances the growth and differentiation of the two erythroid progenitors: burst forming units-erythroid (BFU-E) and colony forming units-erythroid (CFU-E) into normoblasts of increasing maturity. When the normoblast extrudes its nucleus to form a red blood cell, it still has a ribosomal network which, when stained supravitally, identifies it as a reticulocyte, a cell still capable of a limited amount of hemoglobin and protein synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reticulocyte retains its ribosomal network (and its staining characteristics) for about four days, of which three days are generally spent in the marrow and one day in the peripheral blood (",
"    <a class=\"graphic graphic_figure graphicRef61552 \" href=\"UTD.htm?32/34/33325\">",
"     figure 3",
"    </a>",
"    ). The resulting mature RBC circulates for 110 to 120 days, after which it is removed from the circulation by macrophages that detect senescent signals, primarily on the RBC membrane, through mechanisms that are poorly understood.",
"   </p>",
"   <p>",
"    Under steady state conditions, the rate of RBC production equals the rate of RBC loss. Assuming, as a first approximation, survival of mature RBC of 100 days, 1 percent of RBCs are removed from the circulation each day. To achieve a constant RBC mass, RBC losses must be replaced with an equal number of reticulocytes during the same time period.",
"   </p>",
"   <p>",
"    Reticulocytes normally survive in the circulation for one day; after this time they lose their reticulum (RNA) and become mature red blood cells. Under steady-state conditions reticulocytes will represent approximately 1 percent of total circulating RBC (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ). Since the normal RBC count is approximately 5",
"    <span class=\"nowrap\">",
"     million/microL",
"    </span>",
"    (5.0 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      12",
"     </sup>",
"     /liter),",
"    </span>",
"    the bone marrow must produce approximately 50,000",
"    <span class=\"nowrap\">",
"     reticulocytes/microL",
"    </span>",
"    of whole blood each day in order to achieve a stable RBC mass. Lesser rates of RBC production, if persistent, lead to anemia.",
"   </p>",
"   <p>",
"    The rate of red cell production increases markedly under the influence of high levels of erythropoietin (EPO). A normal bone marrow replete with iron, folate, and cobalamin can increase erythropoiesis in response to EPO about fivefold in adults and seven- to eightfold in children. Thus, under optimal conditions, steady-state absolute reticulocyte counts as high as",
"    <span class=\"nowrap\">",
"     250,000/microL",
"    </span>",
"    (2.5 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      11",
"     </sup>",
"     /liter)",
"    </span>",
"    are possible in the adult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Reticulocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reticulocytes can be enumerated manually after supravital staining of a blood sample with dyes such as new",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef74294 \" href=\"UTD.htm?35/61/36822\">",
"     picture 2",
"    </a>",
"    ). The normal range (ie, percent of RBC with positive staining) in adults is 0.5 to 2.0 percent (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ). Reticulocytes can be appreciated on a standard blood smear stained with Wright Giemsa as RBC with a blue tint (polychromatophilia) that are larger than mature RBC, with irregular borders and a lack of central pallor (",
"    <a class=\"graphic graphic_picture graphicRef67042 \" href=\"UTD.htm?31/9/31895\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Reticulocytes can be counted with more accuracy via automated blood counters after staining with a fluorescent dye such as thiazole orange, which binds to the RNA of reticulocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H14#H14\">",
"     \"Automated hematology instrumentation\", section on 'Automated counting of reticulocytes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The utility of reticulocyte counting in some settings can be improved by determination of the absolute reticulocyte count, the corrected absolute reticulocyte count,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the reticulocyte production index. This subject is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\", section on 'Reticulocyte response'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL CONSEQUENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms induced by anemia are dependent upon the degree of anemia and the rate at which it has evolved, as well as the oxygen demands of the patient. Symptoms are much less likely with anemia that evolves slowly, because there is time for multiple homeostatic forces to adjust to a reduced oxygen carrying capacity of blood. Before discussing these issues, it is helpful to first review the normal function of red cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Normal red cell function",
"    </span>",
"    &nbsp;&mdash;&nbsp;RBCs carry oxygen linked to hemoglobin from the lungs to tissue capillaries. Oxygen is then released from hemoglobin according to the characteristics of the oxyhemoglobin dissociation curve, with each gram of hemoglobin carrying 1.3 mL of oxygen. Thus, approximately 20",
"    <span class=\"nowrap\">",
"     mL/dL",
"    </span>",
"    (or 20 volumes percent) can be carried by 15",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    of hemoglobin at full saturation. Approximately 5 volumes percent (25 percent of the total) is normally removed by the tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=see_link\">",
"     \"Oxygen delivery and consumption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=see_link&amp;anchor=H11#H11\">",
"     \"Genetic disorders of hemoglobin oxygen affinity\", section on 'Mutations that decrease the affinity of hemoglobin for 2,3-BPG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms related to anemia can result from two factors: decreased oxygen delivery to tissues, and, in patients with acute and marked bleeding, the added insult of hypovolemia. There is some reduction in blood volume but not plasma volume after acute severe hemolysis, due to the fall in RBC mass. In comparison, total blood volume remains normal in anemia due to chronic, low-grade bleeding, since there is ample time for equilibration with the extravascular space and renal retention of salt and water.",
"   </p>",
"   <p>",
"    Symptoms of impaired oxygen delivery reflect the fall in hemoglobin concentration. The extraction of oxygen by the tissues can increase from a baseline of 25 percent to a maximum of about 60 percent in the presence of anemia or hypoperfusion. Thus, normal oxygen delivery of five volumes percent can be maintained by enhanced extraction alone down to a hemoglobin concentration of 8 to 9",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When the added compensation of increases in stroke volume and heart rate (and therefore cardiac output) are included, oxygen delivery can be maintained at rest at a hemoglobin concentration as low as 5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (equivalent to a hematocrit of 15 percent), assuming that the intravascular volume is maintained [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=see_link&amp;anchor=H2#H2\">",
"     \"Indications for red cell transfusion in the adult\", section on 'Physiology of anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms will occur when the hemoglobin concentration falls below this level at rest, at higher hemoglobin concentrations during exertion, or when cardiac compensation is impaired because of underlying heart disease. The primary symptoms include exertional dyspnea, dyspnea at rest, varying degrees of fatigue, and signs and symptoms of the hyperdynamic state, such as bounding pulses, palpitations, and \"roaring in the ears\". More severe anemia may lead to lethargy and confusion and potentially life-threatening complications such as congestive failure, angina, arrhythmia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    myocardial infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/47/9978?source=see_link\">",
"     \"High-output heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anemia induced by acute bleeding is associated with the added complication of intracellular and extracellular volume depletion. The earliest symptoms include easy fatigability, lassitude, and muscle cramps. This can progress to postural dizziness, lethargy, syncope, and, in severe cases, to persistent hypotension, shock, and death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of volume depletion in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although anemia may be associated with complaints of fatigue, this complaint is non-specific, may be present in a number of other conditions, and may be multi-factorial. This subject is discussed in depth separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=see_link\">",
"     \"Approach to the adult patient with fatigue\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11242?source=see_link\">",
"     \"Cancer-related fatigue: Prevalence, screening and clinical assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CAUSES OF ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two general approaches one can use to help identify the cause of anemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A kinetic approach, addressing the mechanism(s) responsible for the fall in hemoglobin concentration",
"     </li>",
"     <li>",
"      A morphologic approach categorizing anemias via alterations in RBC size (ie, mean corpuscular volume) and the reticulocyte response [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Kinetic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia can be caused by one or more of three independent mechanisms: decreased RBC production, increased RBC destruction, and blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Decreased RBC production",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia will ultimately result if the rate of RBC production is less than that of RBC destruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=see_link\">",
"     \"Anemias due to decreased red cell production\"",
"    </a>",
"    .) The more common causes for reduced (effective) RBC production include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lack of nutrients, such as iron, B12, or folate. This can be due to dietary lack, malabsorption (eg, pernicious anemia, sprue), or blood loss (iron deficiency).",
"     </li>",
"     <li>",
"      Bone marrow disorders (eg, aplastic anemia, pure RBC aplasia, myelodysplasia, tumor infiltration)",
"     </li>",
"     <li>",
"      Bone marrow suppression (eg, drugs, chemotherapy, irradiation). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23914?source=see_link\">",
"       \"Hematologic consequences of malignancy: Anemia and bleeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Low levels of trophic hormones which stimulate RBC production, such as EPO (eg, chronic renal failure), thyroid hormone (eg, hypothyroidism), and androgens (eg, hypogonadism).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A rare cause of anemia due to reduced EPO production has been described in patients with autonomic dysfunction and orthostatic hypotension [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link&amp;anchor=H16#H16\">",
"       \"Treatment of orthostatic and postprandial hypotension\", section on 'Erythropoietin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acquired inhibitors of EPO or the EPO receptor have also been described as causes of anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/36\">",
"       36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8265?source=see_link\">",
"       \"Pure red cell aplasia due to anti-erythropoietin antibodies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anemia of chronic",
"      <span class=\"nowrap\">",
"       disease/inflammation,",
"      </span>",
"      associated with infectious, inflammatory, or malignant disorders, is characterized by reduced availability of iron due to decreased absorption from the gastrointestinal tract and decreased release from macrophages, a relative reduction in erythropoietin levels, and a mild reduction in RBC lifespan. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Increased RBC destruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;A RBC life span below 100 days is the operational definition of hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36326?source=see_link\">",
"     \"Red blood cell survival: Normal values and measurement\"",
"    </a>",
"    .) Hemolytic anemia will ensue when the bone marrow is unable to keep up with the need to replace more than about 5 percent of the RBC mass per day, corresponding to a RBC survival of about 20 days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Examples include (",
"    <a class=\"graphic graphic_table graphicRef72394 \" href=\"UTD.htm?20/27/20924\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inherited hemolytic anemias (eg, hereditary spherocytosis, sickle cell disease, thalassemia major)",
"     </li>",
"     <li>",
"      Acquired hemolytic anemias (eg, Coombs'-positive autoimmune hemolytic anemia, thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, malaria)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Blood loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron deficiency in the United States and Western Europe is almost always due to blood loss. Blood loss is the most common cause of anemia and may take any one of a number of forms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obvious bleeding (eg, trauma, melena, hematemesis, menometrorrhagia)",
"     </li>",
"     <li>",
"      Occult bleeding (eg, slowly bleeding ulcer or carcinoma). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11336?source=see_link\">",
"       \"Evaluation of occult gastrointestinal bleeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Induced bleeding (eg, repeated diagnostic testing [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/38\">",
"       38",
"      </a>",
"      ], hemodialysis losses, excessive blood donation)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of situations in which blood loss can occur and not be easily recognized. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Factitious bleeding, secondary to surreptitious blood drawing by the patient (Lasth&eacute;nie de Ferjol syndrome) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/39-41\">",
"       39-41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bleeding during or after surgical procedures may be extremely difficult to quantitate, and is often underestimated",
"     </li>",
"     <li>",
"      Bleeding into the upper thigh",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      retroperitoneal space can often be significant, but may not be clinically obvious. Such patients may, however, have associated symptoms of abdominal pain or mass, groin or hip pain, leg paresis, or hypotension [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/42\">",
"       42",
"      </a>",
"      ]. This complication may be more common in patients taking anticoagulants, even when results of coagulation tests are within the therapeutic range. CT imaging of the abdomen and thigh is often helpful if this is suspected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the loss of RBCs from the body, which the bone marrow must replace, loss of the iron contained in these cells will ultimately lead to iron deficiency, once tissue stores of iron have been depleted. This usually occurs in males and females after losses of &ge;1200 mL and &ge;600 mL, respectively. However, since about 25 percent of menstruant females have absent iron stores, any amount of bleeding will result in anemia in this subpopulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since availability of iron is normally rate-limiting for RBC production, iron deficiency associated with chronic bleeding leads to a reduced marrow response, worsening the degree of anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Morphologic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of anemia can also be classified according to measurement of RBC size, as seen on the blood smear and as reported by automatic cell counter indices [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/43\">",
"     43",
"    </a>",
"    ]. The normal RBC has a volume of 80 to 96 femtoliters (fL, 10[-15] Liter) and a diameter of approximately 7 to 8 microns, equal to that of the nucleus of a small lymphocyte. Thus, RBCs larger than the nucleus of a small lymphocyte on a peripheral smear are considered large or macrocytic, while those that appear smaller are considered small or microcytic (",
"    <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation of the peripheral blood smear\", section on 'Red blood cells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Automatic cell counters estimate RBC volume cell by cell, sampling millions of RBCs in the process. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link\">",
"     \"Mean corpuscular volume\"",
"    </a>",
"    .) Machine output is a value for the mean corpuscular volume of the sample (MCV), as well as an estimate of the dispersion of values about this mean. The latter value is usually given as the coefficient of variation of RBC volumes or RBC distribution width (RDW).",
"   </p>",
"   <p>",
"    An increased RDW indicates the presence of cells of widely differing sizes, but it is not diagnostic of any particular disorder. However, some automatic cell counters have computer programs which \"flag\" for the presence of abnormalities such as anisocytosis (cells of varying size), microcytosis, macrocytosis, and hypochromia (reduced hemoglobin content per cell) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H5#H5\">",
"     \"Automated hematology instrumentation\", section on 'Red cell distribution width'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Macrocytic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macrocytic anemias are characterized by an MCV above 100 fL (femtoliters) (",
"    <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link\">",
"     \"Macrocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An increased MCV is a normal characteristic of reticulocytes (",
"      <a class=\"graphic graphic_picture graphicRef67042 \" href=\"UTD.htm?31/9/31895\">",
"       picture 3",
"      </a>",
"      ). Any condition causing marked reticulocytosis will be associated with an increased MCV.",
"     </li>",
"     <li>",
"      Abnormal nucleic acid metabolism of erythroid precursors (eg, folate or cobalamin deficiency and drugs interfering with nucleic acid synthesis, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"       hydroxyurea",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Abnormal RBC maturation (eg, myelodysplastic syndrome, acute leukemia, LGL leukemia).",
"     </li>",
"     <li>",
"      Other common causes include alcohol abuse, liver disease, and hypothyroidism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A report from a family practice group found macrocytosis in 2 to 4 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/45\">",
"     45",
"    </a>",
"    ], while a study of 1,784 randomly selected elderly people living at home found macrocytosis in 6.3 percent of men and 3.3 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/46\">",
"     46",
"    </a>",
"    ]. The most common causes were alcoholism, liver disease, hypothyroidism, and the megaloblastic anemias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Microcytic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microcytic anemias are characterized by the presence of \"small\" RBCs (ie, MCV below 80 fL). Microcytosis is usually accompanied by a decreased hemoglobin content within the RBC, with parallel reductions in MCV and MCH, producing a hypochromic (low MCH) as well as a microcytic (low MCV) appearance on the blood smear (",
"    <a class=\"graphic graphic_picture graphicRef64267 \" href=\"UTD.htm?21/45/22232\">",
"     picture 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link&amp;anchor=H19#H19\">",
"     \"Mean corpuscular volume\", section on 'Causes of microcytosis'",
"    </a>",
"    .) The following pathologic processes lead to the production of hypochromic microcytic red cells:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reduced iron availability &mdash; severe iron deficiency, the anemia of chronic disease, copper deficiency",
"     </li>",
"     <li>",
"      Reduced heme synthesis &mdash; lead poisoning, congenital or acquired sideroblastic anemia",
"     </li>",
"     <li>",
"      Reduced globin production &mdash; thalassemic states, other hemoglobinopathies",
"     </li>",
"     <li>",
"      Rare disorders due to defects in iron absorption, transport, utilization, and recycling [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/47\">",
"       47",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The three most common causes of microcytosis in clinical practice are iron deficiency, alpha or beta thalassemia minor, and (less often) the anemia of chronic disease (anemia of chronic inflammation). Since all may have hypochromic and microcytic RBCs, other tests must be used to establish the diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Iron deficiency anemia &mdash; Important discriminating features are a low serum ferritin concentration, an increased total iron binding capacity (transferrin), and low serum iron concentration (",
"      <a class=\"graphic graphic_table graphicRef76236 \" href=\"UTD.htm?32/58/33708\">",
"       table 6",
"      </a>",
"      ). For some physicians, proof of this diagnosis requires a clinical response (ie, increase in HGB or HCT) to treatment with iron.",
"      <br/>",
"      <br/>",
"      For physicians making this diagnosis, it is mandatory to determine the cause of the iron deficient state (eg, occult colonic carcinoma, excessive menstrual losses). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"       \"Causes and diagnosis of anemia due to iron deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Alpha or beta thalassemia minor &mdash; Adults with thalassemia are most often heterozygotes for the alpha or beta forms of this syndrome, and may not be anemic. A family history is therefore often negative. Physical examination may reveal splenomegaly; the peripheral smear shows varying degrees of hypochromia, microcytosis, target cells (",
"      <a class=\"graphic graphic_picture graphicRef56728 \" href=\"UTD.htm?29/23/30071\">",
"       picture 5",
"      </a>",
"      ), tear-drop forms, and basophilic stippling (",
"      <a class=\"graphic graphic_picture graphicRef71989 \" href=\"UTD.htm?39/22/40294\">",
"       picture 6",
"      </a>",
"      ). The RBC count may actually be increased and uncomplicated patients have normal or increased iron stores. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=see_link\">",
"       \"Clinical manifestations and diagnosis of the thalassemias\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The diagnosis of beta thalassemia trait can often be made by demonstrating increased levels of hemoglobin A2 on hemoglobin electrophoresis or liquid chromatography (HPLC), while molecular methods are usually required for the diagnosis of mild alpha thalassemia variants [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/48\">",
"       48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=see_link\">",
"       \"Laboratory diagnosis of the hemoglobinopathies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anemia of chronic disease (inflammation) &mdash; The hallmarks of this condition include a low serum iron, low total iron binding capacity (transferrin), and a normal to increased serum ferritin concentration. Although hypochromic and microcytic red cells can be found in these patients, a low MCV is most frequently seen only in patients with hepatoma or renal cell carcinoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Normocytic anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, the mean RBC volume is normal (MCV between 80 and 100 fL) in patients with normocytic anemia (",
"    <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"     table 4",
"    </a>",
"    ). Approach to this extremely large and amorphous category can be narrowed somewhat by examination of the blood smear to determine if there is a subpopulation of RBCs with distinctive size or shape abnormalities which would place the patient in one of the above categories (ie,",
"    <strong>",
"     early",
"    </strong>",
"    microcytic or macrocytic anemia), or by use of the kinetic approach to determine the mechanism(s) underlying the anemia (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Kinetic approach'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H24\">",
"     'Systemic disorders'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Systemic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia may be the first manifestation of a systemic disorder, along with other nonspecific complaints such as fever, weight loss, anorexia, and malaise. Simple laboratory tests may give additional clues toward the underlying disease process. These include abnormalities on the urinalysis or routine chest x-ray, liver or renal function tests, erythrocyte sedimentation rate, serum protein electrophoresis, WBC count and differential, and reduced (or increased) platelet counts. Anemia in older adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=see_link\">",
"     \"Anemia in the older adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Anemia of chronic renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is a common complication of renal disease, and may be multifactorial. This subject is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37434?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of the management of chronic kidney disease in adults\", section on 'Anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Cardiorenal anemia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiorenal anemia syndrome refers to the simultaneous presence of anemia, heart failure, and chronic renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/49\">",
"     49",
"    </a>",
"    ]. This disorder complex is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6486?source=see_link\">",
"     \"Anemia and left ventricular hypertrophy in chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1705?source=see_link\">",
"     \"Impact of anemia in patients with heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     EVALUATION OF THE PATIENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Initial approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is one of the major signs of disease. It is never normal and its cause(s) should always be sought. The history, physical examination, and simple laboratory testing are all useful in evaluating the anemic patient. The workup should be directed towards answering the following questions concerning whether one or more of the major processes leading to anemia may be operative:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the patient bleeding (now or in the past)?",
"     </li>",
"     <li>",
"      Is there evidence for increased RBC destruction (hemolysis)?",
"     </li>",
"     <li>",
"      Is the bone marrow suppressed?",
"     </li>",
"     <li>",
"      Is the patient iron deficient? If so, why?",
"     </li>",
"     <li>",
"      Is the patient deficient in",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      or vitamin B12? If so, why?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of important components to the history in the setting of anemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is there a history of, or symptoms related to, a medical condition which is known to result in anemia (eg, tarry stools in a patient with ulcer-type pain, rheumatoid arthritis, renal failure)?",
"     </li>",
"     <li>",
"      Is the anemia of recent origin, subacute, or lifelong? Recent anemia is almost always an acquired disorder, while lifelong anemia, particularly if accompanied by a positive family history, is likely to be inherited (eg, the hemoglobinopathies, hereditary spherocytosis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient's ethnicity and country of origin may be helpful, as the thalassemias and other hemoglobinopathies are particularly common in patients from the Mediterranean littoral, Middle East, sub-Saharan Africa, and South East Asia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16984?source=see_link\">",
"     \"Introduction to hemoglobin mutations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=see_link\">",
"     \"Community public health issues and the thalassemic syndromes: Lessons from other countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of medications, both prescribed as well as over-the-counter, should be examined in some detail. Specific questions should be asked about the use of alcohol,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , and nonsteroidal antiinflammatory drugs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=see_link\">",
"     \"NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity\"",
"    </a>",
"    .) A past history of blood transfusions, liver disease, treatment of the patient (or other family members) with iron or other hematinics, herbal preparations, and exposure to toxic chemicals in the workplace or environment should also be obtained. An assessment of nutritional status is especially important in the elderly and alcoholics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major aim on physical examination is to find signs of organ or multisystem involvement and to assess the severity of the patient's condition. Thus, the presence or absence of tachycardia, dyspnea, fever, or postural hypotension should be noted. While evaluation for jaundice and pallor is a standard part of the physical examination, such signs may be misinterpreted, and are not as reliable indicators of anemia as once thought.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Pallor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity and specificity for pallor in the palms, nail beds, face, or conjunctivae as a predictor for anemia varies from 19 to 70 percent and 70 to 100 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/51-54\">",
"     51-54",
"    </a>",
"    ], with wide interobserver differences and widely differing conclusions as to the clinical value of the presence or absence of this finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Jaundice",
"    </span>",
"    &nbsp;&mdash;&nbsp;Jaundice may be difficult to detect under artificial (nonfluorescent) lighting conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/53\">",
"     53",
"    </a>",
"    ]. Even under optimal conditions, it may be missed. As an example, in a double blind study involving 62 medical observers at various levels of training, the presence of scleral icterus was detected by 58 percent at a total serum bilirubin concentration of 2.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (42.8",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    and by only 68 percent at a bilirubin concentration of 3.1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (53.0",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/55\">",
"     55",
"    </a>",
"    ]. False positives were mostly attributable to medical students, while false negatives were not related to the level of training.",
"   </p>",
"   <p>",
"    Other items to search for on physical examination include the presence or absence of lymphadenopathy, hepatosplenomegaly, and bone tenderness, especially over the sternum. Bone pain may signify expansion of the marrow space due to infiltrative disease, as in chronic myeloid leukemia, or lytic lesions as in multiple myeloma or metastatic cancer.",
"   </p>",
"   <p>",
"    It is also important to look for signs of other hematologic abnormalities, including petechiae due to thrombocytopenia, ecchymoses, and other signs of bleeding due to abnormalities of coagulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H6#H6\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'Disorders of platelets or blood vessels'",
"    </a>",
"    .) One should also look for signs and symptoms of recurrent infections secondary to neutropenia or immune deficiency states. Stool obtained during the examination should always be tested for the presence of occult blood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11336?source=see_link\">",
"     \"Evaluation of occult gastrointestinal bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial testing of the anemic patient should include a \"complete\" blood count (CBC). This routinely includes HGB, HCT, RBC count, RBC indices, and white blood cell (WBC) count. A WBC differential, platelet count, and reticulocyte count are not part of the routine CBC in some medical centers; these may have to be ordered separately. Thus, to avoid confusion, the clinician should specifically request a CBC with platelets, WBC differential, and reticulocytes.",
"   </p>",
"   <p>",
"    Many automated blood counters report a RBC distribution width (RDW), a measure of the degree of variation in red cell size (red cell volume) (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Morphologic approach'",
"    </a>",
"    above). However, the RDW alone does not indicate why the RBC size varies (anisocytosis) or what the RBC shapes are (poikilocytosis). Some counters will \"flag\" for the presence of specific RBC changes, such as hypochromia or microcytosis, which can be confirmed by examination of the peripheral smear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link\">",
"     \"Automated hematology instrumentation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Accordingly, the blood smear should always be reviewed by an experienced examiner, since many important changes may be missed by the inexperienced observer and may not be detected by automated blood counters [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H44\">",
"     'Blood smear'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link\">",
"     \"Evaluation of the peripheral blood smear\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Red blood cell indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three RBC indices are usually measured by automated blood counters: mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ). The values for MCH and MCHC generally parallel the information obtained from the MCV (ie, larger or smaller RBCs tend to have higher or lower values for MCH, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Mean corpuscular volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal range for MCV is from 80 to 100 femtoliters (fL). The causes of anemia associated with a low (microcytosis) or high (macrocytosis) MCV are discussed above (",
"    <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"     table 4",
"    </a>",
"    ), (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Morphologic approach'",
"    </a>",
"    above). Values in excess of 115 fL are almost exclusively seen in vitamin B12 or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    deficiency. Even higher values can occur as an artifact when cold agglutinins are present, which causes RBCs to go through the counting aperture in doublets or triplets [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/57\">",
"     57",
"    </a>",
"    ]. Warming the specimen (and reagents) to body temperature prior to a repeat count should return the MCV to normal, and confirm the presence of a cold agglutinin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=see_link\">",
"     \"Mean corpuscular volume\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Mean corpuscular hemoglobin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal MCH ranges from 27.5 to 33.2 picograms of hemoglobin per RBC. Low values are seen in iron deficiency and thalassemia, while increased values occur in macrocytosis of any cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Mean corpuscular hemoglobin concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean normal value for the MCHC is 34 grams of hemoglobin per dL of RBCs (340",
"    <span class=\"nowrap\">",
"     g/L",
"    </span>",
"    of RBCs). The 95 percent confidence limits for the MCHC have been variably given (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ), with lower and upper limits of 31 to 33 and 35 to 36, respectively. Low values occur in the same conditions that generate low values for MCV and MCH, while increased values occur almost exclusively in the presence of congenital or acquired spherocytosis or in other congenital hemolytic anemias in which red cells are abnormally desiccated (eg, sickle cell anemia, hemoglobin C disease, xerocytosis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=see_link\">",
"     \"Hereditary spherocytosis: Clinical features; diagnosis; and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14583?source=see_link\">",
"     \"Xerocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Reticulocyte count",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reticulocyte count, either as a percentage of all RBCs, the absolute reticulocyte count, the corrected absolute reticulocyte count, or as the reticulocyte production index, helps to distinguish among the different types of anemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anemia with a high reticulocyte count reflects an increased erythropoietic response to continued hemolysis or blood loss (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Reticulocytes'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      A stable anemia with a low reticulocyte count is strong evidence for deficient production of RBCs (ie, a reduced marrow response to the anemia). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=see_link\">",
"       \"Anemias due to decreased red cell production\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hemolysis or blood loss can be associated with a low reticulocyte count if there is a concurrent disorder that impairs RBC production (eg, infection, prior chemotherapy) (see",
"      <a class=\"local\" href=\"#H50\">",
"       'Multiple causes of anemia'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      A low reticulocyte percentage accompanied by pancytopenia is suggestive of aplastic anemia, while a reticulocyte percentage of zero with normal white blood cell and platelet counts suggests a diagnosis of pure red cell aplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=see_link\">",
"       \"Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/1/17433?source=see_link\">",
"       \"Acquired pure red cell aplasia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     White blood cell count and differential",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low total white blood cell (WBC) count (leukopenia) in a patient with anemia should lead to consideration of bone marrow suppression or replacement, hypersplenism, or deficiencies of cobalamin or folate. In comparison, a high total WBC count (leukocytosis) may reflect the presence of infection, inflammation, or a hematologic malignancy.",
"   </p>",
"   <p>",
"    Clues to the specific abnormality present may be obtained from the WBC differential, which, in conjunction with the total WBC may show increased or decreased absolute numbers of the various cell types in the circulation. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An increased absolute neutrophil count in infection",
"     </li>",
"     <li>",
"      An increased absolute monocyte count in myelodysplasia",
"     </li>",
"     <li>",
"      An increased absolute eosinophil count in certain infections",
"     </li>",
"     <li>",
"      A decreased absolute neutrophil count following chemotherapy",
"     </li>",
"     <li>",
"      A decreased absolute lymphocyte count in HIV infection or following treatment with corticosteroids",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h3\">",
"     Neutrophil hypersegmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophil hypersegmentation (NH) is defined as the presence of &gt;5 percent of neutrophils with five or more lobes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the presence of one or more neutrophils with six or more lobes (",
"    <a class=\"graphic graphic_picture graphicRef70609 \" href=\"UTD.htm?12/47/13046\">",
"     picture 7",
"    </a>",
"    ). This peripheral smear finding, along with macroovalocytic red cells (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 8",
"    </a>",
"    ), is classically associated with impaired DNA synthesis, as seen in disorders of vitamins B12 and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link&amp;anchor=H2126391#H2126391\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, in one study of 100 subjects with normal values for red cell folate and serum cobalamin, NH (as defined above) was seen in 62 and 4 percent of 50 iron deficient and 50 normal subjects, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/58\">",
"     58",
"    </a>",
"    ]. The mechanism for NH in iron deficiency is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Circulating nucleated red blood cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nucleated RBCs (NRBCs) are not normally found in the circulation. They may be present in patients with known hematologic disease (eg, sickle cell disease, thalassemia major, various hemolytic anemias after splenectomy), or as a part of the leukoerythroblastic pattern seen in patients with bone marrow replacement (",
"    <a class=\"graphic graphic_picture graphicRef68110 \" href=\"UTD.htm?29/43/30390\">",
"     picture 9",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In patients without known hematologic disease, NRBCs may reflect the presence of a life-threatening disease, such as sepsis or severe heart failure. In one study of 4173 patients seen at a university clinic, NRBCs were seen at least once in 7.5 percent of all patients; the highest incidence (20 percent) occurred in patients from the general surgery and trauma intensive care unit [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/59\">",
"     59",
"    </a>",
"    ]. In-hospital mortality was 1.2 and 21.1 percent in those without or with NRBCs, respectively, and increased with increasing concentration of NRBCs. In patients who died, nucleated RBCs were detected for the first time at a median of 13 days before death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Platelet count",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in the platelet count often provide important diagnostic information. Thrombocytopenia occurs in a variety of disorders associated with anemia, including hypersplenism, marrow involvement with malignancy, autoimmune platelet destruction (either idiopathic or drug-related), sepsis, or folate or cobalamin deficiency.",
"   </p>",
"   <p>",
"    High platelet counts, in comparison, may reflect myeloproliferative disease, chronic iron deficiency, and inflammatory, infectious, or neoplastic disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=see_link\">",
"     \"Approach to the patient with thrombocytosis\"",
"    </a>",
"    .) Changes in platelet morphology (giant platelets, degranulated platelets) also may be important, suggesting myeloproliferative or myelodysplastic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Pancytopenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of anemia, thrombocytopenia, and neutropenia is termed pancytopenia. The presence of severe pancytopenia narrows the differential diagnosis to disorders such as aplastic anemia, folate or cobalamin deficiency, or hematologic malignancy (eg, acute myeloid leukemia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link\">",
"     \"Approach to the adult patient with thrombocytopenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild degrees of pancytopenia may be seen in patients with splenomegaly and splenic trapping of circulating cellular elements. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=see_link&amp;anchor=H28#H28\">",
"     \"Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism\", section on 'Extravascular nonimmune hemolysis due to hypersplenism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Blood smear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many clinicians rely on the above RBC parameters and the RDW in evaluating a patient with anemia. However, the RDW is, as noted above, of limited utility, and examination of the peripheral blood smear provides information not otherwise available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link\">",
"     \"Evaluation of the peripheral blood smear\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As examples, the automated counter may miss the red cell fragmentation (\"helmet cells\", schistocytes) of microangiopathic hemolysis (",
"    <a class=\"graphic graphic_picture graphicRef70851 \" href=\"UTD.htm?37/50/38694\">",
"     picture 10",
"    </a>",
"    ), microspherocytes in autoimmune hemolytic anemia, teardrop RBCs in myeloid metaplasia (",
"    <a class=\"graphic graphic_picture graphicRef55274 \" href=\"UTD.htm?42/37/43606\">",
"     picture 11",
"    </a>",
"    ), a leukoerythroblastic pattern with bone marrow replacement (",
"    <a class=\"graphic graphic_picture graphicRef68110 \" href=\"UTD.htm?29/43/30390\">",
"     picture 9",
"    </a>",
"    ), the \"bite cells\" in oxidative hemolysis (",
"    <a class=\"graphic graphic_picture graphicRef73790 \" href=\"UTD.htm?25/28/26054\">",
"     picture 12",
"    </a>",
"    ), or RBC parasites such as malaria or babesiosis (",
"    <a class=\"graphic graphic_picture graphicRef77517 \" href=\"UTD.htm?6/11/6327\">",
"     picture 13",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link\">",
"     \"Evaluation of the peripheral blood smear\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Serial evaluation of hemoglobin and hematocrit",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measuring the rate of fall of the patient's HGB or HCT often provides helpful diagnostic information. Suppose the HGB concentration has fallen from 15 to 10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in one week. If this were due to total cessation of RBC production (ie, a reticulocyte count of zero) and if the rate of RBC destruction were normal (1",
"    <span class=\"nowrap\">",
"     percent/day),",
"    </span>",
"    the HGB concentration would have fallen by 7 percent over seven days, resulting a decline of 1.05",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (0.07 x 15). The greater fall in HGB in this patient (5",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    indicates that marrow suppression cannot be the sole cause of the anemia and that blood loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased RBC destruction must be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h2\">",
"     Evaluation for iron deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;More complete evaluation for iron deficiency is indicated when the history (menometrorrhagia, symptoms of peptic ulcer disease) and preliminary laboratory data (low MCV, low MCH, high RDW, increased platelet count) support this diagnosis. In this setting, the plasma levels of iron, iron binding capacity (transferrin), transferrin saturation, and ferritin should be measured (",
"    <a class=\"graphic graphic_table graphicRef76236 \" href=\"UTD.htm?32/58/33708\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Evaluation for hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemolysis should be considered if the patient has a rapid fall in hemoglobin concentration, reticulocytosis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abnormally shaped RBC (especially spherocytes or fragmented RBCs) on the peripheral smear (",
"    <a class=\"graphic graphic_table graphicRef72394 \" href=\"UTD.htm?20/27/20924\">",
"     table 3",
"    </a>",
"    ). The usual ancillary findings of hemolysis are an increase in the serum lactate dehydrogenase (LDH) and indirect bilirubin concentrations and a reduction in the serum haptoglobin concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combination of an increased LDH and reduced haptoglobin is 90 percent specific for diagnosing hemolysis, while the combination of a normal LDH and a serum haptoglobin greater than 25",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    is 92 percent sensitive for ruling out hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h3\">",
"     Intravascular hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum or plasma hemoglobin and urinary hemosiderin should be measured if intravascular hemolysis is a consideration, as with paroxysmal nocturnal hemoglobinuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link&amp;anchor=H21#H21\">",
"     \"Approach to the diagnosis of hemolytic anemia in the adult\", section on 'Testing for intravascular hemolysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h2\">",
"     Bone marrow examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the bone marrow generally offers little additional diagnostic information in the more common forms of anemia. If erythropoiesis is increased in response to the anemia, the bone marrow will show erythroid hyperplasia, a nonspecific finding. Similarly, although the absence of stainable iron in the bone marrow had previously been considered the \"gold standard\" for the diagnosis of iron deficiency, this diagnosis is usually established by laboratory tests alone (",
"    <a class=\"graphic graphic_table graphicRef76236 \" href=\"UTD.htm?32/58/33708\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H23#H23\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Estimation of iron stores'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for examination of the bone marrow in anemic patients include pancytopenia or the presence of abnormal cells in the circulation, such as blast forms. Such patients may have aplastic anemia, myelodysplasia, marrow replacement with malignancy, or a myeloproliferative disease. Other findings that may be seen in the marrow in anemic patients include megaloblastic erythropoiesis (folate or cobalamin deficiency), absence of recognizable RBC precursors (pure RBC aplasia), vacuolization of RBC precursors (alcohol or drug-induced anemia), and increased iron-laden RBC precursors (the sideroblastic anemias). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=see_link\">",
"     \"Evaluation of bone marrow aspirate smears\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50\">",
"    <span class=\"h2\">",
"     Multiple causes of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is common in pediatric practice for anemia to be caused by a single identifiable disorder. In comparison, multiple causes are frequently present in adults, particularly the elderly. Common examples are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A patient with gastrointestinal bleeding secondary to colon cancer may also have the anemia of chronic disease, leading to a blunted reticulocyte response. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A patient with a chronic hemolytic anemia (eg, sickle cell anemia, hereditary spherocytosis) may develop worsening anemia following acute infection, particularly with parvovirus B19, which may blunt or temporarily ablate erythropoiesis and the reticulocyte response [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/62\">",
"       62",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/1/17433?source=see_link&amp;anchor=H2#H2\">",
"       \"Acquired pure red cell aplasia\", section on 'Etiology and pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A patient with autoimmune hemolytic anemia may develop worsening anemia from gastrointestinal blood loss following treatment with corticosteroids.",
"     </li>",
"     <li>",
"      Anemia, renal failure, and congestive failure are often found together, a condition that has been termed \"cardio-renal anemia syndrome.\" Treatment of the anemia may improve both the renal failure and heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?28/46/29418/abstract/63\">",
"       63",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6486?source=see_link\">",
"       \"Anemia and left ventricular hypertrophy in chronic kidney disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Algorithms for diagnosing anemia (",
"    <a class=\"graphic graphic_algorithm graphicRef54266 \" href=\"UTD.htm?6/61/7123\">",
"     algorithm 1",
"    </a>",
"    ) generally fail in the presence of more than one cause. Under such circumstances, the clinician is advised to obtain answers separately to each of the questions outlined above (see",
"    <a class=\"local\" href=\"#H28\">",
"     'Initial approach'",
"    </a>",
"    above), to examine the peripheral blood smear for abnormal red blood cell populations (eg, microcytes, macrocytes, spherocytes, schistocytes), and proceed from that point.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/15/20721?source=see_link\">",
"       \"Patient information: Anemia of chronic disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=see_link\">",
"       \"Patient information: Anemia caused by low iron (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial approach to the diagnosis of anemia is to perform a complete history and physical examination along with a review of the results of a complete blood count (CBC) with white blood cell differential, platelet count, reticulocyte count, and an examination of the peripheral blood smear (",
"    <a class=\"graphic graphic_table graphicRef64238 \" href=\"UTD.htm?41/52/42827\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Evaluation of the patient'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A HGB &lt;13.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;135",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    or a HCT &lt;41.0 percent represents anemia in men; a value &lt;12.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (&lt;120",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    or &lt;36.0 percent, respectively, represents anemia in women. Differences may also exist between races, in older adults, and in athletes. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'Special populations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23639943\">",
"    <span class=\"h2\">",
"     Diagnostic approach: morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the morphologic approach, the anemia is first classified via the red cell size (ie, mean corpuscular volume, MCV), which is part of the CBC (",
"    <a class=\"graphic graphic_algorithm graphicRef54266 \" href=\"UTD.htm?6/61/7123\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Microcytic anemias are associated with an MCV below 80 fL. The most commonly seen causes are iron deficiency (",
"      <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef76236 \" href=\"UTD.htm?32/58/33708\">",
"       table 6",
"      </a>",
"      ), thalassemia, and the anemia of (chronic) inflammation (see",
"      <a class=\"local\" href=\"#H22\">",
"       'Microcytic anemia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H46\">",
"       'Evaluation for iron deficiency'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Macrocytic anemias are characterized by an MCV above 100 fL (",
"      <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef66772 \" href=\"UTD.htm?9/47/9980\">",
"       table 5",
"      </a>",
"      ). The most common causes include alcoholism, liver disease,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      and vitamin B12 deficiency, and myelodysplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link&amp;anchor=H12#H12\">",
"       \"Macrocytosis\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The MCV is between 80 and 100 fL in patients with normocytic anemia (",
"      <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"       table 4",
"      </a>",
"      ). This is an extremely large and amorphous category, which can be narrowed somewhat by examination of the blood smear to determine if there is a small population of red cells with distinctive size or shape abnormalities which would place the patient in one of the above categories (ie, early microcytic or macrocytic anemia), or would raise suspicion of an acute or chronic hemolytic state (eg, spherocytes, sickle forms, ovalocytes).",
"     </li>",
"     <li>",
"      Hemolysis may have been suspected from the patient's history, physical examination, or examination of the peripheral blood smear (eg, sudden onset of anemia, jaundice, splenomegaly, presence of spherocytes or schistocytes or other red cell shape changes) (see",
"      <a class=\"local\" href=\"#H27\">",
"       'Evaluation of the patient'",
"      </a>",
"      above). It is confirmed by the finding of increased levels of indirect bilirubin and lactate dehydrogenase, and low levels of haptoglobin (",
"      <a class=\"graphic graphic_table graphicRef72394 \" href=\"UTD.htm?20/27/20924\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H47\">",
"       'Evaluation for hemolysis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=see_link&amp;anchor=H16#H16\">",
"       \"Approach to the diagnosis of hemolytic anemia in the adult\", section on 'Diagnostic approach'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of abnormal cells in the circulation (eg, nucleated RBCs, blasts, atypical mononuclear cells)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abnormal increases or decreases in absolute counts for granulocytes, lymphocytes, monocytes, or platelets (",
"      <a class=\"graphic graphic_algorithm graphicRef54266 \" href=\"UTD.htm?6/61/7123\">",
"       algorithm 1",
"      </a>",
"      ) suggests that the anemia is part of a more complex hematologic disorder (eg, leukemia, aplastic anemia, myelodysplastic syndrome, myeloproliferative disorder). Consultation with a hematologist would be appropriate at this point.",
"     </li>",
"     <li>",
"      Anemia may be the first manifestation of a systemic disorder (",
"      <a class=\"graphic graphic_table graphicRef53867 \" href=\"UTD.htm?28/27/29116\">",
"       table 4",
"      </a>",
"      ), along with other nonspecific complaints such as fever, weight loss, anorexia, and malaise. Simple laboratory tests may give additional clues toward the underlying disease process. These include abnormalities on the urinalysis or routine chest x-ray, elevated serum creatinine, abnormal liver function tests, and increased erythrocyte sedimentation rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23639954\">",
"    <span class=\"h2\">",
"     Diagnostic approach: kinetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the kinetic approach, the following three questions are asked in order to determine the mechanism(s) causing the anemia. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Causes of anemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is there evidence for decreased red cell production? (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Decreased RBC production'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Is there evidence for increased red cell destruction (hemolysis)? (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Increased RBC destruction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Is there a history of bleeding? (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Blood loss'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/1\">",
"      Causey MW, Miller S, Foster A, et al. Validation of noninvasive hemoglobin measurements using the Masimo Radical-7 SpHb Station. Am J Surg 2011; 201:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/2\">",
"      Shamir MY, Avramovich A, Smaka T. The current status of continuous noninvasive measurement of total, carboxy, and methemoglobin concentration. Anesth Analg 2012; 114:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/3\">",
"      Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107:1747.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Nutritional anaemias: Report of a WHO scientific group. Geneva, Switzerland: World Health Organization; 1968.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/5\">",
"      Rodgers GM 3rd, Becker PS, Bennett CL, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 2008; 6:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/6\">",
"      Culleton BF, Manns BJ, Zhang J, et al. Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107:3841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/7\">",
"      Patel KV, Harris TB, Faulhaber M, et al. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood 2007; 109:4663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/8\">",
"      Jacob G, Raj SR, Ketch T, et al. Postural pseudoanemia: posture-dependent change in hematocrit. Mayo Clin Proc 2005; 80:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/9\">",
"      Valeri CR, Dennis RC, Ragno G, et al. Limitations of the hematocrit level to assess the need for red blood cell transfusion in hypovolemic anemic patients. Transfusion 2006; 46:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/10\">",
"      Ru&iacute;z-Arg&uuml;elles GJ. Altitude above sea level as a variable for definition of anemia. Blood 2006; 108:2131; author reply 2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/11\">",
"      Stewart RD, Baretta ED, Platte LR, et al. Carboxyhemoglobin levels in American blood donors. JAMA 1974; 229:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/12\">",
"      Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990; 264:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/13\">",
"      Garn SM, Ryan AS, Abraham S, Owen G. Suggested sex and age appropriate values for \"low\" and \"deficient\" hemoglobin levels. Am J Clin Nutr 1981; 34:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/14\">",
"      Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med 1991; 151:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/15\">",
"      Perry GS, Byers T, Yip R, Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr 1992; 122:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/16\">",
"      Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006; 119:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/17\">",
"      Robins EB, Blum S. Hematologic reference values for African American children and adolescents. Am J Hematol 2007; 82:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/18\">",
"      Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 2005; 106:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/19\">",
"      Dufaux B, Hoederath A, Streitberger I, et al. Serum ferritin, transferrin, haptoglobin, and iron in middle- and long-distance runners, elite rowers, and professional racing cyclists. Int J Sports Med 1981; 2:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/20\">",
"      Shaskey DJ, Green GA. Sports haematology. Sports Med 2000; 29:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/21\">",
"      Rudzki SJ, Hazard H, Collinson D. Gastrointestinal blood loss in triathletes: it's etiology and relationship to sports anaemia. Aust J Sci Med Sport 1995; 27:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/22\">",
"      Selby GB, Eichner ER. Endurance swimming, intravascular hemolysis, anemia, and iron depletion. New perspective on athlete's anemia. Am J Med 1986; 81:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/23\">",
"      Berglund B. High-altitude training. Aspects of haematological adaptation. Sports Med 1992; 14:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/24\">",
"      Kehat I, Shupak A, Goldenberg I, Shoshani O. Long-term hematological effects in Special Forces trainees. Mil Med 2003; 168:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/25\">",
"      Sawka MN, Convertino VA, Eichner ER, et al. Blood volume: importance and adaptations to exercise training, environmental stresses, and trauma/sickness. Med Sci Sports Exerc 2000; 32:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/26\">",
"      Greydanus DE, Patel DR. The female athlete. Before and beyond puberty. Pediatr Clin North Am 2002; 49:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/27\">",
"      Beard J, Tobin B. Iron status and exercise. Am J Clin Nutr 2000; 72:594S.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical approach to anemia. In: Hematology in Clinical Practice, Hillman RS, Ault KA (Eds), McGraw-Hill, New York 2001. p.29.",
"    </li>",
"    <li>",
"     Erslev AJ. Reticulocyte enumeration. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, et al. (Eds), McGraw-Hill, New York 1995. p.L28.",
"    </li>",
"    <li>",
"     Normal erythropoiesis. In: Hematology in Clinical Practice, Hillman RS, Ault KA (Eds), McGraw-Hill, New York 2001. p.3.",
"    </li>",
"    <li>",
"     Jones J. Transfusion in oligemia. In: Blood Transfusion in Clinical Medicine, 8th ed, Mollison PL, Engelfriet CP, Contreras M (Eds), Blackwell, Oxford 1987. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/32\">",
"      Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/33\">",
"      Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc 2003; 78:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/34\">",
"      Gomes ME, Deinum J, Timmers HJ, Lenders JW. Occam's razor; anaemia and orthostatic hypotension. Lancet 2003; 362:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/35\">",
"      Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995; 5:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/36\">",
"      Hara A, Furuichi K, Higuchi M, et al. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. Br J Haematol 2013; 160:244.",
"     </a>",
"    </li>",
"    <li>",
"     Mohandas N, Schrier SL. Mechanisms of red cell destruction in hemolytic anemias. In: The Hereditary Hemolytic Anemias, Mentzer WC, Wagner GM (Eds), Churchill Livingstone, New York 1989. p.391.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/38\">",
"      Salisbury AC, Reid KJ, Alexander KP, et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med 2011; 171:1646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/39\">",
"      Karamanou M, Androutsos G. Lasth&eacute;nie de Ferjol syndrome: a rare disease with fascinating history. Intern Med J 2010; 40:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/40\">",
"      Piccillo GA, Miele L, Mondati EG, et al. Eighteen needles to forget...an unnamed past. J Forensic Leg Med 2007; 14:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/41\">",
"      Farcy L, Fillet G, Couvreur V, Triffaux JM. [Anemia by self-injury: the Lasthenie de Ferjol syndrome]. Rev Med Liege 2005; 60:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/42\">",
"      Gonz&aacute;lez C, Penado S, Llata L, et al. The clinical spectrum of retroperitoneal hematoma in anticoagulated patients. Medicine (Baltimore) 2003; 82:257.",
"     </a>",
"    </li>",
"    <li>",
"     Bull BS, Breton-Gorius J. Morphology of the erythron. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, Kipps TJ (Eds), McGraw-Hill, New York 1995. p.349.",
"    </li>",
"    <li>",
"     Morris MW, Williams WJ, Nelson DA. Automated blood cell counting. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, et al. (Eds), McGraw-Hill, New York 1995. p.L3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/45\">",
"      Davenport J. Macrocytic anemia. Am Fam Physician 1996; 53:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/46\">",
"      Inelmen EM, D'Alessio M, Gatto MR, et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study. Aging (Milano) 1994; 6:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/47\">",
"      Camaschella C. How I manage patients with atypical microcytic anaemia. Br J Haematol 2013; 160:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/48\">",
"      Bergstrome JA, Poon A. Evaluation of a single-tube multiplex polymerase chain reaction screen for detection of common alpha-thalassemia genotypes in a clinical laboratory. Am J Clin Pathol 2002; 118:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/49\">",
"      Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 2009; 53:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/50\">",
"      Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc 2001; 76:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/51\">",
"      Nardone DA, Roth KM, Mazur DJ, McAfee JH. Usefulness of physical examination in detecting the presence or absence of anemia. Arch Intern Med 1990; 150:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/52\">",
"      Gj&oslash;rup T, Bugge PM, Hendriksen C, Jensen AM. A critical evaluation of the clinical diagnosis of anemia. Am J Epidemiol 1986; 124:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/53\">",
"      Hung OL, Kwon NS, Cole AE, et al. Evaluation of the physician's ability to recognize the presence or absence of anemia, fever, and jaundice. Acad Emerg Med 2000; 7:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/54\">",
"      Sheth TN, Choudhry NK, Bowes M, Detsky AS. The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med 1997; 12:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/55\">",
"      Ruiz MA, Saab S, Rickman LS. The clinical detection of scleral icterus: observations of multiple examiners. Mil Med 1997; 162:560.",
"     </a>",
"    </li>",
"    <li>",
"     Williams WJ, Morris MW, Nelson DA. Examination of the blood. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, et al. (Eds), McGraw-Hill, New York 1995. p.8.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/57\">",
"      Weiss GB, Bessman JD. Spurious automated red cell values in warm autoimmune hemolytic anemia. Am J Hematol 1984; 17:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/58\">",
"      Westerman DA, Evans D, Metz J. Neutrophil hypersegmentation in iron deficiency anaemia: a case-control study. Br J Haematol 1999; 107:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/59\">",
"      Stachon A, Sondermann N, Imohl M, Krieg M. Nucleated red blood cells indicate high risk of in-hospital mortality. J Lab Clin Med 2002; 140:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/60\">",
"      Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980; 243:1909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/61\">",
"      Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 1982; 2:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/62\">",
"      Serjeant GR, Serjeant BE, Thomas PW, et al. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993; 341:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/46/29418/abstract/63\">",
"      Silverberg DS, Wexler D, Iaina A, Schwartz D. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 2006; 26:296.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7133 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-D4E9CFABE8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29418=[""].join("\n");
var outline_f28_46_29418=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H52\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal range",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Volume status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Special populations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Older adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      THE RBC LIFE CYCLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Reticulocytes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL CONSEQUENCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Normal red cell function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CAUSES OF ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Kinetic approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Decreased RBC production",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Increased RBC destruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Blood loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Morphologic approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Macrocytic anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Microcytic anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Normocytic anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Systemic disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Anemia of chronic renal disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Cardiorenal anemia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      EVALUATION OF THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Initial approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Pallor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Jaundice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Red blood cell indices",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Mean corpuscular hemoglobin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Mean corpuscular hemoglobin concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Reticulocyte count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      White blood cell count and differential",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      - Neutrophil hypersegmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Circulating nucleated red blood cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Platelet count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Pancytopenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Blood smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Serial evaluation of hemoglobin and hematocrit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      Evaluation for iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Evaluation for hemolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      - Intravascular hemolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      Bone marrow examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H50\">",
"      Multiple causes of anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H52\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23639943\">",
"      Diagnostic approach: morphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23639954\">",
"      Diagnostic approach: kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7133\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7133|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?6/61/7123\" title=\"algorithm 1\">",
"      Evaluation of anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7133|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/55/10110\" title=\"figure 1\">",
"      Physiologic anemia of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/53/35677\" title=\"figure 2\">",
"      Serum EPO and anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/34/33325\" title=\"figure 3\">",
"      Reticulocyte shift",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7133|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/49/21265\" title=\"picture 1\">",
"      Manual hematocrit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/61/36822\" title=\"picture 2\">",
"      Reticulocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/9/31895\" title=\"picture 3\">",
"      Polychromatophilia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/45/22232\" title=\"picture 4\">",
"      Microcytic hypochromic anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/23/30071\" title=\"picture 5\">",
"      Beta thalassemia trait",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/22/40294\" title=\"picture 6\">",
"      Basophilic stippling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/47/13046\" title=\"picture 7\">",
"      Hypersegmented neutrophil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/47/4854\" title=\"picture 8\">",
"      Megaloblastic smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/43/30390\" title=\"picture 9\">",
"      Leukoerythroblastic blood smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/50/38694\" title=\"picture 10\">",
"      Schistocytes on peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/37/43606\" title=\"picture 11\">",
"      Tear drop cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/28/26054\" title=\"picture 12\">",
"      Heinz body hemolytic anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/11/6327\" title=\"picture 13\">",
"      Malaria trophozoites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7133|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/52/42827\" title=\"table 1\">",
"      Normal red cell values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/22/38251\" title=\"table 2\">",
"      Anemia in elderly adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/27/20924\" title=\"table 3\">",
"      Causes intra- and extra-vascular hemolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/27/29116\" title=\"table 4\">",
"      Causes of anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/47/9980\" title=\"table 5\">",
"      Causes of macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/58/33708\" title=\"table 6\">",
"      Lab tests in iron deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/1/17433?source=related_link\">",
"      Acquired pure red cell aplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6486?source=related_link\">",
"      Anemia and left ventricular hypertrophy in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=related_link\">",
"      Anemia in the older adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/20/38213?source=related_link\">",
"      Anemias due to decreased red cell production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=related_link\">",
"      Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=related_link\">",
"      Approach to the adult patient with a bleeding diathesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23111?source=related_link\">",
"      Approach to the adult patient with fatigue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43880?source=related_link\">",
"      Approach to the child with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18489?source=related_link\">",
"      Approach to the diagnosis of hemolytic anemia in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24681?source=related_link\">",
"      Approach to the patient with thrombocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=related_link\">",
"      Automated hematology instrumentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11242?source=related_link\">",
"      Cancer-related fatigue: Prevalence, screening and clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38106?source=related_link\">",
"      Clinical manifestations and diagnosis of the thalassemias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41783?source=related_link\">",
"      Community public health issues and the thalassemic syndromes: Lessons from other countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=related_link\">",
"      Diagnostic approach to the patient with polycythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=related_link\">",
"      Evaluation of bone marrow aspirate smears",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11336?source=related_link\">",
"      Evaluation of occult gastrointestinal bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=related_link\">",
"      Evaluation of the peripheral blood smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9194?source=related_link\">",
"      Extrinsic nonimmune hemolytic anemia due to mechanical damage: Fragmentation hemolysis and hypersplenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/4/42055?source=related_link\">",
"      Genetic disorders of hemoglobin oxygen affinity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23914?source=related_link\">",
"      Hematologic consequences of malignancy: Anemia and bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/1/20506?source=related_link\">",
"      Hereditary spherocytosis: Clinical features; diagnosis; and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/42/16042?source=related_link\">",
"      High altitude, air travel, and heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/47/9978?source=related_link\">",
"      High-output heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1705?source=related_link\">",
"      Impact of anemia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16984?source=related_link\">",
"      Introduction to hemoglobin mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/968?source=related_link\">",
"      Laboratory diagnosis of the hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35543?source=related_link\">",
"      Mean corpuscular volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6745?source=related_link\">",
"      NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37434?source=related_link\">",
"      Overview of the management of chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=related_link\">",
"      Oxygen delivery and consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=related_link\">",
"      Patient information: Anemia caused by low iron (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/15/20721?source=related_link\">",
"      Patient information: Anemia of chronic disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8265?source=related_link\">",
"      Pure red cell aplasia due to anti-erythropoietin antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/30/36326?source=related_link\">",
"      Red blood cell survival: Normal values and measurement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20650?source=related_link\">",
"      Regulation of erythropoiesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21050?source=related_link\">",
"      Use of androgens and other hormones to enhance athletic performance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/15/14583?source=related_link\">",
"      Xerocytosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_46_29419="HP classification system";
var content_f28_46_29419=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61909&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61909&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification systems for hypersensitivity pneumonitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Classical classification",
"       </td>",
"       <td class=\"subtitle1\">",
"        Boyd classification",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cormier classification",
"       </td>",
"       <td class=\"subtitle1\">",
"        Selman classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute",
"       </td>",
"       <td>",
"        Acute progressive",
"       </td>",
"       <td rowspan=\"2\">",
"        Active",
"       </td>",
"       <td>",
"        Active nonprogressive and intermittent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subacute",
"       </td>",
"       <td>",
"        Acute intermittent nonprogressive",
"       </td>",
"       <td>",
"        Acute progressive and intermittent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Chronic",
"       </td>",
"       <td rowspan=\"3\">",
"        Nonacute",
"       </td>",
"       <td rowspan=\"3\">",
"        Residual",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Chronic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonprogressive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Progressive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        J Allergy Clin Immunol 1989; 84:839",
"       </td>",
"       <td>",
"        Clin Allergy 1982; 12(Suppl):53",
"       </td>",
"       <td>",
"        Clin Pulm Med 1996; 3:72",
"       </td>",
"       <td>",
"        Interstitial Lung Disease, Schwarz MI, King TE Jr, (Eds), 5th ed, Shelton, CT, People's Medical Publishing House, 2011",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29419=[""].join("\n");
var outline_f28_46_29419=null;
var title_f28_46_29420="Methamphetamine structure";
var content_f28_46_29420=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Methamphetamine structure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 174px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29420=[""].join("\n");
var outline_f28_46_29420=null;
var title_f28_46_29421="rMPI CP diag";
var content_f28_46_29421=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Myocardial perfusion imaging in acute chest pain: Diagnostic studies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sens, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Spec, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        PPV, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        NPV, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        End point",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wackers FJ, Sokole EB, Samson G, et al. Value and limitations of thallium-201 scintigraphy in the acute phase of myocardial infarction. N Engl J Med 1976; 295:1.",
"       </td>",
"       <td>",
"        203",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilodeau L, Theroux P, Gregoire J, et al. Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991; 18:1684.",
"       </td>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        96",
"       </td>",
"       <td>",
"        79",
"       </td>",
"       <td>",
"        86",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        CAD by angiography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Varetto T, Cantalupi D, Altieri A, Orlandi C. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993; 22:1804.",
"       </td>",
"       <td rowspan=\"2\">",
"        64",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        92",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        CAD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Hilton TC, Thompson RC, Williams HJ, et al. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994; 23:1016.",
"       </td>",
"       <td rowspan=\"2\">",
"        102",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        78",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        99",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        83",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        99",
"       </td>",
"       <td>",
"        All events",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997; 29:116.",
"       </td>",
"       <td rowspan=\"2\">",
"        438",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        78",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        82",
"       </td>",
"       <td>",
"        83",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        MI, revascularization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Kontos MC, Jesse RL, Schmidt KL, et al. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1997; 30:976.",
"       </td>",
"       <td rowspan=\"2\">",
"        532",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        71",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        99",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        81",
"       </td>",
"       <td>",
"        76",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        95",
"       </td>",
"       <td>",
"        MI, revascualrization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998; 31:1011.",
"       </td>",
"       <td>",
"        357",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        99",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Duca MD, Giri S, Wu AH, et al. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol 1999; 6:570.",
"       </td>",
"       <td rowspan=\"2\">",
"        75",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        81",
"       </td>",
"       <td>",
"        CAD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kosnik JW, Zalenski RJ, Shamsa F, et al. Resting sestamibi imaging for the prognosis of low-risk chest pain. Acad Emerg Med 1999; 6:99.",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        71",
"       </td>",
"       <td>",
"        92",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        MI, revascularization, cardiac death",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Sens: sensitivity; Spec: specificity; PPV: positive predictive value; NPV: negative predictive value; MI: myocardial infarction; CAD: objective evidence for coronary artery disease.",
"    </div>",
"    <div class=\"reference\">",
"     Soman P, Udelson JE. Imaging patients with chest pain in the emergency department. In: Nuclear Cardiology: State of the art and future directions, 3rd ed, Mosby, Philadelphia 2005.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29421=[""].join("\n");
var outline_f28_46_29421=null;
var title_f28_46_29422="Rey-Osterrieth complex figure";
var content_f28_46_29422=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F53426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F53426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Rey-Osterrieth complex figure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 419px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subjects are asked to draw this diagram, first as a copy, then from memory.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schiffer RB, Lajara-Nanson WA. Neuropsychiatric examination. In: Neuropsychiatry, 2nd ed, Schiffer RB, Rao SM, Fogel BS (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29422=[""].join("\n");
var outline_f28_46_29422=null;
var title_f28_46_29423="Abdominal paracentesis sites";
var content_f28_46_29423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Abdominal paracentesis sites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 411px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abdominal wall anatomy showing the author's preferred site for abdominal paracentesis and the inferior epigastric artery, which should be avoided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_46_29423=[""].join("\n");
var outline_f28_46_29423=null;
